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Abstract 
     About 25% of corneal grafts will fail within five years (mainly due to T-cell-
mediated rejection) and the ex-vivo delivery of immunomodulatory genes to the cornea 
is one attractive method to improve survival rates. Early efforts focused on the use of 
viral vectors, whose toxicity and immunogenicity remain formidable barriers. Here, we 
developed an arginine-rich oligopeptide featuring a novel tri-block design. Each block 
served a specific purpose – DNA binding, endosomal escape and cell membrane 
penetration – and was systematically optimised. The peptides could effectively bind and 
protect DNA from physical and enzymatic degradation. Since the corneal endothelium 
is an important target for therapy, mouse corneal endothelial cells (MCEC) were chosen 
for initial in-vitro testing. The peptides depended heavily on cell surface heparan sulfate 
and utilised multiple endocytosis pathways to gain entry into MCEC. Importantly, they 
mediated indolamine 2,3-dioxygenase (IDO) mRNA and protein expression efficiently 
in both MCEC and murine corneas. IDO catalyses the biodegradation of tryptophan 
which T-lymphocytes sensitively require for growth. Hence, IDO over-expression in the 
cornea can prolong allograft survival by locally suppressing T-cell activity. We 
demonstrated that the IDO expressed was biologically active and could suppress the 
growth of CD4 T-cells in a proliferation assay. Immunohistochemistry further 
determined that IDO expression was localised to the corneal endothelium and 
epithelium. Corneal transplantations were then performed using a fully MHC-
mismatched mouse model. However, the survival of IDO-transfected grafts was only 
marginally prolonged relative to GFP-transfected corneas and was shortened compared 
to untreated corneas. Toxicity, as evidenced by propidium iodide staining, was 
suspected to shorten graft survival following peptide-mediated transfection. Efforts to 
modulate toxicity by reducing the transfection period in the presence of chloroquine 
also failed to prolong graft survival. Future work should therefore focus on reducing 
toxicity while improving the transfection efficiency of this peptide carrier. 
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List of abbreviations 
 
1-MT 1-methyl-DL-tryptophan, a chemical antagonist of IDO activity. 
4N Triethylenetetramine, a straight aliphatic with 4 nitrogen per chain. 
5N Tetraethylenepentamine, a straight aliphatic with 5 nitrogen per chain. 
6N Pentaethylenehexamine, a straight aliphatic with 6 nitrogen per chain. 
ACAID Anterior chamber-associated immune deviation. 
APC Antigen presenting cells. 
APCI-
MS 
Atmospheric pressure chemical ionisation mass spectrometry. 
ASOR Asialoorosomucoid, a type of saccharide. 
BSA Bovine serum albumin. 
CD Circular dichroism, a technique to determine the secondary structures of 
peptides. 
CPP / 
PTD 
Cell penetrating peptides or protein transduction domains. 
CTL Cytotoxic T-lymphocytes, usually referring to the CD8 subset of T-cells. 
CTLA-4 Cytolytic T-lymphocyte antigen-4, binds with B7 molecules on APC to 
produce negative regulatory signals to T-cells. 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene, an organocatalyst for the ROP of 
cyclic carbonates. 
DC Dendritic cells, which are professional APC. 
DCM Dichloromethane, or methylene chloride, an organic solvent. 
DI De-ionised water. 
DIC N,N'-diisopropylcarbodiimide, a coupling reagent used to activate a 
carboxylic group. 
DLKP Deep lamellar keratoplasty. 
DP Degree of polymerisation, the number of monomers making up a 
polymeric chain. 
DSAEK Descemet’s stripping automated endothelial keratoplasty. 
DSC Differential scanning calorimetry, a technique that depends on isothermal 
heat flow to measure Tg and Tm.  
DTH Delayed-type hypersensitivity, an immune response usually mediated by 
CD4 T-cells. 
ER Endoplasmic reticulum. 
ERAD ER-associated degradation, a pathway by which misfolded proteins are 
degraded. 
EtBr Ethidium bromide, a fluorescent DNA intercalator dye. 
FasL Fas ligand. 
FITC Fluorescein isothiocyanate, a fluorescent dye. 
FRET Fluorescence resonance energy transfer, an acceptor excited by a donor 
dye in close proximity.  
GPC Gel permeation chromatography, a technique that depends on column 
elution time to determine the molecular weight of polymers. 
HLA Human leukocyte antigen, the human form of MHC molecules. 
HPRT Hypoxanthine phosphoribosyl transferase, a highly conserved enzyme 
present in most cells. 
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HS Heparan sulphate, a cell surface glycosaminoglycan. 
IC50 Inhibitory concentration of carrier at 50% cell viability. 
IDO Indolamine 2,3-dioxygenase, a cytosolic enzyme that catalyses the 
biodegradation of tryptophan. 
IFN-γ Interferon-γ, a proinflammatory cytokine which is also the signature of 
TH1 T-cells. 
IHC Immunohistochemistry. 
KDEL Lys-asp-glu-leu, an ER retrieval signal. 
KO Knock-out. 
LC Langerhans cells. 
LF Lipofectamine™2000, a proprietary cationic lipid formulation that 
transfects cells efficiently. 
Mab Monoclonal antibody. 
MALDI-
TOF 
Matrix-assisted laser desorption/ionization time of flight, a mass 
spectrometric technique. 
MCEC Mouse corneal endothelial cell. 
MFI Mean fluorescence intensity. 
MHC Major histocompatibility complex molecules, onto which antigens are 
loaded for presentation to T-cells. 
MST Median survival time of a group of corneal grafts. 
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide, usually 
used in toxicity assays. 
Mw / Mn Weight (Mw) and number (Mn) average molecular weights. 
N/P ratio Molar ratio of arginine/polymer nitrogen to the DNA phosphorus content. 
NHS N-hydroxysuccinimide, a coupling reagent used to activate carboxylic 
groups. 
NLS Nuclear localisation signal, a sequence reported to increase nuclear 
accumulation. 
NMR Nuclear magnetic resonance, a technique that detects atoms relative to 
their chemical environments. 
PAMAM Poly(amido amine), a polymer usually dendritic in form. 
PCs Polycarbonates, a biodegradable polymer characterised by CO3 linkages. 
Pd/C Palladium on carbon, frequently used to catalyse hydrogenation 
reactions. 
PDI Polydispersity index, Mw÷Mn, with 1 being perfectly monodisperse. 
PD-L1 Programmed death-1 ligand. 
PEG Polyethylene glycol, or polyethylene oxide (PEO), a hydrophilic 
polymer. 
PEI Polyethylenimine, a highly nitrogen-rich cationic polymer that transfects 
cells efficiently. 
PI Propidium iodide, a fluorescent dye that penetrates compromised 
membranes. 
PK Penetrating keratoplasty, the canonical form of corneal transplantation. 
PLL Poly-L-lysine. 
PMO Phosphorodiamidate morpholino oligomers, an antisense molecule. 
PNA peptide nucleic acid, which are artificial nucleic acid-mimicking 
polymers. 
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RBC Red blood cells. 
RLU Relative light units. 
RNAi RNA interference. 
ROP Ring opening polymerisation, where monomeric rings are polymerised 
into aliphatic chains. 
SEM Scanning electron microscopy. 
siRNA Small interfering RNA. 
SV40 Simian virus 40 T antigen, a classical NLS. 
TCR T-cell receptor, interacts with the peptide-loaded MHC molecules. 
Tg Glass transition temperature, when polymers relax from a brittle glassy 
state to a flowing liquid state. 
TGA Thermogravimetric analysis, a technique used to determine the 
degradation temperature of polymers. 
TGN Trans Golgi network. 
TH1 T helper type 1 subset of CD4 T-cells which produce IFN-γ as their 
signature cytokine. 
Tm Crystalline melting temperature, when crystalline pockets transit into an 
amorphous melt. 
TMC Trimethylene carbonate, a prominent 6-membered cyclic monomer from 
the carbonate family. 
TNF-
α/TNFR 
Tumor necrosis factor-α (a pro-inflammatory cytokine) and its receptor. 
Tp Transportan, a CPP or PTD. 
TRAIL Tumor necrosis factor-related apoptosis-inducing ligand. 
Treg T-regulatory cells.  
Vol% Volume percent. 
Wt% Weight percent. 
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1. Introduction 
1.1 Anatomy of the cornea 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cross-sectional schematics of the human a) eye and b) cornea, with pictures of 
actual specimens obtained from a C3H mouse. c) A frozen histological section of the 
murine cornea stained with haematoxylin to review characteristic features such as the 
multilayered epithelium, the thick stroma with scattered keratocytes and the endothelial 
monolayer. Endothelial cells were further viewed en face using confocal microscopy 
after staining for their nuclei (DAPI) and actin cytoskeleton (phalloidin). 
 
 
 
     The cornea is the transparent window of the eye and physically separates the 
aqueous humor from the external environment (Figure 1a). Together, both cornea and 
lens provide most of the refractive power needed to focus light onto the retina for 
vision. The cornea as a tissue is made up of three main layers separated by two basal 
membranes (Figure 1b and 1c). The epithelium forms the outermost surface and 
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contains 90% of all corneal cells (Niederkorn, 2002). In humans, it is 6-8 cell layers 
thick (George & Larkin, 2004). Epithelial cells replicate constantly to repair physical 
damage and they also form tight junctions which make the layer rather impermeable. 
The Bowman’s zone anchors the epithelium to the stroma, a layer which is about 500 
μm thick in humans and accounts for approximately 90% of the corneal thickness 
(Duncan et al., 2010). The stroma is populated with keratocytes and consists of about 
250 stacked arrays of collagen fibrils. To maintain corneal transparency, the fibrils have 
to be kept precisely aligned and this is the responsibility of the endothelial cells which 
rest below the Descemet’s membrane. In humans, the endothelium consists of a 
monolayer of amitotic cells. Damages to this layer can thus only be repaired by the 
enlargement and sliding of neighbouring cells. The main and critical function of the 
endothelial cells is to maintain homeostatic fluid pressure. They do this by pumping 
water out of the stroma, which otherwise has a natural tendency to soak up fluid from 
the anterior chamber. Without a functional endothelial layer, the collagen fibrils become 
disordered and the cornea loses transparency. This is best illustrated by the opaque 
sclera (the white of the eye) which, like the stroma, is made up of collagen fibres except 
that there is no overall orientation (Duncan et al., 2010). The endothelium is therefore a 
highly important and, as shall be appreciated, clinically significant layer.      
 
1.2 Corneal transplantation: background 
     Corneal transplantation as a technology is more than a century old and the first 
successful surgery was documented in December 1905 by Eduard Zirm, an Austrian 
ophthalmologist (quoted in Armitage et al., 2006). Today, the cornea is the most 
commonly transplanted tissue and more than 40,000 transplants are performed annually 
in the USA alone (Dietrich et al., 2010). In England and Wales, corneal diseases may be 
less important as a cause of blindness – retinal degeneration and glaucoma are the two 
leading conditions (Bunce et al., 2010). Globally, however, corneal dysfunction remains 
a major problem and is second only to cataract as the most frequent cause of blindness 
(Klausner et al., 2007). It was estimated, for instance, that there are in excess of ten 
million people worldwide who are blind in the cornea (Qian et al., 2004). For most of 
these patients, a corneal transplantation will be their only hope of regaining vision. 
 
     Several medical conditions can lead to the need for a corneal transplant. The most 
significant indication is failure of the corneal endothelium, which alone accounts for 
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about half of all transplantations undertaken (Wang et al., 2000). Some other common 
corneal indications are: keratoconus, where the cornea loses its regular smooth 
curvature and misshapes to become more conical; Fuchs’ dystrophy, which is a 
progressive disease characterised by endothelial cells undergoing idiopathic apoptosis 
and a thickened Descemet’s membrane (Jun, 2010); keratitis, where the cornea becomes 
inflamed following infection by a pathogen which can be viral (usually herpes simplex 
virus), bacterial or fungal in nature (Gower et al., 2010); physical or chemical 
traumas/burns and other forms of keratopathy and endothelial decompensation.      
 
     Multiple risk factors for graft failure have been identified such as graft size and 
gender, amongst others (Tan et al., 2008). Donor age is less important as long as the 
endothelial cell density is sufficiently high (typically >2000 cells/mm2) and the quality 
of tissue is good to excellent, as graded by the eye bank (Group, 2008). Vascularisation 
of the graft bed has been strongly associated with an increased risk of graft failure 
(Bachmann et al., 2010). The indication for surgery is important as some diseases (e.g., 
Fuchs’ dystrophy) suffer poorer prognosis than others (e.g., keratoconus) (Tan et al., 
2008). The surgical technique used can also affect outcome. Penetrating keratoplasty 
(PK), where the entire cornea of the recipient is replaced with a full-thickness donor 
tissue, is the canonical and most commonly performed technique. A more recent 
alternative is deep lamellar keratoplasty (DLKP), where the recipient’s endothelium is 
left untouched while donor stroma and epithelium are grafted directly onto the host’s 
Descemet’s membrane (Kawashima et al., 2006). The principal advantage of DLKP 
over PK is that rejection of the endothelium is prevented. However, DLKP is 
technically more challenging and is limited to diseases where the endothelial layer is 
still functional. In contrast, Descemet’s stripping automated endothelial keratoplasty 
(DSAEK) replaces only the host’s endothelium. During DSAEK, grafting of the 
epithelium and stroma – which contain most of the antigenic load – is avoided and 
fewer sutures are needed since only a small incision is made to access the endothelium. 
Patients who underwent DSAEK also reported a more rapid vision recovery with less 
astigmatism (Mashor et al., 2010). However, this technique is even more complicated 
than DLKP and endothelial cell lost after surgery is markedly increased compared to 
PK, presumably due to the extensive handling of the endothelium (Price et al., 2010). 
Moreover, a definitive large-scale and long-term study is needed before DSAEK can be 
validated as a superior alternative to PK. Recently, a novel method was reported where 
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air was used to strip the donor endothelium so as to cause less damage and improve 
outcomes after DSAEK (Busin et al., 2010).  
 
1/2 yrs 
(%) 
5 yrs 
(%) 
10 yrs 
(%) 
Remarks Reference 
- 90 82 USA, N=3640, 1st time grafts Thompson et al., 2003 
- 73 63 France, N=1062, re-grafts included Borderie et al., 2009 
87 (1) 73 60 Australia, N=14622, re-grafts included  Williams et al., 2008 
87 (1) 64 52 Singapore, N=784, re-grafts included Tan et al., 2008 
80 (1) 47 - India, N=1389, 1st time grafts Dandona et al., 1997 
76 (2) - - Africa, N=216, 1st time grafts Yorston et al., 1996 
 
Table 1. Graft survival rates after penetrating keratoplasty performed at different 
regions of the world.  
 
 
 
     Although actual graft survival figures vary depending on the region of the world and 
the specific centres where surgery is being performed (Table 1), corneal transplantation 
can largely be considered to be successful. In general, a survival rate of about 90% can 
routinely be achieved in the first 12 months after an initial graft, tapering to about 75% 
by year five (Fu et al., 2008). Such figures appear even more respectable when taken in 
context that human leukocyte antigen (HLA)-typing is not standard practice before 
corneal transplantation as the benefits of doing so remains to be proven (Forrester, 
2009). Systemic immunosuppressive drugs based on corticosteroids (Wang et al., 2009) 
or cyclosporine (Kaçmaz et al., 2010) are also not usually prescribed as their effects 
seem only modest in the setting of corneal transplantation. Moreover, the risk of 
cataract, glaucoma and other more dangerous forms of side effect associated with the 
prolonged use of such drugs do sometimes make their application tricky to justify in a 
non life-threatening procedure (Klebe et al., 2009). Having said that, local 
corticosteroids are in routine use.  
 
     As will be discussed, the high success rate enjoyed by corneal transplantation is 
usually explained by the fact that the corneal graft bed is an immune-privilege site and 
that the cornea itself is an immune-privilege tissue. However, a significant number of 
corneal grafts do fail and immune rejection, which frequently accounts for close to a 
third of all failures observed in many centres (Tan et al., 2008), is the biggest culprit. 
The dominant site of rejection is the endothelium (Klausner et al., 2007) and prognosis 
is particularly bad in patients who have experienced neovascularisation or previous 
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episodes of rejection. These patients fall under the “high-risk” category because their 
ocular immune privilege has been compromised. 
 
1.3 Corneal transplantation: immunology 
     Like the brain and foetus, the cornea enjoys immune privilege – a status which it 
needs if vision is not to be destroyed by inflammation that is ironically mounted to 
protect the cornea. However, it is important to understand that this privileged status is 
merely relative and the cornea is not exempted from immunological attacks. Put 
differently, it is just that the threshold of inflammation in the cornea is significantly 
raised compared to other parts of the body. 
 
     There are many features in place to bestow privilege status to the cornea and its graft 
bed. 1) Avascularity is a key defensive feature and the normal graft bed is typically 
pristine. The absence of blood vessels or a lymphatic drainage system means that both 
the efferent and afferent arms of the immune response have been severed (Niederkorn, 
1999). The graft is hence effectively invisible to the immune system. 2) Since the mid 
1970s, the central role that major histocompatibility (MHC) molecules play in the 
presentation of antigens to T-cells have been recognised (Carbone & Heath, 2010). 
However, early histological evidence from murine corneas seemed to suggest that the 
cornea at best expresses scant quantities of MHC molecules, of which, almost all are 
confined to the epithelium (Wang et al., 1987). A more recent view is that MHC 
molecules are expressed in all three corneal layers, with class I molecules being 
ubiquitously present and class II molecules being more limited in its expression 
(Forrester, 2009; Niederkorn, 2003). Langerhans cells (LC) are noted to be 
conspicuously absent in normal corneas, although both class II molecules and presence 
of LC can be upregulated during inflammation. 3) The tight blood-retina barrier and the 
impermeable pigmented epithelium that coats the posterior surface of the iris serve to 
sequestrate the cornea and humor environment from systemic circulation (Streilein, 
2003). Nevertheless, such physical barriers are known to break down in models of 
inflammation such as uveitis (Forrester, 2009). 4) The aqueous humor contains a 
cocktail of immunosuppressive factors, of which α-melanocyte stimulating hormone (α-
MSH) and transforming growth factor-β2 (TGF-β2) have been identified to be key. 
TGF-β2, whose expression is restricted to the eye (Streilein, 2003), is particularly 
important and has been implicated in the ability of aqueous humor to suppress T-cell 
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proliferation in vitro (Ohta et al., 2000a). This suppressive property is, however, lost 
during experimental autoimmune uveitis (a model of mouse uveitis) in the presence of 
IL-6, despite TGF-β2 being highly expressed (Ohta et al., 2000a). This suggests that IL-
6 is a potent inhibitor of TGF-β2 activity. Data also showed that humor-resident TGF-
β2 and IL-6 were not recruited from circulation, but produced in situ by the ocular 
parenchymal cells (Ohta et al., 2000b). Additionally, both α-MSH and TGF-β2, when 
used either individually or synergistically, can induce the activation of T-regulatory 
(Tregs) cells in vitro (Nishida & Taylor, 1999). 5) The cornea can actively induce 
tolerance by eliciting a deviant form of immunological response known as anterior 
chamber-associated immune deviation (ACAID) (Streilein, 2003). ACAID is mediated 
by F4/80 macrophages which have captured foreign antigens (Taylor, 2009). They then 
migrate via the blood vessels to the spleen where antigens are presented to lymphocytes 
to elicit the generation of Tregs. Consequently, ACAID can be prevented by removing 
the spleen or by abolishing the suppressive property of the aqueous humor, e.g., by 
upregulating IL-6 production (Ohta et al., 2000b). In mice, ACAID typically appears 
three to eight weeks after allograft surgery (Dietrich et al., 2010; Qian et al., 2001). 6) 
Finally, pro-apoptosis signals are expressed by the corneal endothelium and epithelium. 
These signals act as an additional layer of security by triggering lymphocytes, which 
have somehow managed to bypass all previous barriers, to undergo apoptosis. One 
example is the Fas ligand (FasL or CD95L), which is constitutively expressed by 
corneal cells and induces apoptosis in activated Fas-bearing T-cells (Boise et al., 1995). 
FasL expression was shown to be important as all BALB/c mice rejected their grafts 
from FasL-knock out (KO) C57BL/6 mice, while 45% of the recipients accepted their 
corneas from wild type donors (Stuart et al., 1997). Other pro-apoptosis signals 
expressed by corneal cells include tumor necrosis factor-related apoptosis-inducing 
ligand (TRAIL) (Yang et al., 2009b) and programmed death-1 ligand (PD-L1 or B7-H1) 
(Yang et al., 2009b). Like individual musical instruments within an orchestra or a piece 
of jig-saw, all components must be present for privilege to be maintained. Failure to do 
so can provoke an inflammatory reaction.  
 
     Rejection of corneal allografts is accepted to be a T-cell mediated event, with a 
limited role for antibodies (Coster et al., 2005). This was shown to be true even for 
xenografts, where hyperacute rejection is usually antibody-mediated. Surprisingly, 
guinea pig corneas were rejected acutely by KO mice which were unable to produce 
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antibodies (Tanaka et al., 2000). Multiple evidences also suggest that CD4, rather than 
CD8 T-cells play a more pivotal role in mediating rejection. For instance, it was shown 
that CD4 KO mice accepted allografts from major- or minor-histocompatibility 
mismatched donors, while CD8 KO mice rejected their corneas as rapidly as control 
animals (Yamada et al., 1999). Similarly, mice (He et al., 1991) and rats (Ayliffe et al., 
1992) that had their CD4 population depleted with monoclonal antibodies (mab) either 
accepted or delayed the rejection of their corneal allografts compared to the CD8-
depleted and control groups.  
 
     IL-2 and interferon-γ (IFN-γ) are two key cytokines detected in rejected corneas and 
are signatures of the T helper type 1 (TH1) subset of CD4 T-cells (Pleyer et al., 2000; 
Sano et al., 1998). Therefore, rejection was traditionally thought to be mediated by TH1 
cells. This view, however, has been challenged by data which showed that IFN-γ KO 
mice (Hargrave et al., 2002) or mice which had received intraperitoneal injections of 
anti-IFN-γ mab (Cunnusamy et al., 2010a) rejected their allografts sooner than controls. 
In contrast, more STAT6 KO mice – which were unable to mount an IL-4-mediated TH2 
response – compared to wild type animals accepted their grafts following injections of 
anti-IFN-γ mab (Cunnusamy et al., 2010a). Evidently, suppressing the TH1 response not 
only failed to prevent rejection, but indeed, may have allowed the TH2 response to 
progress unchecked, resulting in the exacerbation of graft rejection. There may, 
therefore, be redundancy in the population of CD4 cells that can mediate rejection. 
Furthermore, the recent discovery of TH17 cells which secrete IL-17A as their signature 
cytokine may have added another suspect to the line-up of cells capable of causing 
corneal rejection. This is especially so after several autoimmune diseases are now 
ascribed to TH17 cells (Palmer & Weaver, 2010) and IFN-γ-producing TH17 cells have 
been described (Steinman, 2010). Interestingly, while TH17 cells are generally classified 
to be pro-inflammatory, recent evidence has implicated them in the mitigation of 
corneal graft rejection. For example, mice injected with anti-IL-17A antibodies rejected 
their grafts sooner compared to isotype-treated animals (Cunnusamy et al., 2010a). This 
is consistent with the emerging view that TH17 cells may be able to cross-regulate the 
activities of TH1 and TH2 cells. 
 
     Considering that class I molecules are more readily expressed in the cornea, it seems 
reasonable to suggest that CD8 T-cells should play a bigger part in the rejection of 
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corneal allografts (Yamada et al., 1999). Indeed, CD8 T-cells were initially suggested to 
be the instigators of rejection. In an early study to elucidate the relative importance of 
CD4-mediated delayed-type hypersensitivity (DTH) and CD8-mediated cytotoxic T 
lymphocytes (CTL) mechanisms, allogenic murine corneas were grafted heterotopically 
onto a vascularised subdermal graft bed (Peeler et al., 1985). At various time points, 
cells were then extracted from spleens and lymph nodes of animals rejecting their grafts 
and assayed for their DTH (using a footpad swelling assay) and CTL (ability to lyse 
target cells preloaded with the radioactive 51Chromium) activity. Data then showed that 
the cells displayed strong CTL but little DTH responses. A similar result favouring CTL 
over DTH activity was also achieved in another study where rats received orthotopic 
corneal transplants (Callanan et al., 1988). Nonetheless, it has to be noted that the 
connection between the identity of cells and their effector function is not always strict 
(He et al., 1991). Therefore, CTL activity may not be the exclusive realm of CD8 T-
cells. Moreover, the effector activity of cells was assayed in vitro, which does not 
always reflect their in vivo behaviour.   
 
     There are two pathways – direct and indirect – by which an alloantigen can be 
presented for T-cell recognition. In the direct pathway, donor antigen presenting cells 
(APC), also termed “passenger leukocytes”, directly prime the host and present antigens 
to T-cells. This contrasts with the slower indirect pathway where host APC has to ingest 
and process antigenic peptide fragments before presentation. Over the years, the indirect 
pathway of allorecognition has proved to be more relevant, at least after transplantation 
onto avascular graft-beds, or the so-called low-risk cases. Support for this was provided 
when BALB/c mice rejected C57BL/6 corneas regardless if the donors were wild-type 
or MHC class II KO animals (Huq et al., 2004). Another piece of evidence was when 
the topical application of IL-1 receptor antagonist suppressed LC migration into the 
cornea and improved survival of both low- and high-risk murine corneas (Dana et al., 
1997). Conversely, using latex beads to stimulate LC infiltration before surgery 
exacerbated the rejection of rat corneas (Callanan et al., 1988).  
 
     The direct pathway can still contribute, albeit not exclusively, in the high-risk setting 
where the graft-bed has been prevascularised or is inflamed. This was shown when mice 
which had suture-induced prevascularised graft beds accepted their grafts for a longer 
period of time if the donors were MHC class II KO animals, as opposed to wild type 
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controls (Huq et al., 2004). Additionally, donor APC isolated from high-risk recipients 
had higher levels of expression of their co-stimulatory molecules (CD40, 80 and 86) 
compared to low-risk recipients. This led the authors to postulate that the inflammatory 
environment may be the trigger for donor APC to upregulate their expression of co-
stimulatory molecules, in turn allowing them to mount a robust direct immune response. 
Indeed, both the direct and indirect responses should be heightened in the high-risk 
setting, which can explain the accelerated speed with which regrafts are rejected.  
 
     Antigen presentation is thought to take place in the lymph nodes, rather than in the 
cornea itself (Kuffova et al., 2008). This in turn accounts for the relative importance of 
the lymphatic (afferent arm) over blood (efferent arm) vessels in the scheme of 
rejection. A study demonstrated this by producing murine graft-beds where the growth 
of either blood or lymphatic vessels was inhibited (Dietrich et al., 2010). Corneas 
transplanted onto graft-beds that had only blood vessels survived as long as control 
corneas transplanted onto avascular beds, while corneas sutured onto beds that had only 
lymphatic vessels were rejected more swiftly.  
 
     A final feature of corneal allograft rejection is that minor antigens seem to be more 
important than MHC antigens. This was demonstrated by the observation that 60% of 
BALB/c mice rejected their corneas from C57BL/6 (fully mismatched) donors while 
only 20% rejected corneas from BALB/b (only MHC-mismatched) donors (Boisgerault 
et al., 2001). This may also explain why HLA-matching has not gained widespread 
validation in human corneal transplantation due to conflicting reports on its benefits 
from different parts of the world (Coster et al., 2005). In reality, the term “minor” 
antigens should be read more as “non-MHC” antigens as researchers are still not clear 
over the identity of the minor antigen(s) responsible for rejection (Forrester, 2009). 
 
     As alluded, the immune privilege status of the cornea and its graft bed plays a pivotal 
role in the high success rate of low-risk transplants. The problem, however, lies with the 
high-risk transplants, which include patients who require re-grafts after their initial 
grafts had failed. Indeed, for these patients, five-year survival rapidly drops to 50% or 
less (Table 2), despite immunosuppression (Huq et al., 2004). The presence of this 
group of high-risk patients with no alternative therapy, together with the fact that little 
improvements have been made in the last few decades with regards to the overall 
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survival rates in corneal transplantation (Coster et al., 2005), justifies the need for novel 
forms of immunomodulation. Here, we explore such a strategy involving gene therapy. 
 
Re-grafts 
5 yrs (%) 
Remarks Reference 
53 USA, N=352 Thompson et al., 2003 
50 France, N=87 Borderie et al., 2009 
54 Australia, N=2540 Williams et al., 2008 
18 Singapore, N=112 Tan et al., 2008 
21 India, N=336 Dandona et al., 1997 
 
Table 2. Patients who have to receive re-grafts are termed high-risk as they suffer an 
alleviated risk of failure compared to the initial graft. Survival rates of re-grafts after 
penetrating keratoplasty performed at different regions of the world. 
 
 
 
     We hypothesize that the ex vivo delivery of a nucleic acid encoding for an 
immunosuppressive protein into the cornea, prior to surgery, can improve graft survival 
rates. The cornea is particularly amendable to such a genetic approach because of its 
simple anatomy – the endothelium, which is the main clinical target, is exposed and 
easily accessible. Conveniently, corneas enucleated from cadaveric donors can be stored 
for a significant period of time without much deleterious effects (George & Larkin, 
2004). This is supported by the Australian corneal graft registry which recently 
published that the nature of storage medium used and the storage time in Optisol (a 
popular chondroitin sulphate-containing corneal storage medium) for up to more than 
six days were insignificant risk factors affecting the success of PK (Williams et al., 
2008). There is therefore a clear window of opportunity for ex vivo manipulation. In 
terms of scientific merit, the possible outcomes after corneal transplantation are limited 
and usually clearly defined – the graft is either surviving (remains transparent) or not 
(becomes opaque). Several animal models for corneal transplantation also exist, of 
which mice are attractive for reasons due to cost and availability. Importantly, their 
immune system is well characterised and various strains of KO mice are available. 
Corneal transplantation therefore provides a versatile platform to evaluate the outcome 
of novel strategies.  
 
     A key bottleneck in gene therapy is the lack of suitable vectors – arguably, it is the 
lack of safe and efficient delivery systems, rather than suitable therapeutic molecules 
that is limiting the success of gene therapy. The primary objective of this study is 
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therefore to develop novel genetic vectors that can be evaluated in the setting of corneal 
transplantation. To achieve this, we first examine how issues at the cellular interaction 
level have shaped the design of modern, multifunctional carriers. These concepts are 
vital to fully appreciate the rationale behind the designs of our novel non-viral vectors. 
For completeness, the various classes of gene delivery agents available will be briefly 
reviewed. Prominent examples of peptide-based vectors are, however, given special 
attention since our main vectors are also based on amino acids. Finally, we narrow 
down to vectors explored in corneal gene delivery, before we justify our vector design 
and choice of therapeutic gene used for this study.  
 
1.4 Gene therapy and the need for gene delivery systems 
     Parts of section 1.4 to 1.7 have been accepted for publication as a book chapter 
(Seow & George, 2011). 
 
     In its most simplistic sense, gene therapy involves the delivery and expression of 
DNA by target cells so as to produce a therapeutic protein. In the case of RNA 
interference (RNAi), it is to shut off or silence the expression of a particular target 
protein. In order to exert its effects, the nucleic acid must first reach its intended site of 
action. DNA molecules (frequently as plasmids) thus have to gain nuclear entry to 
access the transcription machinery. Conversely, RNAi molecules such as small 
interfering RNA (siRNA), short hairpin RNA (shRNA) and micro RNA (miRNA) will 
need to accumulate within the cytoplasm, although shRNA-encoding plasmids will 
require prior nuclear access before transcription into shRNA. However, if administered 
alone, the majority of nucleic acids will be degraded en route. This then necessitates the 
development of delivery systems that protect and ferry nucleic acids to their target site. 
 
1.5 Intracellular barriers in gene therapy: problems and solutions 
     We will concentrate on the delivery of plasmids since the phenomenon of RNAi is 
relatively recent. As such, many strategies for RNAi delivery are borrowed and adapted 
from DNA delivery technology.  
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Figure 2. Chronological sequence of events and challenges that a plasmid faces during 
its treacherous journey towards the nucleus. 1) A naked plasmid is susceptible to 
degradation by nucleases and is likely to be repelled from the plasma membrane. 2) 
Assuming successful uptake via endocytosis, the plasmid has to avoid trafficking into 
lysosomes where it will be degraded. 3) The plasmid thus has to escape into the 
cytoplasm. 4) It now has to diffuse through the viscous cytoplasm towards the nucleus, 
avoid degradation en route and penetrate the nuclear membrane. 5) Transcription into 
mRNA can then occur if the plasmid manages to reach the nucleus intact.   
 
 
 
     Ensuring the arrival of a plasmid at its site of action in a transcriptional state is the 
entire aim of gene delivery systems. However, plasmids face a constant threat of being 
degraded. The challenge begins as soon as they are introduced into the extracellular 
milieu (Figure 2). In most experimental setups, cells/tissues are maintained at 37°C in 
serum-supplemented medium where serum nucleases can extensively damage naked 
plasmids. The plasmid therefore needs protection. Next, the plasmid needs to be 
internalised. However, both DNA (phosphate groups within the backbone) and plasma 
membrane (glycoproteins with their sialic acid groups, glycerophosphates with their 
phosphate groups and proteoglycans which contain sulphate groups) are negatively 
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charged. Electrostatic repulsion then ensures that there is little chance of the plasmid 
being naturally taken up by a cell.  
 
     For these reasons, gene delivery systems are frequently cationic and this fulfils 
several functions. First, the carrier can use its positive charges to mask the negative 
charges on the plasmid and package itself as a carrier/DNA complex with an overall 
positive charge. As expected, positively charged particles are internalised much more 
readily, as confirmed by an elegant study using PRINT (Particle Replication In Non-
wetting Templates) technology to fabricate particles with exquisite control over their 
size, shape and surface charge (Gratton et al., 2008b). By keeping size and shape 
constant, positively charged particles were found in 84% of cells after an hour of 
incubation compared to the <5% uptake of negatively charged particles, proving that 
surface charge alone can influence uptake dramatically. Second, due to a charge 
screening effect, the macromolecular plasmid is collapsed, or condensed into a compact 
structure more amendable for cellular uptake. This condensing process was clearly 
demonstrated using transmission electron microscopy which showed an elongated 
plasmid (long-axis diameter of ~470 nm) being compacted into tight, 80-100 nm toroid-
shaped complexes by polylysine carriers (Wagner et al., 1991). Third, the carrier 
protects its cargo against degradation by nucleases, presumably by steric obstruction.      
 
     A problem with cationic carriers is that negatively charged serum protein can be 
non-specifically attracted. As a result, targeting signals on the carrier can become 
blocked or complexes can start to aggregate. Reducing or removing serum from the 
media during in vitro transfection can mitigate such effects and improve transfection 
(Moore et al., 2009; Moulton et al., 2004). However, this strategy fails during in vivo 
experiments where serum proteins are unavoidably present. Another approach is to mix 
DNA and carrier in precise stoichiometric ratio so as to result in electro-neutral 
complexes (Funhoff et al., 2005). Along similar lines, zwitterionic (McManus et al., 
2004) or anionic (Liang et al., 2005) lipids have been proposed in which binding 
between carrier and plasmid is dependant on hydrophobic forces and the presence of 
divalent cations such as Ca2+, Zn2+ and Mg2+ to screen the disruptive repulsion between 
like charges. Neutral water-soluble polymers such as polyvinyl alcohol (PVA) and 
polyvinyl pyrolidone (PVP) similarly exploit non-electrostatic forces such as hydrogen 
bonding and van der Waal’s attraction to condense plasmids (Park et al., 2006). These 
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particles are however less popular because the lack of positive charge is expected to 
adversely impact cellular uptake. The PEGylation of carriers is another option. 
PEGylation refers to the surface decoration of carriers with flexible chains of 
polyethylene glycol (PEG), which is a highly hydrophilic polymer capable of making a 
surface less susceptible to protein adsorption (Duncan, 2006). Having said that, a major 
concern is that PEGylation obstructs the positive charges and this results in carriers 
which are less efficient in DNA binding and transfection (Lin et al., 2008; Meyer et al., 
2008). Moreover, while PEGylated drug formulations are already in the clinics, PEG is 
non-biodegradable and its chronic use may still be a concern (Urakami & Guan, 2008). 
 
     The positive charges on cationic carriers have also been implicated in the formation 
of pores on the membrane, resulting in cytotoxicity (Park et al., 2006; Rimann et al., 
2008). The observation that carrier/DNA complexes are less toxic to the cells compared 
to the carrier alone can be interpreted as partial evidence that charge compensation on 
the carrier may be a reason, albeit a non-exclusive one, for the reduced toxicity 
(Niidome et al., 1997). Having said that, the exact mechanism is still not totally clear. It 
may be due to the high rates of internalisation of cationic carriers – and not the positive 
charges per se – that is to blame for pore formation. Herein lies a dilemma of the gene 
therapist: a high rate of internalisation can increase transfection efficiency but is also 
frequently paralleled by toxicity (Pouton & Seymour, 2001). Fortunately, cells do have 
membrane repair mechanisms. One example is the membrane repair response where the 
influx of Ca2+ ions triggers lysosomes to donate their vesicular membrane in a concerted 
effort to plug the hole (Palm-Apergi et al., 2009). As always, the challenge is to strike a 
fine balance between two counter-acting events.  
 
     Assume the plasmid has been successfully taken up by a cell via endocytosis and 
now resides within an endosome. Another degradative fate awaits as endosomes 
eventually acidify into lysosomes and activate a broth of acid hydrolases capable of 
degrading nucleic acids. For this reason, a high rate of uptake may not necessarily 
translate into high transfection efficiency if, for example, most of the plasmids are 
degraded in lysosomes (Lundin et al., 2008). To avoid degradation, the plasmid/carrier 
complex will need to escape from the confines of the endosome into the cytosol. A 
popularly cited mechanism by which cationic carriers can achieve this is the proton 
sponge hypothesis, so called because it relies on the buffering capability of the carrier to 
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absorb H+ ions and function as a sink for protons. This model assumes that as the H+-
ATPase pump on the endosomal membrane injects protons into the vesicle during 
acidification, a build-up of positive charges will result due to the ability of the carrier to 
protonate and absorb the protons. This then triggers a concomitant influx of 
compensatory negative ions (e.g., Cl-) and water, leading to the osmotic swelling of the 
vesicle and its eventual rupture. Consistent with this line of argument, carriers must 
therefore contain chemical groups that are capable of undergoing protonation within the 
pH range of the endo/lysosomal transition, i.e., a pKa of 7 to 4. This has motivated 
investigators to design carriers with a large buffering capacity. The polymer 
polyethylenimine (PEI), for instance, has a combination of protonated amines to bind 
plasmids at pH 7 and a stockpile of unprotonated amines that can still undergo 
protonation during the endo/lysosomal transition (Boussif et al., 1995). As such, PEI 
has a large buffering capacity and this feature is frequently cited as a main reason for 
PEI’s status as one of the most efficient non-viral vector commercially available for in 
vitro transfection (Putnam, 2006).  
 
     Another common strategy to promote endosomal escape is to coincubate cells with a 
lysosomotropic agent such as chloroquine. Traditionally used as an anti-malaria drug, 
chloroquine is also a weak base capable of buffering the acidification of endosomes. In 
reality, chloroquine is pleiotropic in nature – besides its lysosomotropic property, 
chloroquine has been reported to be able to aid in the release of plasmid from its carrier 
and also to inhibit DNase activity (Yang et al., 2009a) – and its actual mechanism of 
action remains controversial. Nevertheless, chloroquine does generally improve the 
transfecting capability of many carriers (Pouton & Seymour, 2001). A caveat, though, is 
that chloroquine at the dose normally used (100 μM) is toxic to cells (Wadia et al., 
2004; Zauner et al., 1998). Glycerol is another agent reported to augment transfection 
due to its ability to weaken and make vesicular membrane more susceptible to 
disruption (Zauner et al., 1997). Interestingly, the more obvious effect of adding 
glycerol – its osmotic property – was ruled out as the main cause of vesicle escape. 
Finally, carriers can be functionalised with membrane-disruptive peptides. This strategy 
will be reviewed later, in section 1.7. 
 
     In the cytosol, the plasmid continues its migration towards the nucleus. Current 
dogma suggests that this proceeds via passive diffusion and that nuclear localisation is a 
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hit-or-miss event. The viscous cytosolic environment makes diffusion extremely 
inefficient (Luo & Saltzman, 2000a). The diffusion coefficient of bovine serum albumin 
(BSA) in human fibroblasts, for example, is ~70× lower than in buffer (Wojcieszyn et 
al., 1981). Plasmid protection during migration is also important as cytosolic nucleases 
restrict the half life of naked DNA to about 90 minutes (Belting et al., 2005).  
 
     During migration, another feature of the carrier becomes important – the release of 
its plasmid cargo. To undergo transcription, the plasmid must first be unpackaged from 
its carrier and the trick here, is one of timing. A plasmid that gets released too early will 
risk degradation while one that binds too strongly is not accessible for transcription. For 
this reason, lower molecular weight chitosan transfects better because their higher 
molecular weight counterpart interacts too strongly with their plasmid cargo (Koping-
Hoggard et al., 2004). Another example involves PEI, where acetylation of its 
polymeric chains (which removes the amines) reduced both its buffering capacity and 
plasmid binding strength, but improved its transfection (Gabrielson & Pack, 2006). This 
suggests that vector unpackaging can indeed be a rate-limiting step and a carrier that 
binds in moderation is ideal.    
 
     Nuclear entry is believed to be achieved in two ways: either via the ~10 nm wide 
nuclear pores or during mitosis when the nuclear envelope momentarily disintegrates 
(Luo & Saltzman, 2000a). The latter appears to be a more efficient method for the large-
scale accumulation of complexes. It further provides a possible explanation for why 
amitotic cells or primary cells which proliferate slower are more difficult to transfect 
than cancer-derived cell lines. A dilution effect after mitotic cell division also accounts 
for the transient nature of gene expression mediated by non-integrating vectors. Having 
said that, mitosis is not a pre-requisite (Won et al., 2009) as amitotic cells have been 
successfully transfected – it merely provides a convenient window of opportunity for 
nuclear entry. A proposed method to improve nuclear penetration is to attach a nuclear 
localisation signal (NLS) to the carrier. The quintessential example of a NLS is the short 
peptide sequence corresponding to the Simian virus 40 (SV40) T antigen. However, 
responses regarding the benefits of including a NLS have been mixed, with some 
investigators (Trentin et al., 2005) more convinced than others (Zauner et al., 1998). A 
key issue pointed out was that studies evaluating NLS failed to examine its effect on 
nuclear import per se (Lam & Dean, 2010). Instead, reporter gene expression was 
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frequently used as a proxy and an improved expression was simply accepted to be due 
to the inclusion of NLS. Given that most NLS are cationic, it is debatable if the 
observed increase in transfection is strictly the result of improved nuclear import, or due 
to other non-specific effects such as enhanced plasmid association and uptake. 
Moreover, the fact that a NLS can be sterically hindered by plasmids upon binding also 
contradicts the notion that the NLS has to be freely accessible to importins, the nuclear 
entry regulating proteins (Lam & Dean, 2010). 
 
     In light of the many obstacles that nucleic acids and their carriers have to surmount, 
it is perhaps understandable that less than 10% of the pool of plasmids that made it into 
a cell will go on to accumulate in the nucleus (Lam & Dean, 2010). The challenge 
remains to design a multifunctional vector that can address the issues highlighted above 
and yet, remain safe to use in a human body. 
 
1.6 Overview and classification of gene delivery systems 
1.6.1 Physical systems 
     Gene delivery systems can be classified based on their means of achieving 
transfection (Figure 3). There are systems that utilise physical forces, mostly with the 
aim of disrupting the plasma membrane, to facilitate nucleic acids delivery. For 
instance, electroporation and sonoporation (Xenariou et al., 2010) uses electrical and 
sonication forces respectively to transiently compromise the plasma membrane. The 
ballistic gene gun method, on the other hand, directly shoots DNA-coated metal 
particles (frequently gold) into cells (Merediz et al., 2000). Expectedly, such aggressive 
methods can irreversibly damage the cell membrane and cause widespread cell death. 
Scrape loading, first described in 1984, requires the forceful scraping of cells firmly 
attached to their culture dishes, thereby creating pores on their membrane for plasmid 
entry (McNeil et al., 1984). However, due to its mechanism of action, this technique is 
only applicable to adherent cells. The osmotic lysis of pinosomes was proposed in 1982 
and required that cells capable of pinocytosis be initially exposed to a hypertonic 
medium containing sucrose, PEG and the plasmid of interest (Okada & Rechsteiner, 
1982). Subsequent exchange to a hypotonic medium then released the pinosomal 
content into the cytosol. Although all cells are constitutively capable of pinocytosis, 
such wild fluctuations in osmotic conditions can cause cell death. Finally, 
microinjection refers to the piecemeal injection of plasmids directly into the cell (Luo & 
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Saltzman, 2000a). This technique, while relatively gentle compared to the other 
physical methods, is extremely laborious. As such, it is prone to failure and the number 
of cells that can be processed is limited. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  The different classes and examples of gene delivery systems. This chapter 
will focus on peptide-derived vectors. 
 
 
 
1.6.2 Viral vectors 
     There are systems that function as particulate carriers by ferrying nucleic acids into 
or near to their site of action. Such systems can be viral or non-viral in nature. Viral 
vectors such as adenovirus, adeno-asociated virus (AAV), human immunodeficiency 
virus (HIV), equine infectious anaemia virus (EIAV), herpes simplex virus (HSV) and 
murine leukaemia virus (MLV) have been used and comprehensively reviewed 
elsewhere (Kay et al., 2001). The prime advantage of viral vectors is their transfection 
efficiency which has benefitted from centuries of selective evolutionary pressure. As a 
result, viruses are several orders of magnitude more efficient than non-viral vectors 
(Kircheis et al., 1997) and account for about 70% of all clinical trials involving gene 
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therapy so far (Won et al., 2009). A recent success for viral gene therapy involved the 
use of lentiviruses to deliver a correct copy of a therapeutic gene to an adult patient 
suffering from β-thalassaemia (Cavazzana-Calvo et al., 2010). Such patients suffer from 
defective haemoglobin production and require chronic blood transfusion for survival. 
Upon reinfusing the patient with his own bone-marrow haematopoietic stem cells that 
had earlier been transduced ex vivo, the patient became transfusion free one year after 
treatment and has since been doing well, according to the most recent report 33 months 
after treatment. The longer-term outcome, of course, remains to be seen.  
 
     Viral gene therapy has also been explored to treat eye diseases. AAV, in particular, 
has been intensively evaluated for the treatment of retinal disorders since it is the only 
viral vector that can efficiently transduce all the cellular targets frequently implicated in 
retinal diseases, i.e., the retinal ganglion cells (RGC), rod and cone photoreceptors and 
cells of the retinal pigment epithelium (RPE) (Buch et al., 2008). Additionally, AAV 
can mediate long-term gene expression and is less immunogenic compared to 
adenovirus and HSV (Buch et al., 2008). For instance, AAV-mediated gene therapy was 
used to rescue RGC following axotomy-induced trauma. In one study, mRNA levels of 
the TrkB receptor – which is expressed by RGC and is responsible for the uptake of 
BDNF survival factors – were found to be reduced following axotomy (Cheng et al., 
2002). AAV encoding for TrkB was then injected into the vitreous chambers of SD rats, 
resulting in the extension of RGC survival. Similarly, AAV encoding for other pro-
survival signals such as the Bcl-xL protein (Malik et al., 2005) or fibroblast growth 
factor (Sapieha et al., 2003) had been injected into the vitreous chambers of rats to 
prolong the survival of RGC after axonal injury. In other studies, the intraocular 
expression of anti-angiogenic factors were induced in mice following sub-retinal 
injection of AAV particles (Auricchio et al., 2002). This then inhibited retinal 
neovascularisation, a process which is involved in the progression of several retinal 
dystrophies. The sub-retinal injection of AAV encoding for IL-10 also alleviated the 
severity of experimental autoimmune uveitis induced in mice (Broderick et al., 2005). 
Finally, AAV has shown promise in the treatment of inherited retinal dystrophies such 
as Leber’s Congenital Amaurosis (LCA). LCA is a severe form of early-onset 
retinopathy which causes in impaired vision in children and eventual blindness later in 
their lives. Among others, LCA can be caused by defects in the AIPL1 gene specific to 
photoreceptors or in the RPE65 gene expressed by the RPE, leading to a lost of 
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function. Encouragingly, AAV carrying the AIPL1 gene restored the function and 
promoted the survival of photoreceptors upon sub-retinal injection into AIPL1-deficient 
mice (Tan et al., 2009). In a recent clinical trial primarily aimed at evaluating the safety 
profile of AAV-mediated therapy, three patients with LCA caused by mutation in the 
RPE65 gene were treated with AAV encoding for the correct copy of the gene 
(Bainbridge et al., 2008). A significant improvement in visual function was achieved in 
one patient; but more importantly, there was no adverse systemic reaction to the viral 
vectors, although temporary retinal detachment was observed which resolved six 
months after treatment.             
 
     However, despite the superior transfection efficiency of viruses, investigators have 
not abandoned all forms of non-viral research as there are limitations in the use of viral 
vectors. For example, the technical difficulty of scaling up virus production compliant 
to good manufacturing practices (GMP) may prevent such therapy from being cheaply 
accessible (Sheridan, 2011). The size of the construct that can be delivered is also 
limited. Above all, toxicity and immunogenicity (reviewed in Nayak & Herzog, 2010) 
provoked by the viral vectors can and have brought clinical trials to premature ends. 
Repeated administration is also not possible if the body has mounted a systemic 
immune response.  
 
     The danger of viral gene therapy was first illustrated about a decade ago by the death 
of Jesse Gelsinger (Hollon, 2000). Researchers were using experimental adenoviruses to 
correct his partial ornithine transcarbamylase deficiency affecting the ability of his body 
to metabolise nitrogen. Unfortunately, the systemic inflammatory response syndrome 
was triggered and he succumbed, rather rapidly, to multiple organ failure. In another 
high-profile example, stem cells transduced ex vivo with MLV were used to treat 
children suffering from X-linked severe combined immunodeficiency (Hacein-Bey-
Abina et al., 2003). However, MLV is an integrating retrovirus and can cause 
insertional mutagenesis, which is a phenomenon where random viral integration can 
trigger the activation of an oncogene or disrupt genes with tumor-suppressive 
properties. Consequently, several patients became leukemic and one has died so far 
(Sheridan, 2011). More recently, retroviruses were also used to treat two patients 
diagnosed with X-linked chronic granulomatous disease which affected the ability of 
their phagocytes to clear bacterial infections (Ott et al., 2006). Insertional mutagenesis 
Chapter one: Introduction 
 
 36
was again responsible for a clone of cells whose genes responsible for growth were 
activated, prompting fears that such cells may turn cancerous. In fairness, viral gene 
therapy is not expected to be perfect and its success should be assessed relative to 
currently available treatments. Nonetheless, researchers have yet to completely master 
the use of viruses. There is therefore still a demand for alternative non-viral vectors with 
safer profiles. 
 
1.6.3 Non-viral vectors 
     Diethylaminoethyl (DEAE)-dextran and calcium phosphate (CaPO4) were two of the 
earliest systems popular in the 1970s and 80s. DEAE-dextran has a cationic 
polysaccharide backbone and one of the earliest reports in 1965 used this polymer in a 
1:1 mixture with nucleic acids to transfect rhesus monkey kidney cells (Vaheri & 
Pagano, 1965). Authors of this study also insightfully commented that DEAE-dextran, 
like histones, could bind and protect nucleic acids from degradation. Although these are 
now fundamental concepts in modern carrier design, it may not be as obvious in the 
past. The co-precipitation of CaPO4 with DNA was described in 1973 when it was 
observed that Ca2+ (not Mg2+ or Na+) and PO42- ions, at high enough concentrations, 
could enhance DNA uptake (Graham & Eb, 1973). This technique was further shown to 
be sensitive to pH, amount of DNA used and even the level of CO2 in the incubator 
(Chen & Okayama, 1987). Using an optimised protocol, CaPO4-mediated transfection 
achieved up to 50% efficiency with a murine L cell line (Chen & Okayama, 1987). 
 
     Chitosan as a nucleic acid carrier has recently been reviewed (Mao et al., 2010). It is 
a polysaccharide obtained by the deacetylation of chitin, an exoskeletal component of 
crustaceans. Each deacetylation site contains a primary amine (pKa~6.5) which allows 
chitosan to bind nucleic acids. The degree of deacetylation also determines its 
biodegradability and transfection efficiency. Chitosan was first described as a plasmid 
carrier by Mumper and colleagues in 1995 and is known to be biocompatible, 
mucoadhesive and virtually non-toxic (MacLaughlin et al., 1998). As such, chitosan has 
been evaluated in rabbits, although reporter gene expression in that study was low 
(MacLaughlin et al., 1998). Strong interactions between high molecular chitosan and 
DNA were blamed for the overly-stable complexes that could not release their plasmid 
cargos. Conversely, using lower molecular weight chitosan improved in vitro 
transfection efficiency by up to 24 fold (Koping-Hoggard et al., 2004). Adding histidine 
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(pKa~6) residues to chitosan further improved buffering capacity and overall 
transfection efficiency (Chang et al., 2010). Recently, it was also shown that the 
introduction of thiol groups in N,N,N-trimethylated chitosan improved its efficiency as a 
siRNA carrier (Varkouhi et al., 2010). 
 
     Red blood cells (RBC) were used for the delivery of macromolecules before 
liposomes became popular. To function as carriers, RBC were first loaded up with the 
macromolecule under hypotonic conditions to induce mild lysis. A fusogen was then 
use to cause fusion with target cells. Using this technique, thymidine kinase and BSA 
were introduced into 3T3-4E mouse cells using Sendai virus as a fusogen (Schlegel & 
Rechsteiner, 1975). In another study, horseradish peroxidase (HRP) and 
immunoglobulins (IgG) were delivered into cells expressing hemagglutinin derived 
from influenza virus by exploiting the fusogenic activity of hemagglutinin under mildly 
acidic conditions (Doxsey et al., 1985). Fluorescent IgG and BSA were also delivered 
into human fibroblast cells using PEG as a fusogen (Wojcieszyn et al., 1981).    
 
     Plasmids were initially delivered by synthetic liposomes using concepts adapted 
from RBC technology. In an early study, plasmids were encapsulated within anionic 
liposomes and fused with tobacco mesophyll protoplasts using PEG (Deshayes et al., 
1985). Since 1987, however, surface binding became popular when liposomes made of 
N-[1-(2,3,-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) were 
synthesised for the first time (Felgner et al., 1987). DOTMA contains cationic 
quaternary ammonium groups which can be used for DNA binding. Lipofectin®, the 
prototypical lipid formulation and a workhorse for transfection experiments today, is a 
1:1 mixture of DOTMA and the neutral lipid, dioleoyl phosphatidylethanolamine 
(DOPE). In this formulation, DOPE functions as a fusogen to aid cellular uptake. 
Several other formulations of liposomes have been reported. For example, liposomes 
made out of DOPE and a novel cationic cholesterol derivative, 3β-[N-(N’,N’-
dimethylamino)ethane-carbamoyl] cholesterol (DC-chol), were prepared and used to 
transfect several cell lines with high efficiency (Gao & Huang, 1996). A mixture of 
N′,N′-dioctadecyl-N-4,8-diaza-10-aminodecanoylglycine amide (DODAG) and DOPE 
was also proposed as a novel liposomal formulation good for both DNA and siRNA 
delivery (Mével et al., 2010). In another study, the cationic lipid 1,2-dilinoleyloxy-3-
dimethylaminopropane (DLinDMA) was used as a starting template and systematically 
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modified to yield an optimised construct (Semple et al., 2010).  siRNA targeted against 
transthyretin, a hepatic gene of therapeutic potential, was then delivered into mice and 
monkeys intravenously using the optimised lipid formulation and respectable in vivo 
silencing activities were observed. Although toxicity remains one of the chief issues, 
liposomes are definitely one of the most successful non-viral vectors around. Already, 
several sustained-release liposomal drug formulations have been approved for human 
use and thermosensitive liposomes are being evaluated in clinical trials (Hossann et al., 
2010). Lipids also dominate gene therapy trials aimed at using non-viral vectors to treat 
cystic fibrosis (Griesenbach & Alton, 2009). 
 
     An advantage of using polymeric carriers is that they offer so much structural 
diversity that their potential should (theoretically) be limited only by the imagination of 
chemists. Two of the more archaic examples including PVP and PVA have been 
mentioned. Poly(D,L-lactic-co-glycolic acid) (PLGA), a polymer originally developed 
for controlled drug release, has also been used to encapsulate plasmids for delivery 
(Wang et al., 1999). Most polymeric carriers, however, are cationic in nature. Dendritic 
poly(amido amine) (PAMAM) which contained primary amines for DNA binding was 
further decorated with PEG and sugars (Wood et al., 2005) or peptide (Wood et al., 
2008) for targeting purposes. Linear PAMAM was functionalised with disulfide bonds 
to make the polymer biodegradable and various chemical side-groups were attached to 
test for its impact on transfection efficiency (Lin et al., 2007). A large library of poly(β-
amino ester)s has also been synthesised and systematically screened for transfection 
efficiency (Green et al., 2006). The effects of molecular weight and charge density of 
polyphosphoramidates (PPA) on DNA binding and buffering capacity have been 
reported (Ren et al., 2010). Poly(2-(dimethyl-amino)ethylmethacrylate) (PDMAEMA) 
was also shown to transfect cells with high efficiency (Lin et al., 2008). Indeed, there 
are more classes of polymers being developed than this paragraph can give justice to. 
However, amongst all, the most notable polymer must be PEI.  
 
     PEI was first developed in 1995 (Boussif et al., 1995) and is frequently used in its 
branched, high molecular weight (usually 25 kDa) form. Together with liposomes, they 
are widely acknowledged to be the best non-viral vectors currently available (Putnam, 
2006) and frequently serve as standards to which other novel carriers are referenced. A 
key feature of PEI is that nitrogen (in a mixture of primary, secondary and tertiary 
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amines) accounts for a third of its molecular weight. Since different classes of amines 
possess characteristic pKa, this ensures that not all the nitrogens will be protonated at a 
given pH. Furthermore, the proximity of the nitrogen atoms also means that a 
protonated amine can suppress the protonation of its neighbours due to the energetic 
penalty that gets incurred by situating like charges adjacent to one another (Suh et al., 
1994). This blend of protonated and yet-to-be protonated amines is then suggested to 
endow PEI with its strong DNA binding and buffering abilities. The intracellular 
trafficking properties of PEI/DNA complexes has been studied (Godbey et al., 1999) 
and targeting moieties such as mannose (Diebold et al., 1999) and transferrin (Kircheis 
et al., 1997) were also coupled onto PEI. However, two main concerns of using PEI are 
its toxicity and non-biodegradability. In response to the latter, PEI was functionalised 
with reducible disulfide bonds (Lee et al., 2007) or hydrolysable ester bonds (Liu et al., 
2008) to facilitate biodegradation and at the same time, to aid its plasmid release. 
 
1.7 Peptide-derived vectors for gene therapy 
     Peptide chains can be fabricated from any of the 20 naturally occurring L-amino 
acids. Peptides are thus biocompatible and often degradable. Peptide synthesis also does 
not involve harmful catalysts, which is a concern of some polymeric carriers. 
Furthermore, synthesis can now be automated, courtesy of advances in solid phase 
peptide synthesis, which makes the manufacturing process amendable to up-scaling. 
 
     Before peptides were seen as proper DNA carriers, studies conducted in the 1960s 
with histones had already suggested that cationic amino acids such as lysine and 
arginine can be useful (Akinrimisi et al., 1965). Today, peptide vectors are given 
fanciful names such as “cell penetrating peptides” (CPP) or “protein transduction 
domains” (PTD) to celebrate their ability to efficiently penetrate the plasma membrane 
and mediate the entry of nucleic acids or other macromolecules. Such CPP can be 
derived from proteins existing in nature (e.g., viral proteins or venom proteins of bees 
and wasps) or designed de novo. There is little in common among CPP and the only 
unifying theme seems to be the significant presence of cationic residues (mainly lysine 
and arginine). Amphipathicity has been suggested to be another common feature (Zorko 
& Langel, 2005). However, this is only true for most CPP – oligoarginine being an 
exception. There are two methods by which peptide vectors carry their cargoes. Nucleic 
acids are usually non-covalently (electrostatically) attached, while proteins and other 
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macromolecules are typically covalently coupled (chemical cross-linking or by plasmid 
fusion). The advantages of electrostatic attachment include convenience and the largely 
unaltered chemical properties of the cargo. However, charge interactions are non-
specific and excess peptides are usually needed to bind the plasmid. On the other hand, 
covalent attachment requires chemical modification of the cargo and usually results in 
stable complexes which, as discussed earlier, may not be desirable. In the following 
sections, we review the key classes of peptide vectors and provide non-exhaustive 
examples of strategies that have been used to improve their efficiency as vectors. 
 
Peptide Sequence Short description 
Poly-L-lysine Kn Frequently, n = 50-400 
Tat YGRK KRRQ RRRP PQ HIV-derived, sequence 47-60 
Oligoarginine Rn Frequently, n = 7-9 
Penetratin RQIK IWFQ NRRM KWKK 3rd helix of Antennapedia 
homeodomain 
Tp GWTL NSAG YLLG KINL 
KALA ALAK KIL 
Galanin + mastoparan (wasp venom) 
Tp10 AGYL LGKI NLKA LAAL 
AKKI L 
First 6 residues deleted from TP 
VP22 300-residue long sequence given 
in (Elliott & O’Hare, 1997) 
HSV-1 structural protein 
MPG GALF LGFL GAAG STMG 
AWSQ PKSK RKV 
HIV gp41 + SV40 T-antigen 
CADY GLWR ALWR LLRS LWRL 
LWRA 
Peptide carrier PPTG1-derived 
KALA WEAK LAKA LAKA LAKH 
LAKA LAKA LKAC EA  
Membrane disruptive peptide, also a 
carrier 
GALA WEAA LAEA LAEA LAEH 
LAEA LAEA LEAL AA 
Membrane disruptive peptide 
EB1 LIRL WSHL IHIW FQNR 
RLKW KKK 
Penetratin analogue  
HA2 GLFG AIAG FIEN GWEG 
MIDG 
Influenza virus hemagglutinin protein 
INF5 (GLFE AIEG FIEN GWEG 
nIDG)2K 
HA2-derived, lysine-connected dimer. 
n = norleucine 
INF7 GLFE AIEG FIEN GWEG 
MIDG WYG 
HA2-derived, monomer 
SV40 PKKK RKV Simian virus 40 T antigen NLS 
Melittin GIGA VLKV LTTG LPAL 
ISWI KRKR QQ 
Bee venom 
 
Table 3. The amino acid sequences of all peptides discussed in this chapter.  
 
 
 
1.7.1 Poly-L-lysine (PLL) 
     The amino acid sequence of PLL and all other peptides subsequently discussed can 
be found in Table 3. PLL is the first peptide-based vector to be studied intensively. The 
molecular weight of PLL spans a wide range and depends on the number of repeating 
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units of lysine within a chain, or its degree of polymerisation (DP). For the sake of 
discussion, the molecular weight of PLL is arbitrarily classified as follows: oligolysine 
(DP<20), low (20≤DP<50), medium (50≤DP≤400) or high (DP>400). Most studies use 
PLL of medium molecular weight.  
 
     PLL has been successfully employed to deliver a host of different cargos. By 
covalently coupling human serum albumin or HRP to PLL via amide bonds in a 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide (EDC) catalysed reaction, proteins were 
delivered into L929 mouse fibroblasts for the first time using such a PLL-mediated 
strategy (Shen & Ryser, 1978). More recently, streptavidin-conjugated quantum dots 
(QD) were also attached to biotin-tagged PLL and delivered into HeLa cells (Mok et al., 
2008). However, PLL is most frequently used to deliver nucleic acids where 
electrostatic attachment is preferred. Although polylysine made out of D-amino acids 
has been suggested to transfect better – presumably because they are more resistant to 
enzymatic degradation (Mitchell et al., 2000) – PLL continues to be favoured. Wu and 
partner provided one of the earliest examples of PLL being used to condense plasmids 
for receptor-mediated delivery (Wu & Wu, 1987). In that study, asialoorosomucoid 
(ASOR) was first covalently attached to PLL with N-succinimidyl 3-(2-pyridyldithio) 
propionate (SPDP) as a linker and then used to bind a reporter plasmid. The resultant 
complexes were then shown to accumulate within HepG2 cells (ASOR receptor 
positive) but not in SK-Hep1 cells (ASOR receptor negative).    
 
     Plasmids dissociated more slowly if bound to a higher molecular weight PLL and 
this can negatively affect transfection (Schaffer et al., 2000). To facilitate plasmid 
release, cysteine residues were added to oligolysine, which was then cross-linked using 
disulfide bonds (McKenzie et al., 2000). The intention was to make use of the 
intracellular environment – which is much more reductive due to its elevated levels of 
glutathione (Lee et al., 2007) – to break down the disulfide bonds for polymer 
disintegration and plasmid release. The number of lysine, cysteine and histidine (for 
buffering capacity) residues used and the spacing and ordering between the residues 
were found to influence the final performance of the vector. Upon optimisation, some 
constructs achieved levels of transfection that were comparable or even higher than that 
obtained with LipofectAce, a commercial reagent used as a positive control (McKenzie 
et al., 2000). Disulfide-linked oligolysine was then further functionalised with 
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triantennary N-glycan signals to target hepatocytes and evaluated in vivo (Kwok et al., 
2003). However, contrary to results in vitro, the particles were now not stable enough in 
the reductive intracellular liver environment and premature plasmid release ultimately 
limited gene expression.  
 
     PLL by itself is generally not considered to be an efficient vector (Meyer et al., 
2008) and is frequently coupled with other agents. The imidazole headgroup of histidine 
(pKa~6) can provide endosomal buffering and has been added to PLL to boost 
transfection (Midoux & Monsigny, 1999). Histidine was also added to a K15-based 
oligopeptide, which was then self assembled into cationic micelles for the co-delivery of 
drug and gene (Wiradharma et al., 2009). The HA2 subunit of the hemagglutinin 
glycoprotein present on the surface of influenza virus plays an important role in the 
endosomal escape of viruses. To do this, HA2 exhibits a pH-dependent membrane 
fusion activity. HA2 is not normally lytic at neutral pH. However, protonation of its 
acidic residues during endo/lysosomal transition triggers HA2 to adopt a more α-helical 
secondary conformation. At the same time, it exposes a highly-conserved hydrophobic 
sequence which then interacts and destabilises the endosomal membrane (Wagner et al., 
1992a). To exploit this membrane-disrupting mechanism, 20 amino acids corresponding 
to the N-terminus of HA2 were attached to PLL via cysteine-mediated disulfide bonds. 
The HA2-functionalised PLL was then shown to induce pH-dependent liposomal 
leakage (Wagner et al., 1992a) and to augment transfection to a greater extent than the 
use of chloroquine (Midoux et al., 1993). Melittin, a major component of bee venom, is 
another peptide with fusogenic activity but unlike HA2, melittin is unresponsive to pH. 
As such, it remains fusogenic at pH 7 and can indiscriminately disrupt plasma 
membranes (Chen et al., 2006). To confine fusogenic activity within the endosomes, 
dimethylmaleic anhydride protecting groups were attached to mask the activity of 
melittin at neutral pH. Upon cleavage of the protecting groups under acidic conditions, 
the activity of melittin was restored (Meyer et al., 2008). This protected form of melittin 
was then coupled to PLL via a cysteine-mediated disulfide bond and the entire construct 
mediated siRNA knockdown more efficiently than PEI. Adenovirus, known to display 
pH-dependent membrane disruption as part of its infectious cycle (Curiel et al., 1991), 
has also been coupled to PLL to improve transfection efficiency. Human adenovirus 
type 5 (dl312) was either biotinylated and coupled to a streptavidinylated PLL (Wagner 
et al., 1992b), or simply added as free viral particles into the culture medium to be taken 
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up together with the PLL complexes (Curiel et al., 1991). Chicken embryo lethal orphan 
virus, an adenovirus from a more distant species, was also attached to PLL and 
augmented transfection as well as human adenovirus (Cotten et al., 1993).  
 
     Various signals have also been added onto PLL to improve its uptake or target 
specificity. For instance, galactose containing an isothiocyanate group was reacted with 
the amine groups on PLL to form a thiourea bond and used to mediate gene expression 
in the livers of rats for up to 140 days (Perales et al., 1994). Mannose and lactose were 
also used to target cell lines that have receptors for the specific sugar (Midoux et al., 
1993). ASOR was coupled onto PLL in an EDC catalysed reaction and intravenously 
injected into rats (Wu et al., 1989). However, reporter gene expression by liver cells 
was only transient and disappeared by day four. Transferrin was coupled with PLL via 
disulfide bonds in a SPDP-mediated reaction to increase its accumulation within cells 
(Wagner et al., 1991). Insulin was also coupled to PLL in an SPDP-mediated reaction 
and used with adenovirus (biotin-streptavidin conjugated) to deliver plasmids into pre-
implantation mammalian embryos (Ivanova et al., 1999). PEG was grafted onto PLL via 
amide bonds in an N-hydroxysuccinimide (NHS) catalysed reaction and helped in 
preventing particle aggregation (Rimann et al., 2008). Stearyl-PLL mixed with a low 
density lipoprotein was also used to condense plasmids (~600 nm) into ~100 nm 
complexes, as measured by atomic force microscopy (Kim et al., 1998). Further, the 
lipoprotein was found to be essential for efficient uptake. Finally, peptides themselves 
can serve as targeting signals. For example, a short peptide sequence 
(GACRRETAWACG) suggested to target α5β1 integrins was linked to K16 and mixed 
with Lipofectin® to transfect neuroblastoma cells (Lee et al., 2003). Several groups 
have also used the RGD motif to target integrins. A recent example involved RGD 
being linked to K16 peptides, which were then injected with an intracellularly cleavable 
PEG-lipid formulation to deliver plasmids into mice bearing subcutaneous tumors 
(Tagalakis et al., 2011). The integrin-targeting signal was shown to be important. Upon 
augmentation by the enhanced permeation and retention effect, the complexes were 
mainly distributed to the tumor. 
 
1.7.2 Tat 
     Full length tat has 86 amino acids (sequence 1-86) and it is a regulatory protein 
encoded by HIV-1 that transactivates viral gene expression. The ability of tat to cross 
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cell membrane was initially observed by two groups independently in 1988 (Frankel & 
Pabo, 1988; Green & Loewenstein, 1988). In one study, tat was simply added to a 
culture of HL3T1 cells modified to contain an integrated copy of chloramphenicol 
acetyltransferase (CAT, a reporter gene) under the control of the HIV-1 LTR (long 
terminal repeat) promoter and CAT expression was unexpectedly detected (Frankel & 
Pabo, 1988). Crucially, the amount of CAT expression was dependent on the dosage of 
tat. Unlike earlier experiments, tat did not require any help from the scrape loading 
technique to enter cells. Tat was further dissected into five regions and region II and III, 
together spanning roughly residues 38-62 were identified to be essential and sufficient 
for transactivation activity (Green & Loewenstein, 1988). Region III (roughly residues 
49-62), in particular, was interesting as it was rich in arginine and lysine. Furthermore, 
replacing the three arginines at position 55-57 with alanines drastically reduced 
transactivation activity. Tat was also observed to localise in the nucleus and thought to 
be a NLS (Green & Loewenstein, 1988).     
 
     The region surrounding the arginine and lysine rich domain of tat was keenly 
evaluated as a gene carrier. Today, tat is seldom used in its full length and among the 
many truncated versions being studied (Table 4), tat 47-57 and 48-60 are the two most 
popular sequences. The in vivo half life of free tat 47-57 was calculated to be about 3.5 
minutes (Grunwald et al., 2009) and tat 48-60 exists as an unstructured random coil in 
buffer solutions (by circular dichroism) or when bound to lipid vesicles (by flow linear 
dichroism) (Caesar et al., 2006). 
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Entry Sequence Reference 
1 1-86 Green & Loewenstein, 1988 
2 1-72 Frankel & Pabo, 1988 
3 37-72 Fawell et al., 1994 
4 37-57 Leonetti et al., 2010 
5 43-60 Eguchi et al., 2001 
6 47-57 Wang et al., 2010 
7 48-57 Wadia et al., 2004 
8 48-58 Fittipaldi et al., 2003 
9 48-59 Richard et al., 2005 
10 48-60 Eiriksdottir et al., 2010 
11 49-57 Saleh et al., 2010 
12 49-60 Astriab-Fisher et al., 2000 
 
Table 4. Heterogeneity in tat sequences being reported in the literature. All sequences 
are with respect to the original sequence 1-86 in the first entry. Only one reference is 
provided for each entry, although more may be discussed in text. 
 
     Proteins have been delivered by tat and are usually covalently attached. Fawell and 
colleagues were the first to chemically conjugate several different proteins onto tat 37-
72 (Fawell et al., 1994). One of the model proteins used was β-galactosidase (β-gal), 
which was grafted onto tat using succinimidyl 4-(N-maleimidomethyl)-cyclohexane-1-
carboxylate (SMCC) as a heterobifunctional cross-linker. The β-gal/tat conjugate was 
then intravenously injected into mice and found to accumulate mainly in the heart, liver 
and spleen. In a separate study, β-gal/tat 47-57 conjugates were generated by plasmid 
fusion and injected intraperitoneally into mice (Schwarze et al., 1999). The conjugates 
were then found to be distributed to all tissues, even across the tight blood-brain-barrier. 
GFP/tat 47-57 fusion protein was also delivered into cells and uptake was increased by 
pretreatment with 10% dimethylsulfoxide (DMSO) for one hour prior to transfection 
(Wang et al., 2010). Other classes of macromolecules delivered by tat include peptide 
nucleic acid (PNA), which are artificial nucleic acid-mimicking polymers. PNA was 
either conjugated to tat 48-59 using 2-aminoethoxy-2-ethoxyacetic acid as a cross-linker 
(Richard et al., 2003) or linked via a disulfide bond to a cysteine-modified tat 48-60 
(Lundin et al., 2008) for delivery. 
 
     Nucleic acids, on the other hand, are mostly electrostatically carried by tat. For 
instance, tat 48-60 was used to deliver reporter plasmids into HeLa cells and it was 
shown that efficiency can be further improved by adding the SV40 NLS and a 
dendrimer of seven lysine residues (Yang et al., 2009a). A short membrane active 
peptide, LK15 (KLLKLLLKLLLKLLK) was also conjugated onto tat 49-57 and used 
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for plasmid transfection (Saleh et al., 2010). Antisense oligonucleotides were linked via 
disulfide bonds to cysteine-modified tat 49-60 and delivered into cells to inhibit the 
expression of P-glycoprotein, a transmembrane pump that is responsible for the 
multidrug resistance phenotype of tumor cells (Astriab-Fisher et al., 2000). siRNA was 
also delivered by tat 47-57 and interestingly, photostimulation promoted the escape of 
tat complexes into the cytosol (Endoh et al., 2008). Reactive oxygen species produced 
during laser illumination was postulated to damage the endosomal vesicles for enhanced 
cytosolic access. Finally, tat has played the role of a helper. As an internalisation 
enhancer, tat 43-60 was displayed on the surfaces of phage particles to augment the 
delivery of plasmids encapsulated within the phages (Eguchi et al., 2001). In another 
study, tat 47-57 was used as a NLS during the transfection of CHO cells (Moore et al., 
2009). Unlike many other systems, the presence of serum augmented tat-mediated 
transfection (Astriab-Fisher et al., 2000; Brooks et al., 2005; Eguchi et al., 2001). 
 
     Although tat can deliver nucleic acids and other macromolecules, the pathway(s) 
which tat exploits to do so is unclear. There is little consensus in the literature, except 
for the observation that heparan sulphate, an anionic cell membrane glycosaminoglycan, 
is crucial for uptake (Sandgren et al., 2002; Tyagi et al., 2001). Interestingly, other 
glycosaminoglycans such as chondroitin sulphate and dermatan sulphate have been 
ruled out in the binding/internalisation of full length tat 1-86 (Tyagi et al., 2001) and tat 
37-57 (Leonetti et al., 2010), but not for the shorter tat 48-60 (Sandgren et al., 2002). 
 
     Classical endocytosis is an energy- and ATP-dependent mechanism. For the sake of 
discussion, endocytosis can be classified into clathrin-mediated endocytosis, caveolae-
mediated endocytosis, macropinocytosis and other forms of clathrin- and caveolae-
independent endocytosis (Figure 4). Prompted by the observation that tat 48-60 was 
internalised at 4°C, a temperature normally considered inhibitory for endocytosis, an 
energy-independent pathway was initially suggested to be responsible (Futaki et al., 
2001b). Another group similarly detected low-temperature internalisation of tat 43-60 
and reported that uptake was independent of endocytosis but required the presence of 
caveolae (Eguchi et al., 2001). The ability of free tat 47-57 to enter cells in the presence 
of sodium azide, which blocks intracellular ATP synthesis, also led the authors to 
preclude endocytosis as the uptake mechanism (Ignatovich et al., 2003).  
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Figure 4. Uptake by a cell can occur via any of the above pathways. 
 
 
 
     Several models of energy-independent uptake have been proposed. However, a 
common theme seems to involve the peptide sticking to the cell membrane and creating 
a local mass imbalance. At the same time, it transforms itself into a more non-polar 
compound either due to charge neutralisation (Su et al., 2009) or hydrogen bonding 
(Rothbard et al., 2004) with the anionic membrane proteins. The peptide then partitions 
into the hydrophobic lipid bilayer (Rothbard et al., 2002) and translocates through the 
membrane in a process that is driven by the voltage potential across membrane 
(Rothbard et al., 2004) and/or the need to relieve membrane curvature stress caused by 
the mass imbalance in the initial step (Su et al., 2009). 
 
     In stark contrast, Richard and colleagues reported that the uptake of tat 48-59, in 
both its free and PNA-conjugated forms were sensitive to low temperature and sodium 
azide, indicative of classical endocytosis (Richard et al., 2003). Endocytosis is also 
believed to be responsible for the uptake of protein-conjugated tat 37-72 in another 
study (Fawell et al., 1994). Having agreed that the uptake of tat requires energy, 
opinions are once again divided regarding which of the specific endocytosis pathways 
are involved. For instance, a study singled out clathrin-mediated endocytosis as the 
pathway responsible for the uptake of unconjugated tat 48-59 (Richard et al., 2005). In 
others, caveolae-mediated endocytosis was suggested to be the dominant form of uptake 
for GFP/tat 48-60 fusion protein (Ferrari et al., 2003), and also for GFP/tat 48-58 and 
GFP/tat 1-86 fusion proteins (Fittipaldi et al., 2003). To confound matters, 
macropinocytosis was reported to be mainly responsible for the uptake of PNA-
conjugated tat 48-60 (Lundin et al., 2008) and tat 48-57 fusion protein (Wadia et al., 
2004). In yet another twist, multiple pathways involving both clathrin-mediated 
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endocytosis and macropinocytosis were proposed for the internalisation of unconjugated 
tat 48-60 (Räägel et al., 2009). 
 
     With this amount of confusion in the literature, is there hope of reconciliation? It 
seems that the first step is to recognise that there may not be a single mechanism 
responsible for the uptake of tat or, indeed, all other CPP. CPP are thus unlike 
transferrin (Rejman et al., 2004) or cholera toxin (Torgersen et al., 2001), which are 
accepted to be internalised exclusively via the clathrin- and caveolae-mediated pathway 
respectively in a wide variety of cells. The outcome being observed depends on the 
combination of cell/peptide/detection method chosen for that experiment and 
heterogeneity in conclusion can be expected due to the following reasons. 
 
     Cell: Different cell lines can use different pathways to internalise tat (Brooks et al., 
2005). The nature of cells (primary versus immortalised or adherent versus suspension) 
(Eiriksdottir et al., 2010) and culture conditions such as the type of growth medium 
used (Moulton et al., 2004), passage number of cells or even the Young’s modulus 
(Kong et al., 2005) of the substrate were suggested to influence transfection and uptake. 
 
     Peptide: As can be seen from Table 4, there are at least 12 distinct sequences under 
the same umbrella name of tat – more if one considers chain terminal addition. 
Considering that simply modifying a few residues can drastically affect the property of 
tat, as discussed earlier, it is understandable why the literature cannot seem to agree. 
The concentration of peptide used was also shown to be important. For instance, it was 
reported that below 10 mM, unconjugated tat 47-57 exploited both macropinocytosis 
and caveolae-mediated endocytosis to gain entry but once above 10 mM, a non-
endocytosis mechanism seemed to operate (Duchardt et al., 2007). Perhaps there is a 
concentration threshold above which there is sufficient amount of surface-bound 
peptide to cause the mass imbalance and trigger direct transport through the membrane. 
Finally, the absence or presence of a cargo and the nature of the cargo can also 
influence the mechanism of uptake. For example, unconjugated tat 47-57 was reported 
to enter cells using an energy-independent mechanism but endocytosis was responsible 
upon DNA binding (Ignatovich et al., 2003). 
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     Detection method: This will be discussed in Chapter four, together with results from 
this thesis. 
 
1.7.3 Oligoarginine (Argn, usually n = 7 to 9) 
     The potential of using arginine for gene delivery was firmly established when it was 
shown that replacing most of the arginine residues in tat 1-86 with alanine drastically 
reduced internalisation (Tyagi et al., 2001). Replacing the arginine residues within tat 
48-60 with lysine had a similar effect and abolished internalisation (Thoren et al., 
2004). Clearly, arginine residues are crucial. However, another important (but less 
obvious) message from these experiments is that arginine is more than just a cationic 
residue as replacing it with lysine, another cationic residue, is not good enough.    
 
     Oligoarginine of various lengths have been evaluated. In one study, oligoarginine 
with 4, 6, 8, 10, 12 or 16 residues were compared and it was found that both arg4 and 
arg16 were poorly taken up by cells (Futaki et al., 2001b). Instead, arg8 exhibited the 
highest rate of internalisation both in its free form or when linked via a disulfide bond to 
a model carbonic anhydrase protein. This demonstrated that cationic charge was not 
sufficient to afford efficient uptake. Consistent with this, another study showed that arg7 
was internalised much more efficiently into Jurkat cells than lys7 and his7 (Mitchell et 
al., 2000). There was therefore something unique about the chemical structure of 
arginine that cannot be explained simply by it carrying a cationic charge. Indeed, the 
guanidine (pKa~12) sidegroup of arginine was determined to be key as replacing it with 
a urea (pKa~0.1) sidegroup removed internalisation. Urea differs from guanidine by 
only a single nitrogen atom, which in the former is replaced by an oxygen atom. 
However, this simple modification removed not only the ability of urea to protonate at 
neutral pH, but also its ability to form hydrogen bonds. This ability to form stable 
hydrogen bonds with the anionic phosphates and sulphates on cell membrane was then 
suggested to be the feature that distinguished arginine from lysine and histidine in terms 
of translocation efficiency (Mitchell et al., 2000).  
 
     The spacing between arginine residues can also influence internalisation (Rothbard 
et al., 2002). To study this, a library of oligoarginines was synthesised, all having seven 
residues but separated by 1-6 spacers at all the possible permutations. The addition of 
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spacers was argued to impart flexibility to the arginine backbone which catered for 
better cell membrane translocation.     
 
     A length of 7-9 arginines is usually preferred and the chains exist as random coils in 
buffer solutions or when bound to lipid vesicles (Caesar et al., 2006). Both D- and L-
arginines have been explored with some authors preferring D-arginines (Hyun et al., 
2010; Puckett & Barton, 2009) and others finding no difference between the 
stereoisomers (Mitchell et al., 2000; Nakase et al., 2004). Cargoes of different nature 
have been delivered. Negatively charged QCs were electrostatically bound to arg8 and 
delivered into adipose tissue-derived stem cells for imaging purposes (Yukawa et al., 
2010). The anti-cancer drug, taxol was covalently bound to arg8 via disulfide bonds 
using a novel linker to increase its water solubility and uptake. The drug was also 
designed to be released intracellularly so as to combat multidrug resistant cell lines 
which otherwise have limited accumulation of chemotherapeutic drugs (Dubikovskaya 
et al., 2008). The immunosuppressive drug, cyclosporine A, was coupled with arg7 
using a novel pH-sensitive linker and used for topical delivery in a skin inflammation 
model (Rothbard et al., 2000). Phosphorodiamidate morpholino oligomers (PMO) are 
antisense molecules that interfere with mRNA translation but structurally differ from 
nucleic acids in several aspects. In one study, PMO was electrostatically carried by an 
arg9-based carrier, but the efficiency was not as good as covalently linked ones 
(Moulton et al., 2004). In another study, a short peptide sequence corresponding to the 
C-terminus of the cystic fibrosis transmembrane regulator was joined to arg7 during 
synthesis and laser illumination was used to trigger the release of the conjugate into the 
cytosol of U2OS cells (Maiolo-III et al., 2004). siRNA was electrostatically carried by 
an arg8-based vector and used to transfect mouse bone marrow-derived dendritic cells 
(Akita et al., 2010). Finally, D-arg9 with cysteines added on both terminals (i.e., cys-
arg9-cys) was crosslinked via disulfide bonds to form a mesh of reducible 
poly(oligoarginine) (Hyun et al., 2010). The carrier was then used to deliver plasmids 
encoding for heme oxygenase-1 (useful for the treatment of ischemia/reperfusion-
induced brain stroke) by direct injection into the brain of mice. 
 
     Several modifications have been made to oligoarginine to improve its transfection 
efficiency. For example, arg8 has been combined with GALA, a pH sensitive fusogenic 
peptide to enhance its endosomal escaping property (Akita et al., 2010). The addition of 
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a hydrophobic stearyl chain to arg8 was also shown to greatly increase its transfection 
ability (Futaki et al., 2001a). This was thought to be due to a better association between 
the hydrophobic moieties on the vector and the lipid bilayer (Putnam, 2006). 
Cholesterol was also added to the hydrophobic end of a his5/10-arg10 vector for efficient 
gene delivery (Guo et al., 2008). Indeed, a certain degree of hydrophobicity is a 
common feature of many efficient vectors.      
 
     Low-temperature internalisation was observed and energy-independence was 
originally proposed to characterise the uptake of oligoarginine (Futaki et al., 2001b). 
However, this observation was made with fixed cells. In response to studies that had 
exposed the flaws of using fixed cells (Richard et al., 2003), authors of the original 
study re-evaluated the uptake mechanism using live cells. Consequently, they reported 
macropinocytosis to be a major, but not exclusive pathway for the uptake of 
oligoarginine (Nakase et al., 2004). Macropinocytosis was also proposed to be the main 
form of uptake for protein-conjugated (Takayama et al., 2009) and siRNA-bound arg8 
(Akita et al., 2010). Nonetheless, an energy-independent form of uptake was still 
suggested if the concentration of unconjugated arg9 exceeded 10 mM – otherwise, 
macropinocytosis and caveolae-mediated, but not clathrin-mediated endocytosis seemed 
important (Duchardt et al., 2007). Another study reported that both clathrin-mediated 
endocytosis and macropinocytosis play a role for the uptake of unconjugated arg9 
(Räägel et al., 2009). Finally, an energy-dependent but non-endocytosis mechanism was 
also proposed to be responsible for uptake (Mitchell et al., 2000). Like tat, there is little 
consensus over the internalisation pathway(s) of oligoarginine, although endocytosis is 
generally accepted to play a key role in most cases (Richard et al., 2003). 
 
1.7.4 Penetratin 
     Homeoproteins are regulatory proteins essential for proper physical development. 
The DNA binding domain of these proteins is made up of a highly conserved sequence 
known as the homeobox. The homeobox of the Drosophila antennapedia (pAntp) is 60-
amino acid long (sequence 1-60) and contains three α-helices (Derossi et al., 1994). 
pAntp was first discovered to effectively translocate into nerve cells and accumulate 
within their nuclei (Joliot et al., 1991). To demonstrate the usefulness of pAntp as a 
carrier, a 33-residue peptide cargo corresponding to the C-terminus of rab3, a GTP-
binding protein in human, was linked to pAntp via plasmid fusion and shown to 
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translocate into the nuclei of myoblasts and neurons (Perez et al., 1992). A study later 
revealed that the third helix was actually the domain driving internalisation (Roux et al., 
1993). Based on this, penetratin, a 16-residue peptide within the third helix (sequence 
43-58 of the original pAntp) was described (Derossi et al., 1994). Penetratin 
demonstrated membrane penetrating ability but was prone to aggregation. Aggregated 
particles can enjoy better internalisation due to a sedimentation effect which promotes a 
more intimate particle-cell contact (Luo & Saltzman, 2000b). While this may have 
helped the internalisation of penetratin, aggregation alone was excluded as the dominant 
reason for its efficient internalisation (Derossi et al., 1994).       
 
     The secondary structure of penetratin in buffer is unstructured but becomes α-helical 
when bound to lipid vesicles (Caesar et al., 2006). Raman microscopy on live cells 
further showed that penetratin within the cytosol was either unstructured or in the β-
sheet conformation (Ye et al., 2010). The arginine residues within penetratin are 
important as replacing them with lysine greatly reduced translocation (Caesar et al., 
2006). Various cargoes have been carried by penetratin. Antisense oligonucleotides 
(Astriab-Fisher et al., 2000), PNA (Lundin et al., 2008) and luciferin protein 
(Eiriksdottir et al., 2010) have all been coupled onto a cysteine-modified penetratin via 
disulfide bonds and delivered into cells. siRNA was electrostatically bound to penetratin 
and although the complexes accumulated favourably within cells, there was limited 
silencing activity (Lundberg et al., 2007). HA2 was then added to enhance endosomal 
escape but produced only a modest improvement. Penetratin has been evaluated in vivo. 
In one study, penetratin was directly injected into a rat’s brain and the peptide was 
observed to spread away from the site of injection (Bolton et al., 2000). However, 
dosage-dependent cell death and inflammatory responses were also provoked.     
 
     Penetratin was initially suggested to enter cells using energy-independent 
mechanisms (Derossi et al., 1994; Perez et al., 1992; Roux et al., 1993), but a caveat is 
that fixed cells were used in those studies. Nonetheless, an energy-independent 
mechanism was still suggested to be possible past a concentration threshold of 40 mM, 
below which all three forms of endocytosis should dominate (Duchardt et al., 2007). 
Endocytosis was also reported to be responsible for the uptake of siRNA-bound 
penetratin (Lundberg et al., 2007) while macropinocytosis was suggested to be the main 
form of uptake for PNA-conjugated penetratin (Lundin et al., 2008).     
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1.7.5 Transportan (Tp) and Tp10 
     Tp uses a lysine residue to join the first 12 N-terminus residues of the neuropeptide, 
galanin, to the 14 C-terminus residues of the wasp venom, mastoparan. Tp is thus 27 
residues long (sequence 1-27) and was first shown to penetrate Bowes’ melanoma cells 
rapidly and efficiently (Pooga et al., 1998). However, Tp at a high concentration was 
found to inhibit the GTPase activity of cells. To overcome this side effect, a series of Tp 
analogues was prepared in which amino acids were omitted from the original Tp 
sequence (Soomets et al., 2000). This led to the identification of Tp10 which, upon 
deleting the first 6 residues of Tp (i.e., sequence 7-27 remaining), was internalised as 
efficiently as Tp but did not have any effect on the GTPases. 
 
     PNA (Lundin et al., 2008) and luciferin (Eiriksdottir et al., 2010) were conjugated to 
both cysteine-modified Tp and Tp10 via disulfide bonds. siRNA was also 
electrostatically bound to Tp10 but had little silencing effects when transfected into 
cells (Lundberg et al., 2007). This was surprising insofar as Tp10 was previously shown 
to mediate good levels of plasmid expression. This however resonates with comments 
made by other researchers (Mahon et al., 2010; unpublished observation) who had 
observed that a carrier’s efficiency in plasmid delivery may not automatically apply to 
the delivery of the shorter and stiffer siRNA molecules. Earlier studies with fixed cells 
reported low temperature internalisation of Tp (Pooga et al., 1998) but more recent 
observations have linked endocytosis to the uptake of both Tp (Räägel et al., 2009) and 
Tp10 (Lundberg et al., 2007). 
 
1.7.6 Other notable peptide sequences 
     VP22 is a 300-residue long peptide derived from the structural protein of HSV-1 and 
has been used successfully to deliver GFP as a fusion protein (Elliott & O’Hare, 1997). 
When COS-1 cells were microinjected with plasmids encoding for VP22, an interesting 
pattern was observed in which a central cell would first express VP22 and exhibit 
cytosolic staining when probed with anti-VP22 antibodies. The VP22 peptide was then 
excreted and could infect neighbouring cells before eventually localising to their nuclei. 
CADY is a 20-residue long peptide evaluated for siRNA delivery (Crombez et al., 
2009). It changes from unordered to α-helices in the presence of lipid vesicles which 
then drives its internalisation independently of the endosomal pathway (Konate et al., 
2010). MPG is a 27-residue peptide designed to have a hydrophobic domain (sequence 
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1-17) derived from HIV gp41 and a NLS domain (sequence 21-27) derived from SV40 
(Morris et al., 1997). The uptake of MPG/oligonucleotide complexes was shown to be 
rapid and independent of the endosomal pathway. Other carriers explored for delivery 
include KALA (Wyman et al., 1997) and EB1 (Lundberg et al., 2007).  
 
     Throughout the discussion, various peptides with fusogenic and nuclear localising 
properties were introduced. SV40 is the classical NLS and different sequences exist. 
The most commonly used sequence for SV40 is provided in Table 3. Other sequences 
include “glu-asp-pro-tyr” (Trentin et al., 2005) and “glu-pro-tyr-cys” (Moore et al., 
2009) units being added onto the C-terminus and an even longer form of SV40 has been 
described (Eguchi et al., 2001). INF 5 and INF 7 are examples of two commonly used 
fusogenic peptide and both are derived from the parent HA2 peptide (Plank et al., 
1994). GALA is a 30-amino acid long pH-sensitive fusogenic peptide (Subbarao et al., 
1987).  Upon protonation of its glu residues, its secondary structure changes from 
unordered at neutral pH to being α-helical in acidic environments. Both the 
amphipathicity and degree of α-helicity have been correlated with the ability of GALA 
to interact and destabilise membranes (Parente et al., 1990). 
 
1.8 Gene therapy in corneal transplantation 
     Ex vivo corneal gene therapy is a fairly recent endeavour and started when Larkin 
and colleagues (1996) studied the kinetics of reporter gene expression in transplanted 
rabbit corneas that had been transduced ex vivo with adenoviruses. Since then, the 
strategy of ex vivo manipulation has been very actively pursued, among other methods 
for the transfection of corneal tissues including direct injection into the anterior 
chamber (Borrds et al., 1996) or the topical application of eye-drops (Tong et al., 2010).  
 
     Many systems including physical methods [gene gun (Merediz et al., 2000) and 
electroporation (Bemelmans et al., 2009)], viruses [Adenovirus (Gong et al., 2007), 
AAV (Hudde et al., 2000), lentivirus (Bemelmans et al., 2009), EIAV (Beutelspacher et 
al., 2006) and HSV (Hudde et al., 2000)] and non-viral vectors [liposome (Tan et al., 
2003), dendrimer (Hudde et al., 1999), peptide (Shewring et al., 1997), chitosan (Fuente 
et al., 2008) and polymer (Tong et al., 2010)] have been evaluated in their abilities to 
transfect corneal cells. By far, the viral approach is the most popular and adenovirus, in 
particular, has been the workhorse of corneal gene therapy mainly because of its ability 
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to transfect amitotic cells with impressive efficiency. For instance, a 100% transfection 
efficiency was reported in the rabbit corneal endothelium upon exposure to 
adenoviruses carrying a reporter gene (Larkin et al., 1996). Although a diverse range of 
therapeutic genes have been delivered, strategies often aim to result in the expression 
of: 1) membrane ligands which either cause infiltrating lymphocytes to undergo 
apoptosis or prolong the survival of corneal cells that express the ligands; 2) anti-
angiogenesis factors; 3) cytokines or soluble factors for general immunosuppression.    
 
1.8.1 Strategy 1: membrane ligands 
     PD-1 is expressed on the membranes of activated T-cells and has two potential 
ligands: PD-L1 (B7-H1) and PD-L2 (B7-dendritic cell). The ligation of PD-1 with its 
ligand produces negative regulatory effects, although its actual mechanism of action 
remains debatable. For instance, the induction of apoptosis was argued to be important 
in one study (Hori et al., 2006), but was ruled out in another which suggested instead 
that the suppression of proliferation and cytokine production were pathways to regulate 
PD-1-expressing T-cells (Yang et al., 2009b).  
 
     Immunohistological data showed that PD-L1 is constitutively expressed by the 
corneal epithelium and endothelium (Yang et al., 2009b). The expression of PD-L2, on 
the other hand, is more limited. Therefore, in the context of corneal transplantation, PD-
L1 appears to be more important. Furthermore, adding anti-PD-L1 blocking antibody to 
co-cultures of human corneal endothelial cells and activated T-cells significantly 
increased IFN-γ and tumor necrosis factor-α (TNF-α) production by the latter, whereas 
adding anti-PD-L2 blocking antibody had no effect (Yang et al., 2009b). The expression 
of PD-L1 can be upregulated by IFN-γ. Cell contact is also required for PD-L1 to 
achieve its effect (Sugita et al., 2009). PD-L1 expression by ocular cells can thus be an 
important target for gene therapy. 
 
     TRAIL is another pro-apoptosis transmembrane protein and it bears high homology 
to FasL. TRAIL is suggested to be constitutively expressed by corneal cells (Yang et al., 
2009b), although this is contested when immunohistochemistry failed to detect TRAIL 
expression in untreated murine corneas (Xie et al., 2003). In one study, adenovirus was 
used to deliver plasmids encoding for TRAIL into C57BL/6 donor corneas before 
transplantation onto BALB/c eyes. Doing so, the mean graft survival time was 
Chapter one: Introduction 
 
 56
prolonged to 22.0 days, compared to 17.7 days from the control group (Xie et al., 2003). 
More apoptotic cells were also detected in the adenovirus/TRAIL transfected corneas. 
 
     Conversely, anti-apoptotic signals can be expressed to promote longevity of the 
corneal cells. Bcl-xL belongs to the pro-survival bcl-2 family. Mediated by lentiviruses, 
Bcl-xL protein was expressed by the corneal endothelia of C57BL/6 mice and 
significantly prolonged survival upon suturing onto BALB/c eyes (Barcia et al., 2007).      
 
1.8.2 Strategy 2: anti-angiogenesis factors 
     Pre- or post-operative vascularisation of the cornea or its graft bed can be 
encouraged by the presence of vascular endothelia growth factor (VEGF) and is a 
leading risk factor for graft failure (Vassileva & Hergeldzhieva, 2009). The application 
of VEGF-neutralising antibody is thus a promising treatment strategy and has been 
shown to significantly reduce angiogenesis in both humans (Vassileva & 
Hergeldzhieva, 2009) and rats (Rocher et al., 2011) after PK.  
 
     Endostatin and angiostatin are both anti-angiogenesis proteins that are exploited in 
anti-cancer therapy to inhibit the growth of new blood vessels that tumor cells depend 
on for proliferation. Both proteins have also been used synergistically to inhibit the 
differentiation of human umbilical vein endothelial cells in an in vitro angiogenesis 
assay, and to retard the in vivo (but not in vitro) growth of retrovirally-transfected 
B16F10 melanoma cells (Scappaticci et al., 2001). In terms of corneal gene therapy, 
lentiviruses encoding for a bifunctional anti-angiogenesis protein – a fusion of 
endostatin with the fifth kringle domain of angiostatin – were used to transfect rabbit 
corneas (Murthy et al., 2003). Prolonged mRNA expression of the fusion protein was 
then detected up till day 40 after surgery. Treated corneas also survived longer and 
suffered less neovascularisation than untreated or mock virus-transfected samples. 
 
1.8.3 Strategy 3: cytokines or soluble factors – IL-4 
     As mentioned earlier in section 1.3, cytokine profiling initially suggested that 
corneal allograft rejection was chiefly mediated by CD4 TH1 cells (Pleyer et al., 2000; 
Sano et al., 1998). Since TH1 and TH2 cells are thought to be mutually regulating, a 
strategy could be to exploit the inhibitory effects of TH2 cytokines on TH1 cell 
development (Pleyer et al., 2000). The usefulness of eliciting a TH2 phenotype was also 
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suggested in rat cardiac transplants where high levels of IL-4 and IL-10 were detected 
in animals which had accepted their allografts for longer periods of time (Heidecke et 
al., 1996). However, compelling evidences described earlier have discredited the 
simplistic view that TH1 cells are the sole instigators of rejection. Instead, current 
thinking is that both the TH1 and TH2 subsets can contribute (Cunnusamy et al., 2010b). 
 
     The overexpression of IL-4, the classical TH2 cytokine, was once pursued as a 
strategy to dampen TH1 responses. For instance, adenovirus was used to efficiently 
deliver DNA encoding for IL-4 into rat corneas where an in vitro expression of up to 
day six was detected (Ritter et al., 1999). However, as also pointed out by the authors, 
an extended in vitro expression profile may not correlate with that in vivo, as shown 
previously when rabbit corneas transfected with adenovirus expressed a reporter gene 
for up to 14 days in vitro but only up to day four in vivo (Larkin et al., 1996). The 
reason for the shortened in vivo expression is not known. Nonetheless, the 
overexpression of IL-4 as a treatment strategy was challenged when the survival of 
adenovirus/IL-4-transfected rat corneas was not significantly prolonged when compared 
to the untreated control groups (Pleyer et al., 2000). Recent studies have also questioned 
the relevance of IL-4 in the initial development of TH2 cells in vivo on the basis that 
naïve T-cells do not produce IL-4 (Pulendran et al., 2010).  
 
1.8.4 Strategy 3: cytokines or soluble factors – IL-10 
     IL-10 has immunosuppressive properties and human (hIL-10), ovine (oIL-10) or 
viral – which can be encoded by Epstein-Barr virus (EBV-IL-10), equine herpesvirus 
(EHV-IL-10), cytomegalovirus (CMV-IL-10) or the orf parapoxvirus (ORF-IL-10) – 
forms have been described (Haig & Fleming, 1999). Like hIL-10, oIL-10 strongly 
suppressed the production of TNF-α when added to cultures of activated macrophages, 
but could co-stimulate the in vitro proliferation of mast cells in the presence of IL-3 and 
IL-4 (Imlach et al., 2002). In this respect, EBV-IL-10 seems advantageous because it 
inhibits the release of pro-inflammatory cytokines by activated macrophages but yet 
does not stimulate the growth of mast cells or lymphocytes (Haig & Fleming, 1999). 
 
     EBV-IL-10 was successfully delivered into rabbit corneas using transferrin-Tfx-50 
lipids (Tan et al., 2001). In this study, the immunosuppressive property of EBV-IL-10 
was demonstrated when the supernatant of EBV-IL-10-transfected corneas retarded the 
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proliferation of responder cells in a mixed lymphocyte reaction. However, rat corneas 
transfected ex vivo with adenovirus encoding for EBV-IL-10 failed to survived longer 
than controls, in contrast to the systemic injection of the viral particles, which 
significantly prolonged graft survival. (Gong et al., 2007). Compared to the untreated 
controls, an elevated level of IL-10 mRNA was also detected in the draining lymph 
nodes but not in the corneas of the systemically treated animals. This suggests that 
immunomodulation in the lymph nodes, which is more accessible via the systemic 
route, is equally, if not more important than in the graft itself. On the contrary, oIL-10 
was successfully expressed by sheep corneas upon ex vivo adenovirus-mediated 
transfection and significantly prolonged graft survival compared to controls (Klebe et 
al., 2001). It is tempting to speculate that the larger graft size used in ovine 
transplantations could mean that more cells are available to produce oIL-10. However, 
the reality may also be that the process of corneal immune rejection in sheep is not as 
clearly understood as that in rodents.      
 
1.8.5 Strategy 3: cytokines or soluble factors – CTLA-4 
     In addition to the specific interaction between the antigen-loaded MHC complex and 
the CD3/T-cell receptor (TCR) complex (signal 1), T-cells need a second co-stimulation 
signal (signal 2) to achieve full activation, assuming that all required cytokines are 
available (sometimes termed signal 3). The archetypical and most potent form of co-
stimulation involves CD28 on the T-cell and either CD80 (B7.1) or CD86 (B7.2) on the 
APC. Strategies were therefore formulated to block this interaction to result in non-
responsive T-cells. 
 
     The molecule most intensely studied for co-stimulation blockade is cytolytic T-
lymphocyte antigen-4 (CTLA-4). CTLA-4 is upregulated on T-cells upon activation and 
shares both structural homology (~30%) and binding targets (i.e., CD80 and 86) with 
CD28 (Alegre et al., 2001). The important distinction is that CTLA-4 ligation triggers a 
negative regulatory signal instead of achieving co-stimulation. The mechanism of action 
of CTLA-4, however, is more debatable. A popular and intuitive mechanism builds on 
the fact that the binding affinities of CTLA-4 for CD80 and 86 are up to 20-fold higher 
than that compared to CD28 (Finger & Bluestone, 2002). As a result, CTLA-4 can out-
compete CD28 for ligand binding. In cases where the availability of the ligands is 
limiting, this will then lead to a lack of co-stimulation and subsequent 
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unresponsiveness. However, it has been pointed out that this mechanism alone cannot 
satisfactorily account for the observation that CTLA-4 can still inhibit proliferation in 
the absence of CD28 or when mab were used to crosslink CD28 (Rothstein & Sayegh, 
2003). Alternatively, CTLA-4 signalling was shown to inhibit the production of IL-2, a 
key cytokine in the differentiation of TH1 cells (Walunas et al., 1996). Another proposed 
pathway is that CTLA-4 ligation induces IFN-γ production which then subsequently 
activates the APC to secrete indolamine 2,3-dioxygenase (IDO), an immunosuppressive 
enzyme which will be discussed in greater detail in the next section. CTLA-4, being 
rapidly endocytosed (Alegre et al., 2001), was also suggested to be able to extract B7 
molecules from the APC and sequester them intracellularly (personal communication 
with Omar Qureshi, University of Birmingham). 
 
     To exploit the ligand competition pathway, DNA encoding for CTLA-4 Ig (i.e., the 
extracellular CTLA-4 epitope anchored to the heavy chain portion of an Ig) was 
delivered into human corneas using adenovirus and functionally active CTLA-4 Ig was 
detected in the culture supernatant for up to 28 days (Oral et al., 1997). In rats, corneas 
transfected ex vivo with adenovirus encoding for CTLA-4 Ig survived modestly longer 
than controls (Comer et al., 2002). In that study, the intraperitoneal injection of CTLA-4 
Ig fusion protein also marginally improved survival. The most significant effect, 
however, was achieved with a single intravenous injection of viral particles encoding 
for CTLA-4 Ig, following which, serum levels of CTLA-4 Ig remained high until at 
least the onset of rejection. Thus, in addition to having access to the lymph nodes, 
another advantage of systemically applied adenoviral particles is the possibility of 
having a relatively sustained expression of the target molecule. The key disadvantage is 
the generation of anti-adenovirus antibodies (to be discussed later). The superiority of 
systemically administered adenoviruses encoding for CTLA-4 Ig was again shown in 
another study where the survival of rat corneas was more significantly prolonged 
relative to no treatment or ex vivo manipulation alone (Gong et al., 2006).       
 
     On a related note, another set of co-stimulation interaction targeted is that between 
CD40 on APC and CD40L (CD154) on activated T-cells (Larsen & Pearson, 1997). 
This pathway is thought to target the APC more directly than the T-cell as it provides a 
maturation signal to the APC which, in turn, presents antigen more potently to T-cell 
(Rothstein & Sayegh, 2003). Antibody-mediated therapy is more popular than gene 
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therapy in the blockade of this co-stimulation pathway. For example, anti-CD154 mab 
injected intraperitoneally into BALB/c mice significantly prolonged graft survival in 
both the normal and suture-induced vascularised graft bed (Qian et al., 2001). Local 
application of anti-CD154 mab via subconjunctival injection also prolonged graft 
survival, although the effects were more modest compared to systemic administration 
(Qian & Dana, 2002). A word of caution is that co-stimulation blockade with anti-
CD154 mab remains a risky strategy as ligation of anti-CD154 mab with CD154 (so 
termed “immune complexes”) can activate platelets in vitro (Robles-Carrillo et al., 
2010). Indeed, thrombosis was observed in monkeys (Kawai et al., 2000) and mice 
(Robles-Carrillo et al., 2010) following anti-CD154 mab treatment, necessitating the use 
of heparin as an anticoagulant in the former group of animals.      
 
     In addition to the CD28-B7 and CD40-CD154 interactions, several other co-
stimulation pathways exist and have been comprehensively reviewed by Rothstein and 
Sayegh (2003). Considering that there is most probably redundancy among pathways, 
targeting more than one pathway simultaneously appears to be more beneficial. 
However, no additional prolongation of corneal graft survival was observed when both 
the CD28 and CD154 pathways were blocked with intraperitoneal injections of CTLA-4 
Ig and anti-CD154 mab (Ardjomand et al., 2003), suggesting that the amount of 
redundancy in co-stimulation pathways may be higher than expected. 
 
1.8.6 Strategy 3: cytokines or soluble factors – TNFR 
     The level of the pro-inflammatory cytokine, TNF was observed to be elevated in the 
aqueous humor of high risk rabbit transplants before and after rejection (Rayner et al., 
2000). Adenovirus was therefore used to deliver DNA encoding for TNF receptor 
(TNFR) into rabbit corneas before grafting onto pre-vascularised graft beds (Rayner et 
al., 2001). The intention was so that TNFR can neutralise TNF for localised 
immunosuppression. Unfortunately, prolongation of survival in the adenovirus/TNFR 
treated group was only observed in comparison to the blank adenovirus treated controls, 
but not the untreated controls. The immunogenic nature of the viral particles 
presumably negated any beneficial effects due to TNFR production.  
 
Chapter one: Introduction 
 
 61
1.8.7 Strategy 3: cytokines or soluble factors – IDO 
     IDO is a molecule with immunosuppressive property and its ex vivo expression is the 
therapeutic strategy of this thesis. Unlike other molecules described in this category so 
far, IDO does not act in the extracellular milieu. Instead, IDO is a cytosolic, IFN-γ 
inducible enzyme that uses dioxygen chemistry to catalyse the first and rate-limiting 
step of tryptophan catabolisation down the kynurenine pathway (Muller & Prendergast, 
2007). In this cascade, tryptophan is first converted into N-formylkynurenine, which 
itself breaks down to give kynurenine. Picolinic acid or quinolinic acid is finally 
generated in the last step of tryptophan degradation (Frumento et al., 2005). In humans, 
IDO is encoded by the INDO gene and is widely distributed in all tissues except the 
liver where another heme-containing enzyme, tryptophan 2,3-dioxygenase (TDO) is 
present (Batabyal & Yeh, 2007). Together, IDO and TDO are the only enzymes in the 
body that can catalyse the metabolism of tryptophan (Munn et al., 1999).  
 
     Two leading mechanisms are thought to account for the immunosuppressive property 
of IDO. The first is the starvation model which posits that the depletion of tryptophan, 
an essential amino acid, is by itself enough to inhibit the growth of T-cells. The critical 
dependence of T-cells on tryptophan was neatly shown in an experiment when T-cells 
stimulated with immobilised anti-CD3 and anti-CD28 mab failed to enter their S-phase 
of cell cycle (no DNA synthesis) when cultured in tryptophan-free medium (Munn et 
al., 1999). Supplementing tryptophan to the medium not only restored the proliferative 
activity of the cells but interestingly, these cells now took only 12-16 hours to enter 
their S-phase, in contrast to the 28-32 hours required by control cells cultured in 
tryptophan-supplemented medium. This suggests that there is a checkpoint (estimated to 
be during the first 14 hours) within the cell cycle that is keenly sensitive to tryptophan, 
without which T-cells get arrested in their G1-phase. Further, it was shown that unlike 
normal T-cells that are committed to cell division, growth arrested T-cells due to the 
absence of tryptophan need a second round of TCR signalling in order to restore 
proliferation. The relevance of this mechanism in vivo has, however, been challenged. 
For example, to create an environment inhibitory for T-cell proliferation, tryptophan has 
to be extensively depleted (<1 μM). The feasibility of achieving such an extreme 
environment seemed questionable, especially since the plasma tryptophan concentration 
is 50-100 μM and diffusion is fast relative to degradation (Terness et al., 2002). This 
was acknowledged by authors of the starvation model, who cited the oxygen-deprived 
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state within muscle tissues during exercise as circumstantial evidence in support of their 
belief that a local microenvironment severely depleted of tryptophan is possible.  
 
     The second model proposes that it is the accumulation of toxic tryptophan catabolites 
that causes the apoptosis and/or inhibition of T-cell proliferation (Frumento et al., 
2005). In support of this hypothesis, three breakdown products of tryptophan – 
kynurenine, picolinic acid and quinolinic acid – were added during culture and shown to 
inhibit the proliferation of NK- and T-cells but not B-cells. Importantly, it was shown 
that the effective inhibitory concentration of each catabolite was lowered in the absence 
of tryptophan. Thus, the effect of tryptophan depletion can be to lower the activation 
threshold of the catabolites (Frumento et al., 2005). In another study, 3-
hydroxykynurenine and 3-hydroxyanthranilic acid were also identified as catabolites 
which could retard T-cell proliferation and cause cell death, as revealed by 7-AAD 
(amino actinomycin D) staining (Terness et al., 2002). Indeed, the administration of 3-
hydroxykynurenine either intraperitoneally or topically prolonged the survival of 
murine corneal allografts (Zaher et al., 2011). Having said that, it is important to 
recognise that the two mechanisms of IDO activity are more synergistic than mutually 
exclusive. It is thus more likely that both contribute to the immunosuppressive property 
of IDO.  
 
     Since IDO resides in the cytosol, tryptophan degradation occurs intracellularly and 
the functional activity of IDO is usually shown by detecting kynurenine in the culture 
supernatant. Using such an assay, functional IDO was detected only with activated 
dendritic cells (DC) which could further inhibit T-cell proliferation (Hwu et al., 2000). 
This then provided a mechanism whereby DC can negatively regulate T-cell activity. In 
vivo, CTLA-4 ligation can act as the trigger for IDO secretion, although the ability to 
produce IDO via this pathway may be limited to the smaller CD8α DC subset and the 
B220 plasmacytoid DC (Munn et al., 2004). 
 
     IDO produced by cells in the placenta protects the foetus, which otherwise is 
allogenic and should trigger an immune response from the maternal T-cells. Removing 
this form of IDO-mediated immune privilege can cause the foetus to be destroyed. This 
was elegantly demonstrated with pregnant mice where the skin implantation of pellets 
releasing 1-methyl-tryptophan (1-MT), a specific inhibitor of IDO activity, caused the 
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rejection of allogenic pregnancies (Munn et al., 1998). This treatment had no effect on 
syngenic pregnancies, proving that the effect of 1-MT was specific to the immune 
restoration of the allogenic foetus.  
  
     IDO is also useful in the induction of tolerance after transplantation. In lung 
transplantation, rat lungs transfected with plasmids encoding for IDO survived longer 
than untransfected lungs (Liu et al., 2009). The proliferation and CTL killing ability of 
CD8 T-cells (the main instigators of acute lung rejection) were also shown to be 
suppressed in vitro and in vivo. In the context of corneal transplantation, EIAV/IDO-
infected mouse corneas survived significantly longer compared to vehicle-treated 
controls (Beutelspacher et al., 2006).  
 
     The immunosuppressive property of IDO can, however, become a liability. Evidence 
now suggests that IDO is constitutively expressed by a wide range of tumor cells in vivo 
without IFN-γ induction and can be exploited by tumors to evade detection (Uyttenhove 
et al., 2003). This was shown using the P815 mouse tumor model (Uyttenhove et al., 
2003). Intraperitoneal injections of cancerous P815 cells are usually fatal to the animals. 
Authors of this study first identified P815B cells, a subline of P815 cells that did not 
produce IDO and either transfected them with DNA encoding for IDO or left them 
untreated. Upon intraperitoneal injection, mice pre-immunised against one of the tumor 
antigens then rejected the wild-type P815B cells but succumbed to IDO-expressing 
P815B cells. This clearly implicates IDO as the cause of immunological ignorance. It 
also appears that the immunological protection afforded by IDO is more important to 
the tumors than the consequence of tryptophan depletion. 
 
1.9 Research objectives 
     While viruses (adenovirus in particular) dominate experimental corneal gene 
therapy, their clinical application, in reality, can be extremely tricky. Dangers due to the 
toxicity and immunogenicity of viral gene therapy have been highlighted in an earlier 
section. Similar concerns also plague the viruses explored for corneal transplantation. 
For instance, adenoviruses are persistent and in one study, adenoviral DNA was 
detected 56 days after ex vivo transfection of human corneas, long after expression of 
the reporter gene had waned (Oral et al., 1997). In another study, adenovirus injected 
into the anterior chamber caused inflammation which resulted in the detachment of 
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infected endothelial cells (Borrds et al., 1996). The humoral immune response following 
systemic injection of adenoviral particles is a widely acknowledged problem and 
indeed, elevated titers of anti-adenovirus antibody were detected in systemically 
injected animals using enzyme-linked immunosorbent assay (Gong et al., 2007). 
Importantly, several studies also reported that the ex vivo application of adenoviral 
particles can itself be deleterious to the graft, as evidenced by the shortening of survival 
in the adenovirus-treated vehicle control group, compared to untreated animals (Qian et 
al., 2004; Rayner et al., 2001). 
 
     Presently, non-viral systems do not rival viruses in transfection efficiency, although 
the former approach benefits from being less immunogenic. Synthetic systems also 
offer the versatility of rational design. Nonetheless, gene expression mediated by non-
viral vectors is transient as they do not integrate into the host’s genome. While this is a 
valid concern, non-viral vectors can still contribute to the long-term survival of corneal 
grafts. In the low risk cases, transient expression mediated by non-viral vectors can be 
useful in promoting short-term survival until ACAID is induced, which subsequently 
ensures the long-term viability of the graft. In high risk eyes where the effects of 
ACAID are not sufficient, non-viral vectors can then be employed as part of a multi-
component treatment regime to enhance the effects of, for instance, the topical 
application of immunosuppressive drugs. Moreover, the window of treatment proposed 
here is during the ex vivo culture prior to transplantation where no manipulation is 
presently done on the donor tissue. Hence, any beneficial effect achieved with the non-
viral vectors already represents an improvement over the current standard of care.  
 
     Having said that, non-viral vectors that are currently being explored for corneal gene 
therapy are mostly available commercially and suffer from low efficiencies. We are 
therefore motivated to develop novel and efficient non-viral vectors for evaluation in 
the context of corneal transplantation. The advantages of peptide-based vectors were 
described and some of the more prominent peptide-based vectors were reviewed in 
section 1.7. For this study, we have rationally designed several novel tri-block 
oligopeptides. They feature a cationic octaarginine block, a pH-sensitive histidine 
segment and a hydrophobic block (Figure 5). Arginine was chosen because it has a 
pKa~12.5 and is strongly protonated at physiological pH. It is therefore ideally suited 
for the condensation of DNA. In addition, oligoarginine was reported to have cell 
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penetrating and nucleus localisation properties, much akin to the arginine-rich region 
within the HIV-tat membrane fusion protein. The length of eight residues was 
previously optimised for this purpose (Futaki et al., 2001a). The histidine block was 
then incorporated to aid endosomal escape, since the imidazole sidegroup (pKa~6.0) 
could provide proton scavenging effects upon internalisation into acidic intracellular 
compartments. Finally, a block of hydrophobic amino acids – isoleucine, phenylalanine 
or tryptophan, in order of decreasing hydrophobicity (Kyte & Doolittle, 1982) – was 
added to promote better DNA binding and cell membrane association.  
 
 
 
 
 
 
 
 
 
Figure 5. Rational peptide design. Schematic of the peptides with 1) octaarginine for 
DNA binding and membrane penetration, 2) histidine residues for acidic compartment 
escape and 3) a hydrophobic segment for enhanced cellular uptake. Colour scheme: 
grey = C; white = H; blue = N; red = O and green = sidegroups of either I, F or W. 
 
 
 
     Although the amino acid sequence used in our peptide design is novel, we 
acknowledge that the general concept of a multidomain carrier is well developed. As 
extensively reviewed in section 1.7, various signals have been attached to peptide-based 
carriers. For instance, the SV40 NLS was grafted onto tat 48-60 to improve transfection 
efficiency (Yang et al., 2009a). To improve endosomal-disrupting capabilities, either 
HA2 (Wagner et al., 1992a), melittin (Meyer et al., 2008), GALA (Akita et al., 2010), 
adenovirus (Curiel et al., 1991) or oligohistidines (Chen et al., 2001), amongst others, 
was added to the main peptide carrier. To enhance plasma membrane interaction and 
penetration, cholesterol (Guo et al., 2008) or stearyl chains (Futaki et al., 2001a) were 
grafted onto the peptide carrier. For targeting purposes, transferrin (Wagner et al., 
1991), insulin (Ivanova et al., 1999), RGD (Tagalakis et al., 2011) and various 
carbohydrate moieties – such as galactose (Perales et al., 1994), ASOR (Wu et al., 
 
2) His for buffering 
3) Hydrophobic for uptake 
1) Arg for DNA binding 
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1989), mannose and lactose (Midoux et al., 1993) – can be attached. Nonetheless, 
investigators usually design their carriers based on a di-block template – a segment to 
bind DNA and another for membrane disruption, for example. We now propose a tri-
block architecture which incorporates more qualities of an efficient carrier (i.e., 
buffering capacity, binding efficiency and hydrophobicity) into a single peptide-based 
vehicle. The main strength of this study, however, lies in its systematic approach. 
Unlike studies which merely assessed the performance of a multidomain carrier at the 
gene expression level, we optimised each segment individually and investigated how 
the physical attributes of each block can influence final transfection ability. Important 
insights are therefore provided on the structure-property-performance relationship of the 
carrier.  
 
     We have selected IDO to be our therapeutic target. On top of its immunosuppressive 
property, IDO was also chosen for practical reasons since it can be easily detected 
(mRNA and protein) and its biological activity can be conveniently followed by 
spectrophotometrically measuring levels of kynurenine. Initial experiments were 
conducted with several cell lines including the relevant mouse corneal endothelial cells 
(MCEC) and reporter genes encoding for luciferase or GFP. Subsequent experiments 
then involved plasmids encoding for IDO and actual corneal tissues. Transplantation of 
ex-vivo manipulated mouse corneas finally provided the most stringent test for our non-
viral approach. We expect the following research questions to be applicable: 
 
1) How will the modification of the nature and length of each peptide segment affect 
the physical, biophysical and most importantly, transfection ability of the carriers? 
2) How long does it take for the peptide/DNA complex to be trafficked to the nucleus 
of the cells and more specifically, when and where does DNA release take place? 
3) Is the IDO expressed functional and can it inhibit CD4 T-cell proliferation? 
4) How does transfection efficiency and kinetics change from cell line to tissue? 
5) Is IDO expression limited to a particular layer of the cornea? 
6) Ultimately, will the optimised peptide design and transfection conditions result in 
gene expression at a therapeutically useful level so as to prolong the survival of 
corneal allografts? 
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2. Experimental methods (peptide) 
2.1 Peptide synthesis 
     Peptides were either synthesised at Anaspec (San Jose, USA), GL Biochem 
(Shanghai, China), Mimotopes (UK) Ltd. (Wirral, UK), or prepared in-house via the 9-
fluorenylmethoxycarbonyl (Fmoc) approach with an Apex 396 peptide synthesiser 
(Aapptec, KY, USA) according to methods reported earlier (Seow & Yang, 2009b). All 
peptides were purified using high performance liquid chromatography (HPLC) to >96% 
purity and fidelity of the products was confirmed using matrix-assisted laser 
desorption/ionization time of flight (MALDI-TOF) mass spectrometry (Autoflex II, 
Bruker Daltronics, MA, USA). The [M+H]+ found/expected for NH2-H4R8-CONH2 (H), 
NH2-I5H4R8-CONH2 (I), NH2-F5H4R8-CONH2 (F) and NH2-W5H4R8-CONH2 (W) was: 
1814.9/1815.1; 2381.5/2381.9; 2551.5/2552.0; 2745.5/2747.2.  
 
2.2 Peptide and PEI/DNA complex formation 
     Peptide complexes were formed at various N/P ratios (defined here as the molar ratio 
of arginine to the DNA phosphorus content) by the drop-wise addition of equivolume 
solutions of peptide into DNA. 10 mM phosphate buffer (pH 7.0) was used to form the 
particles for all experiments unless otherwise stated. The desired N/P ratios were 
achieved by fixing the amount of DNA and varying the amount of peptide added. The 
mixture was then vortexed for ~10 seconds and left to stand for ~30 minutes before use. 
Polyethylenimine (PEI, branched, 25 kDa, Sigma) complexes were similarly formed in 
de-ionised (DI) water. 
 
2.3 DNA binding, protection, heparin displacement and serum degradation assays 
     Agarose gel electrophoresis was conducted to study the DNA binding ability of the 
peptides. Peptide/DNA complexes were first formed at various N/P ratios (50 µg/mL of 
DNA). Agarose gel (1 wt%) electrophoresis with ethidium bromide staining was then 
conducted with 10 µL of complex solution at 80 V for 50 minutes to detect DNA.  
 
    To evaluate if the complexes were able to protect their DNA cargo against physical 
and enzymatic degradation, the complexes were first sonicated (VC750, Sonics and 
Materials Inc., CT, USA) at 35% power for 15 seconds. The same samples were then 
subjected to a consecutive digestion step using deoxyribonuclease I (DNase, Sigma, 
Singapore) according to the manufacturer’s recommendations. DNase was then 
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inactivated by chelating with Ca2+ ions using EDTA. To separate DNA from the 
complexes, 10 µL of trypsin solution (10×, Invitrogen, Singapore) was added to 15 µL 
of sample and incubated at 37ºC for 1 hour to completely digest the peptide carrier. Gel 
electrophoresis was then carried out, as above, to image the released DNA. 
 
     For the heparin displacement assay, 50 µL of peptide complexes were first formed at 
N/P 20 (50 µg/mL of DNA) and then incubated with 50 µL of heparin (0.1 to 20 mg/mL 
final concentration) for 1 hour at room temperature (22°C). Gel electrophoresis was 
used to detect DNA released by heparin treatment. DNA still bound to peptide was 
either seen within the loading well or was not visible due to the inability of ethidium 
bromide to intercalate condensed DNA. 
 
     To assess plasmid stability in serum, DNA was added to fetal bovine serum (FBS) 
(5.0 µg/mL of DNA) and maintained at 37°C. At selected time points, the stock solution 
was mixed briefly and 50 µL was aliquoted out for immediate storage at -80°C. At the 
end of experiment, all samples were then resolved using gel electrophoresis. 
 
2.4 Cell culture: luciferase, GFP and IDO transfection assays 
     Reporter genes used were either the 6.4 kb firefly luciferase (pCMV-luciferase 
VR1255C) driven by the cytomegalovirus promoter (Carl Wheeler, Vical, San Diego, 
CA, USA.) or the 4.7 kb GFPmut1 variant (pEGFP-C1) driven by the SV40 early 
promoter (Clontech, Palo Alto, CA, USA.). For a therapeutic gene, the 8.5 kb 
pSMART-2G plasmid encoding for IDO under control of the cytomegalovirus promoter 
was used. All cell lines used were from ATCC (VA, USA), except for the SV40-
immortalised BALB/c strain MCEC (Beutelspacher et al., 2006). MCEC, HEK 293, 
HepG2 and MCF 7 cells were maintained in DMEM, while 4T1 and CHO cells were 
cultured in RPMI 1640 at 37°C with 5% CO2. All growth media used were completed 
with 10% FBS, 100 µg/mL of streptomycin and 100 U/ml of penicillin, unless 
otherwise stated. Cell cultures were routinely checked for mycoplasma contamination 
using the MycoAlert® mycoplasma detection kit (Lonza, Basel, Switzerland).  
 
     Cells were seeded one day before experiments. For the luciferase transfection assay, 
0.5 mL of medium containing 6-8×104 cells (depending on cell type) were seeded into 
each well of a 24-well plate, while for the GFP and IDO transfection assay, 1 mL of 
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medium containing 1-2×105 cells were pipetted into each well of a 12-well plate. Media 
were always freshly replaced before the start of transfection, and again 4 hours after the 
introduction of DNA complexes, unless otherwise stated. 
 
     For the luciferase expression assay, 50 μL of complex solution containing 2.5 μg of 
plasmids was used. Analysis was carried out by first washing cells with 0.5 mL of 
phosphate-buffered saline (PBS) before the addition of 0.2 mL of ‘Reporter Lysis 
Buffer’ (Promega, Madison, WI, USA). Membrane lysis was completed with 2 freeze-
thaw cycles and manual cell scratching between the cycles. The cell suspension was 
centrifuged at 20800×g for 10 minutes. 20 μL of supernatant was removed and mixed 
with 100 µL of a luciferase assay reagent (Promega, Madison, WI, USA). The relative 
light unit (RLU) was measured with a luminometer (Lumat LB 9507, Mandel Scientific, 
Ontario, Canada) and protein concentration with a bicinchoninic acid protein assay kit 
(Pierce, Rockfort, IL, USA). Luciferase activity was expressed as RLU per mg protein ± 
standard deviation (n ≥ 4).  
 
     For the GFP transfection assay, 100 μL of complex solution containing 3.5 μg of 
plasmids was used. Cells were harvested for analysis by first washing with 1 mL of PBS 
and detached with 0.3 mL of trypsin (0.5 g/L in PBS). The cell suspension was then 
centrifuged at 20800×g for 10 minutes, followed by resuspension in a dilute trypsin 
solution (0.2 g/L) to further digest and remove any surface-bound peptide complexes. 
The cell pellet was again collected and finally resuspended in PBS for flow cytometry 
(FACSCalibur, BD Bioscience, San Jose, CA, USA). 10000 events were recorded and 
percentage of cells expressing GFP was reported as a mean ± standard deviation (n ≥ 4). 
Cells were defined to be GFP positive by setting the gating region to include 1% of cells 
mock-transfected with plasmids encoding for luciferase. 
 
     For the IDO mRNA expression assay, 100 μL of complex solution containing 3 μg 
of plasmids was used. Lipofectamine™2000 (LF) (Invitrogen, UK) was also used at a 
ratio of 1:2.5 (DNA:LF) according to the manufacturer’s protocol. Cells were harvested 
48 hours post-transfection. Total RNA was isolated using Trizol reagent (Invitrogen, 
UK) and reverse-transcription into cDNA was achieved with M-MLV reverse 
transcriptase (Invitrogen, UK), according to the manufacturers’ protocol. Samples were 
then analysed using the Sybr-Green PCR Mastermix (Applied Biosystem, Warrington, 
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UK) and a 7900 HT Fast Real Time PCR system (Applied Biosystems, UK). Specificity 
of the amplicons was confirmed by the observation of a single dissociation peak and a 
single major band after gel electrophoresis. IDO mRNA expression was normalised to 
hypoxanthine phosphoribosyl transferase (HPRT) mRNA. The thermal profile and 
primers used for IDO and HPRT have been described elsewhere (Beutelspacher et al., 
2006). 
 
2.5 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) viability assay 
     Cells were seeded into 96-well plates at 6-10×103 cells/100 µL one day before 
experiment. Cells were then transfected with 10 µL of complex solution at the desired 
N/P ratio containing 0.5 µg of plasmids encoding for luciferase for 4 hours. 3 days later, 
cell viability was assessed by first replacing all wells with fresh media and an additional 
20 µL of MTT solution (Sigma, 5 mg/mL in PBS) for 3 hours. All wells were then 
carefully aspirated, filled with 0.15 mL of DMSO to dissolve the purple formazan 
crystals and homogenised. Absorbance was measured with a microplate reader 
(PowerWave X, Bio-Tek Inc., Winooski, VT, USA) at 550 nm and referenced to a 
wavelength of 690 nm. Cell viability was represented by the average of 
(absorbance550nm – absorbance690nm) expressed as a percentage of the controls ± standard 
deviation (n ≥ 8). For complexes of both F and I, an N/P ratio of 20 will approximately 
correspond to a final peptide concentration of 32 µM. 
 
2.6 In vivo luciferase expression by 4T1 tumors 
     The animal protocols were approved by the Animal Care and Use Committee, 
Faculty of Medicine, National University of Singapore (NUS). Female BALB/c mice 
(Centre for Animals Resources, NUS) weighing 18-20 g were subcutaneously injected 
with 0.1 mL of serum-free RPMI 1640 containing 4×105 4T1 cells. A tumor was then 
allowed to develop in each mouse for 10-12 days. PEI and I/DNA complexes were 
prepared as before and 30 µL of sample containing 4 µg of DNA was injected directly 
into each tumor. The tumors were harvested 2 days later.    
 
     To analyze for luciferase activity, each tumor was first homogenised in lysis buffer, 
followed by two further freeze-thaw cycles. The mixture was then centrifuged and the 
supernatant assayed for luciferase activity as described above (n ≥ 4). 
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2.7 Uptake studies 
     Uptake of complexes into MCEC was either measured using flow cytometry or 
imaged unfixed by confocal microscopy. In both cases, plasmids encoding for luciferase 
were labelled using the Label IT® Cy5 labelling kit from Mirus (Madison, WI, USA) 
according to the manufacturer’s recommendation and purified by ethanol precipitation. 
The labelling density was determined to be about 1 Cy5 dye per 135 base pairs by 
absorbance at 649 and 260 nm.  
 
     Cells were either seeded into 12-well plates at 2.2×105 cells per well or confocal 
chambers (Nunc, Rochester, NY, USA) at 1.2×105 cells per chamber and transfected 
with the Cy5-labelled DNA for 3 hours at 37°C. Cells were then washed thoroughly and 
either harvested for flow cytometry (3-laser LSR II, BD Bioscience, San Jose, CA, 
USA) as described above, or stained with the Hoechst nuclear dye for live confocal 
imaging (LSM 5 DUO, Carl Zeiss, Jena, Germany). The parameter used to quantify 
uptake in flow cytometry was the mean fluorescence intensity (MFI) from 10000 gated 
cells. Cells transfected with unlabelled DNA were used as negative controls. 
 
2.8 Circular dichroism (CD) 
     CD measurements were made at 25°C with a Jasco J-815 (Easton, MD, USA). 
Peptide solutions were prepared in various 10 mM buffers (pH 5.0, 6.3 or 7.0) to a final 
concentration of 0.5 mg/mL. A quartz cuvette with a path-length of 1 cm was used.  
 
2.9 Titration experiments 
     Titration experiments were carried out with an automatic potentiometric titrator (AT-
610, Kyoto Electronics Manufacturing, Tokyo, Japan) against 0.01 M NaOH. The 
temperature was maintained at 25°C by a circulating water bath and the electrodes were 
calibrated with standards before use. 16 mL of peptide solution (0.5 mg/mL) was used 
for all titration experiments. 
 
2.10 Fluorescence resonance energy transfer (FRET) 
     Plasmids encoding for luciferase were sequentially labelled with Cy3 and Cy5 
(approximately 1.5 Cy3 dye : 1 Cy5 dye : 100 base pairs of the plasmid) according to 
the manufactuerer’s (Mirus) protocol. Cells were seeded into confocal chambers (Nunc, 
Rochester, NY, USA) at 1.2×105 cells per 0.5 mL media. 50 µL of peptide complexes 
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(N/P 20) were formed with the double-labelled DNA (50 µg/mL of DNA) and incubated 
with the cells for 2 hours at 37°C, followed by extensive washing with PBS. The cells 
were then returned to the incubator until live cell imaging at selected time points. 
During imaging, Cy3 was excited with the 543 nm laser. Cy5 would only be excited if 
there was FRET. Both the emissions of Cy3 (560-615 nm band-pass) and Cy5 (650 nm 
long-pass) were collected. FRET images were then quantified with Matlab R2006 
ver7.2.0.232 by binary-scoring each pixel as +/- for fluorescence. The ratio of Cy5-
positive to Cy3-positive pixels was used to indicate the extent of FRET for each image.          
 
2.11 Haemolysis assay 
     0.2 mL of fresh RBC from Wistar-Kyoto rats was washed 3 times with 5 mL of PBS 
until the supernatant was clear. The pellet was then reconstituted in 10 mL of PBS. 20 
μL of peptide/DNA complex containing 1 μg of DNA was formed at various N/P ratios 
and incubated with 200 μL of RBC for 1 hour at 37°C. Intact RBC and cell debris were 
separated by centrifugation at 4000×g for 5 minutes and the supernatant was transferred 
to a 96-well plate. Haemoglobin release was measured by absorbance at 540 nm. 
Complete haemolysis (100%) was assigned as the absorbance value of RBC incubated 
with 0.1 vol% triton X-100. Percentage haemolysis was calculated as: [(sample540 – 
PBS540) ÷ (triton X-100540 – PBS540)] × 100. 
 
2.12 Ethidium bromide (EtBr) exclusion assay 
     To quantify the extent of DNA binding, EtBr was added to 100 µL of peptide/DNA 
complexes (N/P 20) pre-formed at different pH containing 5 µg of DNA. A Safire II 
microplate reader (Tecan, Singapore) was used to measure the residual fluorescence 
(excitation/emission: 530/610 nm). Results were then normalised to the fluorescence 
obtained with the same amount of naked DNA (100%) at the respective pH after 
background correction.  
 
2.13 Scanning electron microscopy (SEM) 
     A drop of the peptide complex was dripped onto the surface of a freshly prepared Si 
wafer and air-dried for 4 hours. The wafer was then sputter-coated with Pt and SEM 
observations (JSM-7400F, Jeol, Tokyo, Japan) were carried out at 8.0 kV.  
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2.14 Calcium phosphate (Ca3(PO4)2)-mediated ransfection 
     MCEC was transfected with DNA/Ca3(PO4)2 according to an optimised protocol 
(Chen & Okayama, 1987). Briefly, 2.5 µg of DNA was mixed with 25 L of 2× BES-
buffered saline (Sigma, Singapore) and 25 L of 0.25 M CaCl2. Prior to mixing, the pH 
of 2× BES-buffered saline was adjusted to 6.95 with dilute HCl. The Ca3(PO4)2 solution 
was then added drop wise onto the cells and incubated for 4–14 hours at 3% CO2. After 
the desired incubation time, cells were rinsed extensively and incubated until analysis 
for luciferase expression was done. 
 
2.15 Co-localisation with endocytosis markers 
     Cells were concurrently incubated with 50 µL of peptide complexes (N/P 20) 
containing 2.5 µg DNA labelled with TM-rhodamine (Mirus, USA) and one of the 
following markers (all purchased from Invitrogen, USA) for specific endocytosis 
pathways: transferrin-AlexaFluor488 (25 µg/mL), cholera toxin-AlexaFluor488 (5 
µg/mL) and dextran (10 kDa, neutral overall charge)-Texas Red (10 µM). 30-40 
minutes later, the cells were extensively rinsed with PBS, stained with Hoechst and 
immediately imaged using confocal microscopy. Z-stacking was done to confirm that 
signals originate from within the cells in all confocal experiments.     
 
2.16 Endocytosis inhibitor studies 
    The effects of various inhibitors were assessed at both the uptake and luciferase 
expression level. Depending on the experiment, cells were pre-incubated with one of the 
following inhibitors (all purchased from Sigma, USA) for 1 hour before transfection: 
nocodazole (4.5 µg/mL) (Gratton et al., 2008a), cytochalasin D (5.0 µg/mL) (Torgersen 
et al., 2001), dynasore (6.8 µg/mL) (Macia et al., 2006), sodium azide (0.5 mg/mL) with 
2-deoxyglucose (4.1 mg/mL) (Gratton et al., 2008a), methyl-β-cyclodextrin (5.2 
mg/mL) (Wadia et al., 2004), filipin III (1.0 µg/mL) (Gratton et al., 2008a) or EIPA (25 
µg/mL) (Wadia et al., 2004). Inhibitors that had limited water solubility were first 
dissolved in DMSO to make a stock solution. The cells were then replaced with fresh 
media containing the respective inhibitors before addition of peptide complexes (N/P 
20) containing either fluorescently labelled or unlabelled DNA encoding for luciferase. 
No preincubation was carried out for experiments involving heparin (50 µg/mL) (Ferrari 
et al., 2003) or chloroquine (100 µM) (Wadia et al., 2004), which was present only 
during transfection. All inhibitor solutions were 0.22 µm filtered. Analyses by flow 
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cytometry and confocal microscopy were performed 3 hours later while luciferase 
expression was quantified 72 hours later. All data were presented relative to control 
cells transfected in the presence of vehicle control (DMSO or water) (100%). A suitable 
working concentration for the various inhibitors was also established in preliminary 
experiments for which excessive cell death was not evident. The final working 
concentration used for each inhibitor is stated above and may not agree with their 
references, which are only used to provide a suitable concentration range for 
optimisation experiments. 
 
2.17 Western blot 
     Cells were transfected in 24-well plates, as above, and then lysed 48 hours later by 
re-suspension in Laemmli reducing sample buffer (Sigma, UK). Protein lysates were 
further homogenised by probe sonication and then heating at 90°C for 3 minutes before 
being resolved on a 12% SDS-polyacrylamide gel at 110 V for 50 minutes. Protein was 
then blotted onto a nitrocellulose membrane at 100 V for 90 minutes. Blocking was 
done with 5% milk solution in PBS containing 0.1% Tween at room temperature for 1 
hour with gentle shaking. Either anti-mouse IDO mab (MAB5412, Chemicon, CA, 
USA) or anti-β-actin mab (Sigma, UK) was used as a primary probe at 1:1000 dilution 
in the blocking milk solution overnight at 4°C with gentle shaking. This was followed 
by HRP-conjugated rabbit anti-mouse antibody (P0161, DakoCytomation, UK) at 
1:2000 dilution in the blocking milk solution for 2 hours at 4°C with gentle shaking. 
Blots were developed using the Lumigen PS-3 (Lumigen, MI, USA) system according 
to the manufacturer’s recommendation. 
 
2.18 L-kynurenine functional assay 
     The biological activity of the expressed IDO was determined by colourimetrically 
measuring the levels of L-kynurenine, the metabolic product of tryptophan. Cells were 
cultured in 24-well plates using media supplemented with 200 µM of tryptophan. Cells 
were either transfected with peptide F (IDO), mock-transfected (GFP) or untransfected 
for 4 hours. During transfection, 50 µL of complex solution containing 2.5 µg of 
appropriate plasmids were used. Where appropriate, 1-methyl-DL-tryptophan (1-MT) 
(Sigma, UK) was added at a final concentration of 0.75 mM to inhibit the activity of 
IDO. The level of L-kynurenine in the supernatant was then quantified 48 hours post-
transfection. Briefly, 100 µL of culture supernatant was incubated with 100 µL of 30% 
Chapter two: Experimental methods (peptide) 
 
 76
trichloroacetic acid (Sigma, UK) at 50°C for 30 minutes in a 96-well plate. The 
precipitated protein was then spun down and 100 µL of the clear supernatant was 
transferred to a new 96-well plate for incubation with 100 µL of freshly prepared 
Ehrlich’s reagent at 65°C for 15 minutes. Absorbance was then measured at 492 nm 
with a spectrophotometer (Anthos Labtec HT 2, Salzburg, Austria). A calibration curve 
(R2 > 0.99) was generated with samples of known L-kynurenine concentration.                
 
2.19 T-cell proliferation assay 
     CD4+ responder T-cells were freshly isolated from the spleens of C3H mice using 
Dynal® mouse CD4 cell negative isolation kit (Invitrogen, UK), according to the 
manufacturer’s recommendation. Purity of the isolated T-cells was then assessed by 
staining for their surface markers (CD19, CD16/32, CD3, CD4 and CD8) using 
appropriate mAbs and isotype controls. Prior experiments had also determined the 
optimised MCEC to CD4 T-cells ratio. 105 T-cells (stimulated with anti-CD3 and CD28 
beads) in 100 µL of R10 media (RPMI + 0.1% 2-mercaptoethanol) were then added to 
each well of a 96-well plate already containing 5×104 MCEC in 100 µL of DMEM. The 
MCEC had earlier been treated with 40 µg/mL of mitomycin C for 30 minutes to stop 
proliferation and were either untransfected or transfected with peptide F containing 
plasmids encoding for IDO or GFP (see Figure 35 for experimental scheme). The 
MCEC was transfected in the 24-well format, as reported earlier, before being 
transferred to the 96-well plates for the addition of T-cells. Where appropriate, 1-MT 
was added at a final concentration of 0.75 mM. After 3 days of co-incubation, 30 µL of 
[3H]thymidine solution (1 µCi/well, Amersham Pharmacia Biotech, UK) was added. 
The amount of incorporated radioactivity was measured 16 hours later with a 1450 
MicroBeta TriLux (PerkinElmer, Shelton, CT, USA). 
 
2.20 Ex vivo culture and transfection of murine corneas 
     2 mm corneal buttons were excised from the eyeballs of either C3H or BALB/c mice 
(Harlan Laboratories, UK) and cultured in standard completed DMEM at 37°C with 5% 
CO2. For transfection, each cornea was placed, endothelial facing up, in individual wells 
of a 96-well plate containing 200 µL of DMEM. 20 µL of peptide/DNA complex 
containing 2 µg of IDO plasmids was then added and the corneas were incubated for 
various durations before medium change. Chloroquine was either absent or present (100 
µM) during the period of transfection. 
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2.21 RNA extraction from murine corneas for RT-PCR   
     Total RNA was isolated from 5 pooled corneas using the FastRNA® Pro Green Kit 
(MP Biomdical, CA, USA). Samples were first homogenised using the FastPrep-24 
Instrument (MP Biomedical) at a speed setting of 6.0 for 200 seconds (5 rounds of 40 
seconds). Purified RNA was then dissolved in 16 µL of DEPC water (Sigma, UK) and 
treated with RQ1 RNase-free DNase (Promega, UK) according to the manufacturer’s 
recommendation. Reverse transcription and subsequent quantification using RT-PCR 
were performed as described earlier.    
 
2.22 Immunohistochemistry (IHC) 
     Cornea tissues were snap-frozen in Shandon Cyromatrix (Thermo Scientific, USA) 
using liquid nitrogen, cut into 5 µm sections with a cryostat (model OTF, Bright 
Instrument, UK) and left to dry overnight. Sections were then fixed in cold acetone (-
20°C) for 10 minutes and then rehydrated with PBS for another 10 minutes. 
Endogenous peroxidase activity was eliminated with 0.3% H2O2 solution for 10 minutes 
and non-specific interactions were blocked with a 10% milk solution for 1 hour at room 
temperature. Having determined a suitable concentration to use from earlier 
optimisation experiments, sections were then probed with either a rabbit anti-mouse 
antibody against IDO (KR101, Transgenic Inc., Japan) or a rabbit IgG isotype control 
(Sc-2027, Santa Cruz Biotechnology Inc., USA) at a final concentration of 0.005 µg/µL 
for 1 hour at room temperature. Positive staining was then visualised with a Dako 
EnVision+ System-HRP (DAB) rabbit kit (K4010, Dako, USA) according to the 
manufacturer’s protocol. Sections were differentiated in haematoxylin for 60 seconds, 
dehydrated in graded ethanol/xylene solutions and mounted with DePex mounting 
medium (VWR International Ltd., UK). Observations were carried out using an 
Olympus BX40 microscope (USA) equipped with a Qimaging Retiga 2000R fast 1394 
camera.  
 
2.23 Corneal transplantation 
     1-2 months old female C3H/He (H-2k) mice were used as donor and BALB/c (H-2d) 
mice as the recipient. 2 mm corneal buttons were cut out from the donor and transfected 
ex-vivo for 24 hours in the absence of chloroquine or 4 hours in the presence of 
chloroquine (100 µM). On the day of surgery, the recipient’s pupil was first dilated with 
phenylephrine hydrochloride 10% (Chauvin Pharmaceuticals, Surrey, UK), tropicamide 
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1% (Chauvin Pharmaceuticals) and atropine (Moorfields Pharmaceuticals, London, UK) 
before the intra-peritoneal injection of an anaesthetic cocktail consisting of appropriate 
dilutions of Hypnorm® (fentanyl citrate 0.315 mg/mL, fluanisone 10 mg/mL, 
VetaPharma Ltd., Leeds, UK) and Hypnovel® (midazolam 5mg/mL, Roche, UK). 
Donor cornea was then sutured (Ethilon, polyamide, size 11-0, Ethicon, USA) onto the 
right eyeball of the recipient. Chloramphenicol ointment (1% w/w, Martindale 
Pharmaceutical, UK) was applied to the surgical site and the eyelid was sutured shut 
(PDS II, polydioxanone, size 7-0, Ethicon) for 5 days to protect against scratching. The 
corneal sutures were removed on day 7 and scoring of corneal clarity was performed 
daily according to the scale as described (Ardjomand et al., 2003). Grafts with a score 
of 3 and above were considered rejected. Survival curves were plotted using Prism 3 
(GraphPad Software, USA) and compared using the Logrank test with a p<0.05 being 
accepted as statistically significant. At all times, animal treatment compiled with the 
United Kingdom Home Office regulations for care of experimental animals. 
 
2.24 Confocal microscopy for murine corneas           
     The state of transfected and control corneas was compared using confocal 
microscopy. To stain for their F-actin, corneas were first washed in PBS and fixed with 
10% neutral buffered formalin (Sigma, UK) for 10 minutes. Phalloidin-TRITC (Sigma, 
UK) at a final concentration of 1 ug/mL in PBS containing 0.5% triton X-100 was then 
introduced for 90 minutes at room temperature. The tissue was washed twice with PBS 
and then flat-mounted, endothelial upwards, using Vectashield mounting medium with 
DAPI (Vector Laboratories, UK). For staining with propidium iodide (PI), corneas were 
first washed in PBS and immediately exposed to PI (Sigma, UK) at a final concentration 
of 2.5 µg/mL for 15 minutes. Specimens were then fixed and flat mounted, endothelial 
upwards, using Dako fluorescence mounting medium (Dako, USA). Confocal 
observations were carried out using a TCS SP5 confocal microscope (Leica 
Microsystems GmbH, Germany). 
 
2.25 Statistical anaylsis 
     Unless otherwise stated, statistical significance was determined using the 2-tailed t-
test with a p<0.05 being accepted as significantly different. Between comparison 
groups, p<0.05 was also indicated by * in the relevant graphs. 
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3. Results (peptide) 
     Data in Chapter three (results) and four (discussion) have appeared in the following 
publications (Seow & George, 2011; Seow & Yang, 2009b; Seow et al., 2009, 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. A summary of the composition of amino acids used for the main peptides in 
this study.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The chemical structures of amino acids used for the main peptides in this 
study. 
 
 
 
 
Peptide 
 
Colour 
scheme 
Hydrophobic block Hydrophobic 
 (length) 
Histidine 
(length) 
Arginine 
(length)  
I  Isoleucine 5 4 8 
F  Phenylalanine  5 4 8 
W  Tryptophan 5 4 8 
H  - 0 4 8 
F2  Phenylalanine 2 4 8 
F8  Phenylalanine 8 4 8 
H8  Isoleucine 5 8 8 
G4  Isoleucine 5 4 (Glycine) 8 
 
 
 
 
 
 
 
                Increasing hydrophobicity 
 
                                                                                    (pKa = 12.5)         (pKa = 6.0)   
   Tryptophan       Phenylalanine       Isoleucine            Arginine               Histidine           Glycine 
C
COOH
NH2 H
CH2
C
COOH
NH2 H
CH2
N
H
C
COOH
NH2 H
H
C
COOH
NH2 H
CH2
N
H
N
C
COOH
NH2 H
CH
CH3 CH2
CH3
C
COOH
NH2 H
CH2
CH2
CH2
NH
C
NH2 NH
                             Hydrophobic                                        Hydrophilic (cationic)                Neutral 
Chapter three: Results (peptide) 
 
 81
3.1 DNA was effectively condensed by the peptides 
     In this study, novel tri-block oligopeptides were designed and they featured an 
arginine sequence for DNA binding, a histidine block for buffering capacity and a 
hydrophobic segment for enhancing uptake and DNA binding ability (Figure 5). We 
started with four peptides: NH2-I5H4R8-CONH2 (I), NH2-F5H4R8-CONH2 (F), NH2-
W5H4R8-CONH2 (W) and NH2-H4R8-CONH2 (H) (Table 5 and Figure 6). To evaluate if 
the peptides could condense DNA, plasmids were bound to each peptide in 10 mM 
phosphate buffer (pH 7.0) at several N/P ratios and then separated by gel 
electrophoresis. Figure 7 showed that except for the naked DNA control, no bands were 
observed for other lanes. This demonstrated that I, F, W and H were all able to bind and 
retard DNA migration from N/P 2 onwards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. DNA binding ability of peptides. Plasmids were bound to peptides a) H, b) I 
and c) F or W at the N/P ratios specified and then separated by gel electrophoresis. 
DNA which was stably bound by the peptides gave no bands.  
 
 
 
3.2 Condensed DNA was protected against physical and enzymatic degradation 
     Serum contains nucleases which can extensively degrade naked DNA. To illustrate 
this, unprotected DNA was incubated in serum for varying durations before their 
physical integrity was assessed using agarose gel electrophoresis. As can be seen from 
Figure 8, degradation of naked DNA began within 30 minutes of incubation. Thus, on 
top of being well condensed, it is also crucial that plasmids are protected. 
 
F (N/P) 
  0       2        5      10     20     30      2       5      10     20      30      0  c) 
W (N/P) 
a) 0    2     5    10   15   20   30 
H (N/P) 
b) 0    2     5    10    15   20   30 
I (N/P) 
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Figure 8. DNA degradation study. Serum contains nucleases which can extensively 
damage unprotected DNA. Naked DNA was incubated in serum for the indicated 
amount of time before being flash frozen for storage. The physical integrity of the DNA 
samples was eventually assessed using agarose gel electrophoresis. 
 
 
     To test if the peptides could protect the DNA against physical and enzymatic insults, 
I/DNA complexes were first formed and then sonicated for 15 seconds. The same 
sample was next subjected to a consecutive digestion step using DNase. Finally, the 
DNase was inactivated before DNA was released by trypsin digestion and imaged after 
gel electrophoresis. As can be seen in Figure 9, unprotected DNA was observed to be 
extensively damaged by either sonication or DNase digestion alone (lane 2 and 3, 
respectively). In sharp contrast, DNA released from the complexes was still intact (lane 
4 and 6) and yielded bands comparable to the naked DNA control (lane 1). As expected, 
DNA still bound to the peptide gave no bands (lane 5 and 7). This shows that condensed 
DNA benefited from being sterically shielded by the peptides against the effects of 
DNase and sonication. 
 
 
 
 
 
 
 
Figure 9. Protection of DNA from sonicative shearing and DNase digestion by peptide 
I. Lane 1: untreated DNA control; 2: naked DNA sheared by sonication; 3: naked DNA 
digested with DNase; 5 and 7: complexes (N/P 15 and 30, respectively) after successive 
sonication and DNase treatment; 4 and 6: DNA released from peptide by trypsination 
after successive sonication and DNase treatment. 
                   DNA in serum at 37°C (hours) 
PBS                                                                       PBS 
10s 10s 0.5  1   1.5   2   2.5   3  3.5   4   4.5   5   24  24 hours 
Pure serum at 37°C (hours) 
1       2        3       4        5       6      7
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3.3 Peptides mediated efficient gene expression without causing extensive toxicity 
     To screen for their efficiencies as non-viral vectors, preliminary in vitro transfection 
experiments were conducted on three cell lines – HEK293 human embryonic kidney 
cells, HepG2 human hepato-carcinoma cells and 4T1 mouse breast cancer cells – using 
plasmids encoding for either luciferase or GFP. As observed in Figure 10a-c, the 
amount of luciferase expressed was dependent on the cell line, the nature of the peptide 
and N/P ratio used. In general, I, F and W mediated luciferase expressions that were 2-5 
orders higher than H. This may be due to a better cell membrane association promoted 
by the hydrophobic blocks (see later experiments on cellular uptake in section 3.11) and 
indicates that the presence of a hydrophobic component is crucial in the design of an 
efficient vector. 
 
    Differences in luciferase expression were also observed by varying the degree of 
hydrophobicity of the peptides. W, being the least hydrophobic, constantly induced the 
least luciferase expression. Conversely, F gave the highest expression in both HEK293 
and HepG2 cells, while I was optimal in 4T1 cells. More encouragingly, peptide I 
transfected 4T1 cells more efficiently than PEI without causing extensive cytotoxicity 
(Figure 11). For instance, I complexes mediated a peak expression level that was 6.4 
times higher than PEI in 4T1 cells with nearly 90% of the cells still viable. Pure I was 
also less toxic than PEI with an IC50 (concentration of I at 50% cell viability) value that 
was 5.0 times lower. 
 
     The percentage of cells successfully transduced with the reporter gene encoding for 
GFP was next quantified using flow cytometry and we selected the best peptide (in 
terms of luciferase expression) for these experiments. As shown in Figure 10d, a greater 
percentage of HepG2 and 4T1 cells were transfected by peptides F (at N/P 35 and 45) 
and I (at N/P 20 to 35), respectively, compared to PEI. PEI, however, still transfected 
more HEK293 cells than peptide F, albeit at the expense of more cell death. Taken 
together, these initial experiments demonstrate the potential of the peptides to be 
efficient vectors. 
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Figure 10. In vitro gene expression. a-c) Luciferase expression by HEK293, HepG2 and 
4T1 cells, respectively, when transfected with various peptide/DNA formulations. d) 
Percentage of cells expressing GFP when transfected with selected peptides. PEI/DNA 
complexes were prepared either in 10 mM phosphate buffer (pH 7.0) or in de-ionised 
(DI) water. PEI at different N/P ratios were used but only the best result achieved in 
each cell line is presented for comparison (PEI peaked at N/P 20 for HepG2 and N/P 10 
for HEK293 and 4T1). Error bars represent standard deviation of quadruplicates at least.  
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Figure 11. MTT viability assay. The viability of a) HEK293, b) HepG2 and c) 4T1 cells 
following exposure to pure peptide, peptide/DNA complexes or PEI at various 
concentrations was assessed 72 hours post-transfection with the various 
peptide/polymer formulations. The MTT assay was used and viability was expressed 
relative to untreated control cells, which were assigned to be 100% viable. Pure peptide: 
F for HEK293 and HepG2; I for 4T1. For complexes of F, I and W, a peptide 
concentration of 0.02 and 0.10 mg/mL will correspond to N/P 5 and 25, respectively. 
For H, a peptide concentration of 0.03 and 0.09 mg/mL will correspond to N/P 10 and 
30. For PEI, a polymer concentration of 0.0029 and 0.0058 mg/mL will correspond to 
N/P 5 and 10. Error bars represent standard deviation of octuplicates.  
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3.4 Peptides F and I lacked distinct secondary structures 
     The secondary structure of a peptide can influence its interaction with the cell 
membrane. CD measurements were therefore performed with peptides F and I (Figure 
12), two of the most promising peptides from earlier transfection experiments. Their CD 
signals evolved with pH and, presumably, the extent of protonation of histidine (pKa~6). 
Nonetheless, at the three pH values tested, the characteristic minimum ellipticity at 
~198 nm indicates that the secondary structures of F and I were predominately 
unordered.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. The secondary structures of pure peptide formulations in buffers. CD 
measurements were made with peptides a) F and b) I in different buffer solutions (10 
mM; pH 5.0, 6.3 or 7.0) prepared at 0.5 mg/mL. 
 
 
 
3.5 Particle size of peptide complexes 
     The morphology and size distribution of peptide I/DNA complexes were next 
investigated using dynamic light scattering and scanning electron microscopy (SEM). It 
was observed that complexes of peptide I were heterogeneous in size. The complexes 
mainly displayed a bimodal distribution and could be separated into two populations 
upon centrifugation. The sediment consisted of large 15-50 µm particles (Figure 13a) 
while the supernatant contained the smaller particles at 50-300 nm (Figure 13b). In 
contrast, H/DNA complexes were all distributed within the range of 0.8-2.0 µm. While 
the large size of the I/DNA complexes rules out their systemic application, they can still 
be useful in the ex vivo manipulation of corneas or other tissues/cells. On the other 
hand, H/DNA complexes, although smaller in size, were several orders less efficient 
than peptides I and F in reporter gene expression (Figure 10). 
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     A particle selected from the bigger I/DNA population was then examined under 
higher magnification (Figure 13c). The complex was irregularly shaped and the surface 
appeared rough. Along the longest axis, the particle was ~25 μm. The lack of 
granulation or clear internal boundaries seem to suggest that the particle was formed as 
a mass, rather than just the result of simple aggregation of smaller particles. However, 
we currently cannot rule out the latter possibility.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Particle morphology examined using SEM. I/DNA complexes were formed 
at N/P 15 and separated into a) the bigger and b) smaller population after centrifugation. 
The particles were then deposited onto a Si wafer for examination using a SEM.  c) A 
particle selected from the bigger population was further examined at a higher 
magnification.  
 
 
 
     The particle sizes of other peptide/DNA complexes were also investigated using 
light microscopy and similarly found to aggregate (Figure 14). For the sake of 
completeness, images of DNA complexes formed with peptides G4 and H8 have been 
included in Figure 14, although they will only be discussed later, in section 3.12. 
 
a b 
c 
Chapter three: Results (peptide) 
 
 88
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Particle morphology of various peptide/DNA formulations. Complexes were 
formed with a) F, b) W, c) G4 or d) H8 at N/P 20 and observed to form aggregates 
under a light microscope.  
 
 
 
3.6 Peptide I mediated in vivo luciferase expression following localised injection  
     As a proof of concept that the large peptide complexes can still find use in biological 
systems, an in vivo luciferase expression experiment was performed. Peptide I was 
chosen based on initial in vitro transfection results with 4T1 cells. In this experiment, 
subcutaneous 4T1 tumors were first allowed to grow in BALB/c mice. Subsequently, 
the animals received an injection of I or PEI/DNA complexes directly at their tumor 
sites. All animals were observed to be active when they were sacrificed two days later. 
Their tumors (<5 mm) were then homogenised and luciferase expression was 
quantified. From Figure 15, peptide I at its peak N/P ratio of 35 mediated about 13 
times more luciferase expression than PEI.    
 
a 
b 
c 
d 
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Figure 15. In vivo luciferase expression by subcutaneous 4T1 tumors in mice following 
localised injection of either I or PEI/DNA particles at their tumor sites. Mice were then 
sacrificed two days later and their tumors homogenised for quantification. Results were 
expressed as the mean ± standard deviation of four animals.  
 
 
 
3.7 Validation and optimisation of tri-block design with MCEC 
    We moved on to transfect mouse corneal endothelial cells (MCEC), a cell line that is 
highly relevant to our intended application. Unless otherwise stated, MCEC will, 
hereon, be used in all cell culture experiments. We first systematically validated the tri-
block design of the peptides. 
 
     The octaarginine block serves to bind DNA and therefore is a necessary component 
of the design. Furthermore, the length of eight repeat units was previously optimised for 
plasmid delivery into COS-7 cells (Futaki et al., 2001a).  
 
3.8 Hydrophobic block was crucial for efficient transfection 
     To evaluate the importance of the hydrophobic block, peptides I, F, W and H were 
compared in their ability to mediate luciferase expression in MCEC. As shown in 
Figure 16a, there was a general dependence on N/P ratio for expression efficiency. 
Consistent with earlier observations, removing the hydrophobic block in H drastically 
reduced (by orders of magnitude) the amount of gene expression across the range of 
N/P ratios tested. This confirms that the presence of the hydrophobic block is important 
in achieving efficient transfection.  
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Figure 16. Effects of the hydrophobic block on the properties of the oligopeptide 
vectors. Luciferase expression levels by MCEC when transfected with a) W, F, I, H or 
PEI complexes and b) F2, F or F8 complexes. c) Heparin displacement assay with 
H/DNA and F/DNA complexes incubated with increasing concentrations of heparin for 
one hr at room temperature. Naked DNA was the positive control. d) Relative uptake 
quantified with flow cytometry after MCEC were transfected with either peptide H, F or 
W complexed to Cy5-labelled DNA. The negative control refers to MCEC transfected 
with F/unlabelled DNA at N/P 20. e) Confocal images of live MCEC showing uptake of 
peptide H or F complexed to Cy5-labelled DNA (red). Nuclei of cells were stained with 
Hoechst (blue) prior to imaging. All error bars represent standard deviation of 
quadruplicates at least.  
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     Differences in expression level were also observed by varying the degree of 
hydrophobicity of the peptides. Consistent with earlier observations, W mediated the 
least expression while F and I performed comparably. Both F and I were also superior 
to PEI. This shows that the degree of hydrophobicity can indeed influence the efficiency 
of the vector. Data for lower N/P ratios were not presented due to poor efficiency. For 
instance, the expression levels achieved by F at N/P 5 and 10 were 1% and 5% of that at 
N/P 15, respectively.  
 
3.9 A length of five hydrophobic residues was optimal 
     The length of the hydrophobic block was next optimised. Further peptide sequences 
were synthesised with varying length of the hydrophobic block – NH2-F2H4R8-CONH2 
(F2) or NH2-F8H4R8-CONH2 (F8) – and used to transfect MCEC. As seen in Figure 
16b, peptide F mediated significantly more luciferase expression than F2 or F8. The 
length of five hydrophobic residues was thus optimal.   
  
3.10 Hydrophobic block increased complex stability 
    Hydrophobic groups can increase complex stability due to favourable interactions 
between the hydrophobic domains of vector and DNA (Jadhav et al., 2008). To study 
complex stability, we conducted a competitive heparin displacement assay in which H 
and F complexes were first formed at N/P 20 and then incubated with a range of heparin 
concentrations for one hour. Displacement of DNA by the anionic heparin was then 
detected by gel electrophoresis. As shown in Figure 16c, 1 mg/mL of heparin was 
sufficient to completely displace the DNA condensed by H. F complexes, on the other 
hand, remained stable up to 20 mg/mL of heparin. Similarly, complexes of I were also 
stable up to 20 mg/mL of heparin (data not shown). This suggests that the presence of a 
hydrophobic block can result in complexes that are more resistant to heparin-induced 
dissociation. Implicitly, such complexes are more stable which, in turn, may have 
improved transfection efficiency. We nonetheless note that while a more stable complex 
can better condense the DNA, it can also prevent the intracellular release of DNA, thus 
limiting its bioavailability. However, this does not seem to be a concern as F complexes 
still transfected significantly better than H.          
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3.11 Hydrophobic block enhanced complex internalisation 
     The presence of hydrophobic moieties has also been reported to improve cellular 
uptake due to favourable interactions with membrane lipids (Duncan, 2006). To 
investigate this, H and F peptides were used to deliver Cy5-labelled DNA encoding for 
luciferase into MCEC. For this experiment, cells were exposed to the respective 
complexes for three hours at 37°C before washing and analysis. Using the mean 
fluorescence intensity (MFI) as a parameter, results from flow cytometry showed that F 
complexes were internalised about eight times more efficiently than H complexes 
(Figure 16d). Additionally, F complexes were also more efficiently internalised than W 
complexes, which can possibly account for the higher luciferase expression achieved 
with the former. As a negative control, cells were also transfected with F complexes 
(N/P 20) containing unlabelled plasmids to show that the difference in MFI was due to 
DNA uptake and not novel protein expression or other nonspecific effects of 
transfection. The adequate removal of surface-adsorbed particles was proved by 
incubating the cells with sodium azide/2-deoxyglucose (NaN3/DOG), which inhibited 
energy-dependent endocytosis but not surface binding (Gratton et al., 2008b). Doing so, 
the MFI was reduced to background levels (to be discussed with results in section 3.20).  
 
     The observation that F complexes were more readily internalised than H complexes 
was further corroborated with confocal microscopy where strong fluorescence was 
detected upon exposure to F complexes containing Cy5-labelled DNA (Figure 16e). In 
sharp contrast, little to no fluorescence was seen in cells exposed to H complexes. As 
above, the addition of NaN3/DOG blocked the internalisation of F complexes (to be 
discussed with results in section 3.20) and validated the efficient removal of surface-
bound particles. 
 
3.12 Histidine block increased buffering capacity and transfection efficiency 
     We next investigated whether the buffering histidine block was a useful component 
of the peptide design. The imidazole sidegroup of histidine has a pKa~6.0 and as such, 
is suited to disrupt endosomal vesicles under the proton sponge hypothesis, as discussed 
in Chapter one. To directly test for the influence of the histidine block on buffering 
capacity, we synthesised additional peptide sequences in which the length of the 
histidine block was either increased to eight, i.e., NH2-I5H8R8-CONH2 (H8), or totally 
replaced with non-functional glycine spacers, i.e, NH2-I5G4R8-CONH2 (G4). We then 
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compared the pH profiles of peptides I, H8 and G4 upon titration against a standard 
solution of sodium hydroxide (0.01 M). Their relative ability to mediate luciferase 
expression was also investigated. Figure 17a indicates that a larger amount of base was 
needed per unit increase in pH of H8, followed by I and then by G4. This demonstrates 
that a larger buffering capacity was indeed achieved with a longer histidine block and 
can partially explain why I transfected better than G4 (Figure 17b). Another possible 
reason may be that glycine, unlike histidine, is incapable of protonation and cannot 
contribute to DNA binding. As a result, complexes of G4 are less stable than I, as 
shown by a heparin displacement assay in which DNA can be displaced from G4 
complexes with 1 mg/mL of heparin (Figure 17c). While it cannot be ascertained which 
effect is more dominant, the histidine residues clearly improved complex stability, 
buffering capacity and transfection efficiency. The histidine block is thus an important 
design consideration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Effects of the histidine block on the properties of the oligopeptide vectors. a) 
Titration experiments with 16 mL of 0.5 mg/mL peptide (G4, I or H8) solution or DI 
against 0.01 M NaOH. b) Luciferase expression levels in MCEC transfected with 
indicated peptide/DNA complexes. Error bars represent standard deviation of 
quadruplicates. c) Heparin displacement assay with I and G4 complexes incubated with 
increasing concentrations of heparin for one hour at room temperature. Naked DNA was 
the positive control.  
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3.13 FRET revealed that difficulty in DNA release limited efficiency of H8 
     A larger buffering capacity does not always result in stronger transfection ability. As 
shown in Figure 17b, peptide I mediated more luciferase expression than H8, despite the 
latter having a greater buffering capacity. This may be because the process of 
endosomal escape, albeit important, is but one of the several challenges encountered by 
the DNA complex en route to the nucleus (Figure 2). DNA release, for instance, can be 
another potential limitation. To test for this, we conducted fluorescence resonance 
energy transfer (FRET) experiments with peptides I and H8. For this study, plasmids 
encoding for luciferase were double-labelled with a FRET pair – Cy3 (donor) and Cy5 
(acceptor) – and then delivered into MCEC. During live-cell imaging, only Cy3 was 
excited but emissions from both Cy3 and Cy5 were collected. If the DNA was 
condensed, Cy3 and Cy5 would be close enough for FRET to occur (Itaka et al., 2002). 
Upon complex dissociation and DNA uncondensation, FRET was reduced and mainly 
Cy3 would be detected. To aid interpretation, images were also binary-scored according 
to the number of pixels positive for Cy 3 (green) or Cy5 (false-coloured red). The ratio 
of red to green pixels (R/G) was then used to indicate the extent of FRET, with a ratio 
of one indicating maximal FRET and DNA condensation. 
 
     Figure 18 shows that at six hours post-exposure to complexes, strong co-localisation 
of red and green signals were observed in cells transfected with either H8 (R/G = 0.81) 
or I (R/G = 0.84). This suggests that the DNA remained condensed, presumably by the 
peptides up to this point. In both cases, the extent of FRET was reduced after 25 hours 
of incubation, consistent with the intracellular digestion of peptide and release of DNA 
over time. However, while FRET was largely diminished in cells transfected with I 
(R/G = 0.04), significant FRET could still be seen in cells transfected with H8 (R/G = 
0.40). This suggests that compared to I complexes, DNA release by H8 complexes was 
more hindered, which may account for the lower luciferase expression mediated by H8.    
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Figure 18. MCEC were exposed to peptide I or H8/DNA complexes (N/P 20) formed at 
pH 7.0. FRET was used to show if the DNA was still condensed at selected time points. 
The DNA was double-labelled with Cy5/Cy3. During imaging, only Cy3 was excited. If 
there was FRET, Cy5 (false-coloured red) can also be detected, which then co-localised 
with Cy3 (green) to give yellow signals in the merged image. All cells were stained for 
their nuclei with Hoechst (Hoe) and presented with the bright field (BF) images. 
 
 
 
 
 
 
 
 
 
Cy 5 Cy 3 Merge BF + Hoe 
H8 
6 hrs 
R/G = 0.81  
I 
6 hrs 
R/G = 0.84  
H8 
25 hrs 
R/G = 0.40  
I 
25 hrs 
R/G = 0.04  
Chapter three: Results (peptide) 
 
 96
3.14 Peptide-mediated GFP expression in MCEC 
     Based on luciferase expression results, two of the best peptides (F and I) were 
selected to deliver plasmids encoding for GFP into MCEC. As shown in Figure 19a, F 
and I were generally comparable and more efficient (>5 times) than PEI in mediating 
GFP expression in MCEC. However, while peptide I performed better than F at N/P 25, 
I complexes were also more toxic (Figure 20). At N/P 20 and 25, for instance, the 
viability of cells transfected with I complexes was ~70% and ~65%, respectively, 
compared to viabilities of ~90% and ~80% with F complexes. As a compromise 
between transfection efficiency and toxicity, peptide F at N/P 20 (peptide concentration 
~32 µM) was selected for further studies. 
 
     GFP expression was observed in MCEC up to a period of 14 days post transfection 
with peptide F at N/P 20 (Figure 19b). The number of GFP positive cells (but not 
necessarily the proportion) appeared to increase and then decrease, consistent with cell 
proliferation and death. Due to technical limitations, it was not possible to quantify the 
percentage of cells expressing GFP upon prolonged incubation.     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. GFP expression by MCEC. a) Flow cytometry was used to quantify that 
percentage of MCEC expressing GFP two days post transfection with peptides I, F or 
PEI. Error bars represent standard deviations from triplicates. b) Confocal images 
showing MCEC expressing GFP up to 14 days after transfection with F/DNA 
complexes (N/P 20). Each image is a merger of several z-stack images acquired as the 
cell layers became overly confluent with the long incubation period. Cells also started to 
detach from the culture chambers after prolonged incubation, explaining the apparent 
reduction in cells expressing GFP on day 14.   
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Figure 20. Viability of MCEC after exposure to peptide I or F at different N/P ratios for 
four hours. The MTT assay was carried out 72 hours post-transfection and viability was 
expressed relative to untreated control cells (assigned to be 100% viable). Error bars 
represent standard deviation of octuplicates. 
 
 
 
3.15 Peptides were mildly haemolytic towards rat erythrocytes 
     To investigate if there was a correlation between cytotoxicity and the extent of 
membrane disruption caused by the peptide complexes, we conducted a haemolysis 
experiment. As per transfection experiments, complexes of F or I were formed at pH 7.0 
and then incubated with RBC freshly obtained from WKY rats. Haemoglobin release 
was then measured by absorbance at 540 nm and normalised to the value obtained with 
triton X-100 treatment (assigned as 100% lysis). Background absorbance was accounted 
for by incubating the RBC with PBS (assigned as 0% lysis). Figure 21 shows that 
haemolytic activity increased with N/P ratio, consistent with trends in cytotoxicity. In 
general, complexes of F and I were both only mildly haemolytic and caused less than 
25% haemolysis even at the highest N/P ratio tested. Complexes of F, however, were 
more haemolytic than I at the higher N/P ratios.  
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Figure 21. RBC haemolysis assay. Rat erythrocytes were incubated with DNA 
complexes of F or I at different N/P ratios for one hour. The amount of haemoglobin in 
solution was then quantified by absorbance. Incubation with triton X-100 provided the 
reference for 100% haemolysis. Data is shown as the mean ± standard deviation of 
quadruplicates.    
 
 
 
3.16 Serum and prolonged exposure to peptides augmented gene expression 
    We moved on to study the various transfection parameters that could affect 
expression efficiency. Contrary to other arginine-rich vectors (Moulton et al., 2004), the 
presence of serum during transfection significantly augmented both luciferase (Figure 
22a) and GFP (Figure 22b) expression mediated by peptide F. A possible contributing 
factor may be due to the enhanced viability of cells in the presence of serum (Figure 
22a). This finding is particularly useful as it is preferable to culture corneal tissues in 
the presence of serum throughout the ex vivo manipulation. Additionally, we also 
observed that gene expression increased significantly upon prolonged exposure to the 
complexes. For instance, increasing the incubation period from four to six hours 
produced a 2.5 times increment in the amount of luciferase expressed (Figure 22c). 
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Figure 22. Optimisation of transfection conditions. Effects of serum on a) the luciferase 
expression level and viability and b) GFP expression of MCEC. Effects of c) complex 
exposure time, d) amount of DNA used and e) duration of post-transfection incubation 
on the relative luciferase expression levels of MCEC. In a) and d), peptide F/DNA 
complexes were formed at N/P 20. In e) quantification of luciferase expression was 
performed one (D1) to six days (D6) following transfection and media were replaced 
every two days to maintain cell viability. Unless otherwise stated on the axis, results are 
presented relative to a reference treatment regime (assigned 100%). All error bars refer 
to standard deviation of quadruplicates.  
 
0
25
50
75
100
125
2.5 1.25 0.6252.5           1.25          0.625 
 
             DNA (μg) 
125 
 
100 
 
75 
 
50 
 
25 
 
0 Re
la
tiv
e 
R
LU
/m
g 
pr
ot
ei
n 
(%
) 
d) 
0
20
40
60
80
100
120
140
RLU / mg protein Viability
Serum
Serum-free
RLU/mg protein      Viability 
 
120 
 
80 
 
40 
 
0 
R
el
at
iv
e 
le
ve
ls
 (%
) 
a) 
0
10
20
30
40
10 15 20 25 30
Serum
Serum-free
10       15      20       25      30 
 
     N/P ratio 
40 
 
30 
 
20 
 
10 
 
0 
%
 G
FP
 p
os
iti
ve
 
b) 
0
100
200
300
15 20
0.5 1 2 4 5 6 hours
c) 
10                      20 
 
         N/P ratio 
300 
 
200 
 
100 
 
0 Re
la
tiv
e 
R
LU
/m
g 
pr
ot
ei
n 
(%
) 
0
50
100
150
200
15 25
D1
D2
D3
D4
D6
15                      25 
 
         N/P ratio 
200 
 
150 
 
100 
 
50 
 
0 Re
la
tiv
e 
R
LU
/m
g 
pr
ot
ei
n 
(%
) 
e) 
Chapter three: Results (peptide) 
 
 100
3.17 Expression profile varied with DNA dosage and post-transfection incubation 
     We next determined if gene expression was sensitive to the amount of plasmid used. 
Figure 22d shows that at a fixed N/P ratio, reducing the dosage of plasmid from 2.5 μg 
(the typical amount used for luciferase expression assays) to 1.25 μg resulted in a 
modest drop (~15%) in the amount of luciferase expressed. Further reduction to 0.625 
μg of plasmid, however, caused a drastic drop (~98%) in luciferase expression. This 
shows that the system was relatively insensitive to the amount of plasmid used within 
the range of 2.5 to 1.25 μg and may provide us with a strategy to moderate toxicity 
without compromising excessively on transfection efficiency.  
 
     The post-transfection incubation period also influenced the amount of luciferase 
detected. Figure 22e shows that luciferase expression, which was already significant one 
day after transfection, peaked on day two. Thereafter, the amount of luciferase detected 
declined rapidly from day three to six, possibly due to a dilution effect of the rapidly 
dividing MCEC and the non-integrating nature of non-viral vectors. Nonetheless, on 
day six, the amount of luciferase present was still more than three orders higher than 
that in untransfected MCEC. Given the short half-life of luciferase (~3 hours) (Kichler 
et al., 2001), this indicates that active transcription and translation of the plasmid 
continued up to day six at least. 
 
3.18 A lower pH increased strength of DNA binding by complexes but limited release  
     The pH used for complex formation also influenced the properties of the vector. It 
was observed that DNA binding became increasingly efficient as pH was reduced from 
7.0 to 5.0, as shown by an ethidium bromide exclusion assay (Figure 23a). This was 
consistent with the more extensive protonation of histidine at a lower pH. In contrast, 
the level of luciferase expression mediated by complexes formed at pH 7.0 was 
significantly higher than those formed at pH 6.3 or 5.0 (Figure 23b). We do not expect 
cell viability to be affected to any large extent since the culture media made up >90% of 
the volume and the peptide exposure period was short relative to the duration of 
incubation. A possible explanation may thus be that the DNA, being more efficiently 
condensed at a lower pH, had a reduced propensity of being released. To determine if 
this was a valid hypothesis, FRET experiments were conducted to compare the DNA 
release profiles of F/DNA complexes formed at pH 5.0 or 7.0. Indeed, Figure 24 shows 
that the release of DNA was slower with complexes formed at pH 5.0 (R/G = 0.70 at 25 
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hours post-transfection) compared to those formed at pH 7.0 (R/G = 0.28 at 25 hours 
post-transfection). This likely contributes to the poorer transfection ability of complexes 
formed at a lower pH.    
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Effects of pH on peptide F/DNA complex formation. a) Percentage of 
ethidium bromide fluorescence remaining upon peptide F/DNA complex formation 
(N/P 20) at different pH. 100% was assigned to the fluorescence intensity obtained with 
the same amount of naked DNA at the respective pH.  b) Relative luciferase expression 
mediated by F/DNA complexes (N/P 20) formed at different pH. 100% was assigned to 
the luciferase expression level achieved with complexes formed at pH 7.0. All error bars 
represent standard deviation of quadruplicates.   
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Figure 24. Effects of complex formation pH on the propensity for DNA release. MCEC 
were exposed to peptide F/DNA complexes (N/P 20) formed at pH 5.0 or 7.0 for 1.5 
hours and then washed extensively. FRET was then performed with DNA double-
labelled with Cy5/Cy3 and used to show if the DNA was still condensed at selected 
time points. All cells were stained for their nuclei with Hoechst (Hoe) and presented 
with the bright field (BF) images. 
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3.19 Large complex size may help but is insufficient to afford efficient transfection 
     Earlier results showed that the peptide/DNA complexes comprised of large and small 
particles (Figure 13). We wanted to find out their relative contribution to overall 
transfection efficiency. The two populations were therefore separated from the parent 
mixture by centrifugation and used to transfect MCEC individually. Doing so, we 
realised that the sediment containing the bigger particles was significantly more 
efficient than the supernatant in mediating luciferase expression in MCEC (Figure 25a). 
That bigger particles transfect better due to a sedimentation effect has been reported in 
in vitro systems (Luo & Saltzman, 2000b). However, large aggregated particles have 
also been observed to be poorly taken up by cells (Kwok et al., 2000). Here, we argue 
that while precipitation can contribute, it is not sufficient to ensure high transfection 
efficiency – aspects of their molecular design, on the other hand, were clearly shown to 
be important (see later discussions in Chapter four). We also note that the luciferase 
expression level mediated by F complexes was on average more than two orders higher 
than that achieved using calcium phosphate (Figure 25b), a system known to efficiently 
transfect cells by precipitation (Chen & Okayama, 1987). 
 
 
 
 
 
 
 
 
 
 
Figure 25. a) Relative contribution of the sediment (big particles) and supernatant (small 
particles) to the overall transfection efficiency. The big and small particles were 
separated from the parent mixture by centrifugation. b) Comparison of luciferase 
expression levels mediated by peptide F (at the various N/P ratios, all with 4 hours of 
incubation) and calcium phosphate (Ca) precipitation (with either 4 or 14 hours of 
incubation). DNA refers to transfection with naked plasmids. Error bars show standard 
deviation of quadruplicates. 
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3.20 Internalisation was energy-dependent and involved multiple pathways 
     Having justified the tri-block design and demonstrated the ability of the peptides to 
deliver genetic cargoes efficiently into MCEC, we next investigated the mechanism(s) 
by which the peptide complexes were internalised. Uptake can take place via the 
pathways illustrated in Figure 4. We co-cultured the cells with peptide F complexes 
(N/P 20) containing rhodamine-labelled DNA and either one of the following 
fluorescently labelled makers for specific endocytosis pathways: transferrin, cholera 
toxin or dextran, which are known to be internalised exclusively via the clathrin-
mediated (Rejman et al., 2004), caveolae-mediated (Torgersen et al., 2001) and 
macropinocytosis (Lundin et al., 2008) pathway, respectively. After a brief incubation, 
cells were washed extensively with PBS and observed for any co-localisation of the 
complexes and endocytosis markers. Cells were observed live to avoid artefacts due to 
fixation. Interestingly, we observed that the complexes exhibited partial co-localisation 
with all three endocytosis markers (Figure 26). Evidently, all three mechanisms can 
contribute to the uptake of peptide complexes, which seems reasonable in light of the 
heterogeneity in particle sizes. The observation that chloroquine increased luciferase 
expression by 3.5 to 7.6 fold (Figure 27) further supports the involvement of pathways 
(e.g., clathrin-mediated endocytosis) that produce vesicles which undergo acidification. 
 
     We next quantified the effects of various endocytosis inhibitors on both the uptake 
(Figure 28a) and gene expression (Figure 28b) by MCEC. This therefore allows us to 
determine whether a pathway is biologically relevant as efficient internalisation may not 
lead to high expression if the DNA is ultimately not bioavailable. All data were 
normalised to cells transfected in the presence of vehicle control (DMSO or water) 
alone. A suitable working concentration for the various inhibitors was also established 
in preliminary experiments for which excessive cell death was not evident. 
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Figure 26. Co-localisation studies to determine the relevant internalisation pathways of 
DNA complexes. Peptide F complexed with DNA (red) at N/P 20 was incubated with 
markers for specific endocytosis pathways like transferrin (Tfr, green) for clathrin-
mediated endocytosis, cholera toxin B (CT-B, green) for caveolae/lipid raft-mediated 
endocytosis or dextran (Dex, false-coloured green) for macropinocytosis. Cells were all 
stained with the Hoechst nuclear dye (blue) and presented with the bright field (BF) 
images. Imaging was done 40-90 minutes post exposure to peptide/DNA complexes.    
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Effect of chloroquine on the transfection efficiency of F/DNA complexes. 
Chloroquine was either absent or present during transfection and the resultant luciferase 
expression was expressed as mean ± standard deviation of quadruplicates. 
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Figure 28. Effects of various inhibitors on the a) uptake and b) gene expression of 
MCEC transfected with F complexes (N/P 20). Cells were preincubated with inhibitors 
for one hour prior to exposure to F complexes containing Cy5-labelled DNA (for uptake 
quantification using flow cytometry) or unlabelled DNA (for gene expression). Values 
were all referenced to control cells transfected with F complexes without any inhibitors 
(assigned as 100%). Where inhibitors had to be dissolved in DMSO, control cells were 
also transfected in the presence of pure DMSO. Error bars represent standard deviation 
of quadruplicates.   
 
 
 
     The combination of NaN3/DOG blocks intracellular ATP synthesis and inhibits 
energy-dependent translocation (Gratton et al., 2008b). Incubating the cells with 
NaN3/DOG drastically reduced their ability to endocytose (~87.7% inhibition) and 
express the plasmid (~98.2% inhibition), confirming that energy-dependent endocytosis 
is the main form of uptake in this system. Live-cell confocal observations further 
corroborated the impaired uptake upon NaN3/DOG treatment (Figure 29). Usefully, 
these results also validate earlier experiments by confirming that surface-adsorbed 
particles were adequately removed by the washing steps prior to observation.         
 
     The actin cytoskeleton (required during the early budding process of vesicles near 
the cell surface), GTPase dynamin (known to mediate the budding of pits) and 
microtubules (required for the subsequent trafficking of budded vesicles) are all 
reported to be important for the trafficking of endosomes, caveosomes and 
macropinosomes (Mayor & Pagano, 2007; Pelkmans et al., 2002). Furthermore, both 
the clathrin- and caveolae-mediated pathways have been shown to be sensitive to 
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cholesterol depletion (Mayor & Pagano, 2007). Treatment of the cells with cytochalasin 
(which disrupts the actin cytoskeleton) (Belting et al., 2005), dynasore (which inhibits 
the GTPase activity of dynamin) (Macia et al., 2006), nocodazole (which disrupts 
microtubule depolymerisation) (Gratton et al., 2008a) and methyl-β-cyclodextrin 
(MβCD, which extracts cholesterol from cell membrane) (Rodal et al., 1999) thus 
significantly reduced uptake by 58.5%, 64.7%, 58.2% and 41.9%, respectively. Gene 
expression also dropped by 89.3% and 35.0% after cytochalasin and MβCD treatment, 
respectively. The effects of dynasore on gene expression cannot be examined due to its 
pronounced toxicity which became evident following the longer incubation period used 
for gene expression assays. Nocodazole, on the other hand, increased gene expression 
2.4 times. A possible reason may be that disruption of the microtubule network also 
inhibited late-stage trafficking. For instance, it was reported that internalised molecules 
remained sequestered longer within early endosomes in nocodazole-treated cells 
(Gruenberg et al., 1989). The delay in maturation into digestive lysosomes may present 
the complexes with more opportunity to escape into the cytosol, in turn increasing the 
chance of their genetic cargoes being expressed.      
 
    The involvement of both the caveolae-mediated pathway and macropinocytosis is 
given further credit by using inhibitors that reportedly inhibits the respective pathways. 
Filipin is a specific inhibitor of the caveolae-mediated pathway (Gratton et al., 2008a) 
and treatment with this drug reduced uptake and gene expression by 48.6% and 88.4%, 
respectively. Similarly, 5-(N-ethyl-N-isopropyl)amiloride (EIPA), an inhibitor of 
macropinocytosis (Duchardt et al., 2007), reduced uptake and expression by 32.9% and 
75.1%, respectively.  
 
3.21 Internalisation depended heavily on heparan sulphate 
     Cell-surface glycosaminoglycans, in particular, heparan sulphate (HS) appear to be 
key mediators in the initial binding events leading to internalisation (Wadia & Dowdy, 
2005). Our results suggest that interaction with HS is indeed pivotal as the presence of 
heparin, which competes with HS for binding with the complexes, dramatically reduced 
uptake and luciferase expression by 91.4% and 99.9%, respectively. Based on earlier 
heparin displacement results (Figure 16c), the concentration of heparin used for this 
experiment (50 µg/mL) is not expected to affect the stability of the complexes. 
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Figure 29. Confocal images showing the effects of various inhibitors on the uptake of F 
complexes containing DNA labelled with TM-rhodamine (red) and the corresponding 
bright field images with the nuclei stained blue with Hoechst (BF+Hoe). Inhibitors 
soluble in water include: sodium azide/2-deoxyglucose (NaN3/DOG), methyl-β-
cyclodextrin (MβCD) and heparin. Inhibitors soluble in DMSO include: nocodazole 
(Noco), cytochalasin D (Cyto), dynasore (Dyna) and 5-(N-ethyl-N-isopropyl)amiloride 
(EIPA). Control cells were transfected in water (control) or DMSO.  
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3.22 FRET revealed post-internalisation fate of complexes 
     While previous confocal studies determined the locality of the DNA, they gave no 
information as to whether the DNA remained condensed; and if so, for how long. To 
study this, we conducted a time-course FRET experiment involving peptide F and 
MCEC. Figure 30a shows that strong co-localisation of Cy3 and Cy5 (R/G = 0.92) was 
observed up to 4.5 hours after transfection, indicating that the DNA was still condensed. 
There was also evidence of early stage nuclear entry of condensed DNA, as indicated by 
the co-localisation of yellow and blue Hoechst signals. This suggests that the 
peptide/DNA entered the nucleus as an associated complex. Similar nuclear entry of 
associated PEI/DNA complexes was previously reported, albeit at different time-points 
(Godbey et al., 1999).          
 
     By 8.5 hours, however, there was evidence of DNA uncondensation. This was 
accompanied by a decrease in Cy5 signal (Figure 30b). The merged image therefore 
appeared more green than yellow (R/G = 0.41). By 26 hours, large amount of DNA had 
accumulated within the nuclei which showed little FRET signal (R/G = 0.05) and so 
was no longer condensed (Figure 30c). Figure 30d focuses on a nucleus at 26 hours 
exhibiting large-scale accumulation of uncondensed DNA (R/G = 0.00). To ensure that 
the disappearance of Cy5 signals was due to a lost of FRET and not simply an artefact 
of photobleaching or degradation, we excited Cy5 alone. This resulted in the 
disappearance of signals due to Cy3 and the appearance of Cy5 fluorescence (Figure 
31). 
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Figure 30. Intracellular trafficking of DNA complexes followed using FRET. Confocal 
images taken of live MCEC at row a) 4.5 hrs, row b) 8.5 hrs and row c) 26 hrs after 
initial exposure to peptide F/DNA complexes at N/P 20. The DNA was double-labelled 
with Cy5/Cy3. Row d) a nucleus at 26 hrs showing large scale accumulation of 
uncondensed DNA. All cells were stained for their nuclei with Hoechst (blue) and 
presented with the bright field (BF) images.   
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Figure 31. Control experiment to show that the disappearance of Cy5 signals was due to 
a lost of FRET and not due to the photobleaching or degradation of dyes. MCEC was 
imaged 26 hours after transfection with plasmids double-labelled with Cy5/Cy3. In a) 
FRET was carried out normally with only the Cy3 laser turned on. b) To show that the 
Cy5 dye had not been photobleached or degraded, the Cy3 laser was switched off and 
instead, the Cy5 laser was switched on. Doing so, signals due to Cy3 disappeared while 
signals due to Cy 5 appeared.     
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3.23 Peptides mediated IDO mRNA and protein expression in MCEC 
     The expression of the immunosuppressive enzyme, IDO, is a target of this study. We 
next used peptide F to deliver plasmids encoding for IDO (F/IDO) into MCEC. IDO 
mRNA expression normalised to the reference HPRT mRNA was then quantified using 
RT-PCR (Figure 32a). As can be seen, there was a strong increase in the amount of IDO 
mRNA following peptide-mediated transfection, compared to untransfected and mock-
transfected (GFP) MCEC. More significantly, the levels of IDO mRNA expression 
induced by peptide F were also higher (by up to 17 fold) than those induced by PEI or 
lipofectamine™2000. IDO protein was also detected by western blotting after cells were 
transfected with peptide F/IDO complexes (Figure 32b).   
 
 
 
 
 
 
 
 
 
 
Figure 32. IDO expression by MCEC after peptide-mediated transfection. a) IDO 
mRNA expression in MCEC transfected with peptide F, PEI or lipofectamine™2000 
(LF). Negative controls include untransfected MCEC (Blank) or mock transfection with 
F/GFP complexes (GFP) at N/P 30. Error bars represent standard deviation of 
quadruplicates. b) IDO protein expression detected by western blot following 
transfection with peptide F at N/P ratios 15-30. Mock transfection with F/GFP 
complexes (GFP) at N/P 30 served as the negative control. 
 
 
 
3.24 IDO expressed by MCEC catalysed the degradation of tryptophan 
     To show that the IDO expressed was functional, the amount of L-kynurenine – the 
main breakdown product of tryptophan – in the culture supernatant was measured 
(Figure 33). As can be seen, the levels of L-kynurenine were elevated in the supernatant 
of IDO-transfected MCEC compared to untransfected and mock-transfected controls. 
The IDO produced by the cells was therefore biologically functional. Further, the levels 
of L-kynurenine detected were reduced significantly, though to a variable extent, by the 
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addition of 1-MT, an inhibitor of IDO. This shows that the effect of L-kynurenine 
production was due to IDO activity. 
 
 
 
 
 
 
 
 
 
 
Figure 33. IDO catalyses the degradation of tryptophan and L-kynurenine is the main 
breakdown product. To show functional activity, the levels of L-kynurenine in the 
supernatants of MCEC transfected with F/IDO or F/GFP (GFP) complexes at N/P 30 or 
untransfected (MCEC) were measured. The addition of IDO antagonist, 1-MT, reduced 
the catalytic activity of IDO and the amount of L-kynurenine detected by varying 
degrees. Statistical significance indicated for F is with respect to the MCEC control. 
Error bars represent standard deviation of quadruplicates.         
 
 
 
3.25 IDO expressed by MCEC suppressed the proliferation of CD4 T-cells 
     As discussed in Chapter one, CD4 T-cells are the chief mediator of ocular 
inflammation. It was therefore important to evaluate the effect of IDO production on the 
proliferation of CD4 T-cells. MCEC transfected with F/IDO complexes were thus 
incubated with CD4 responder T cells freshly isolated from the spleens of C3H mice. 
Antibody-mediated staining of surface markers confirmed that the responder cell 
population was highly enriched (>96%) in CD4 T-cells (Figure 34). The T-cells were 
also stimulated with anti-CD3 and CD28 beads prior to their addition to the transfected 
MCEC. Their proliferation was then measured three days later by [3H]thymidine 
incorporation (see Figure 35 for the overall experimental scheme). It was observed that 
the proliferation of T-cells incubated with IDO-transfected MCEC, but not GFP-
transfected MCEC, was reduced by up to 70% compared to the untransfected MCEC 
control (Figure 36). Further, the inhibitory effect was reversed by the addition of 1-MT. 
These data show that the suppressed growth of T-cells was specifically due to the 
effects of IDO activity. 
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Figure 34. Responder CD4 T-cells used for the proliferation assay were freshly isolated 
from the spleens of C3H mice and purity was ascertained by flow cytometry after 
surface marker staining. Cells were enriched in CD4 T-cells, but depleted in CD8 T-
cells, B-cells (CD19) or other leukocytes (CD16/32).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Schematic of the proliferation assay. a) MCEC were seeded on day 0 and b) 
transfected with F/IDO complexes on day 1. c) Mitomycin was added on day 3 for 30 
minutes to stop the proliferation of MCEC before d) freshly isolated CD4 T-cells 
stimulated with anti-CD3 and CD28 beads were added to the culture. e) Proliferation of 
the responder T-cells was assessed on day 6 by 3H-thymidine incorporation.   
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Figure 36. T-cell proliferation assay. CD4 T-cells stimulated with anti-CD3 and CD28 
beads were either incubated alone (T-cells) or with MCEC in a 3-day proliferation 
assay. The proliferation rate of CD4 T-cells was then assessed by [3H]thymidine 
incorporation. MCEC used were either untransfected (MCEC), or transfected with 
F/IDO or F/GFP complexes at N/P 30. The addition of 1-MT (F/IDO+1-MT) reversed 
the inhibiting effects of IDO activity. Error bars represent standard deviation of 
quadruplicates. 
 
 
 
3.26 Peptides mediated IDO mRNA expression in murine corneal tissues 
     We next progressed into using actual tissue samples. We first screened two of the 
most promising peptides – F and I – for their ability to mediate IDO expression in full 
thickness murine corneas. Corneas were thus exposed to either of the peptides for 48 
hours before being homogenised. IDO mRNA was then quantified using RT-PCR and 
referenced to HPRT mRNA. A DNase digestion step was included to eliminate 
contaminating genomic or plasmid DNA. As seen in Figure 37a, IDO mRNA 
expression was upregulated in the IDO-transfected corneas, but not in the untreated or 
mock-transfected (GFP) samples. I, however, was about 1.5 times more efficient than F 
and was chosen for future studies.      
 
     We next established the appropriate amount of time to transfect the corneas before 
transplantation. Corneas were exposed to peptide I for 4, 24 or 48 hours before the 
medium was changed. All samples were then analysed at the 48-hour time point using 
RT-PCR. From Figure 37b, IDO mRNA expression increased with a lengthening of 
peptide exposure period, consistent with our observations with MCEC. However, from 
our experience, culturing the cornea for more than 24 hours is undesirable as the tissue 
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becomes oedematous and difficult to manipulate. Moreover, the epithelium frequently 
overgrew into the endothelium upon prolonged culture (Comer et al., 2002), which may 
compromise critical endothelial functions. For these reasons, we selected 24 hours as a 
practical transfection period for the corneas before transplantation. 
 
     All post-PCR products were then separated on an agarose gel to verify the specificity 
of the amplification process. As seen in Figure 37c, all the lanes had clean dominant 
bands whose positions agreed well with the expected sizes of the IDO (196 bp) and 
HPRT (177 bp) amplicons. Nonetheless, we note that a band corresponding to IDO 
amplification can still be detected with corneas mock-transfected with plasmids 
encoding for GFP and this observation will be discussed in Chapter four. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Full thickness murine corneas were transfected with peptides (N/P 30) and 
assessed for their IDO mRNA expression after DNase treatment. a) Corneas were either 
untreated or transfected for 48 hours with peptide I or F containing plasmids encoding 
for IDO. Corneas were also mock transfected with peptide F containing plasmids 
encoding for GFP. b) Corneas were then transfected with peptide I/IDO for various 
durations (4, 24 or 48 hours) before changing the medium. All IDO mRNA expression 
was assessed 48 hours after initial exposure to peptides. c) The amplicons from the 
various reactions were separated on an agarose gel and showed good agreement with 
their expected sizes. 
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3.27 IDO was expressed by the corneal endothelium and epithelium 
     The cornea is composed of three distinct layers held together by two basal 
membranes (Figure 1). To determine the locality of IDO expression within the cornea, 
we performed IHC on corneas transfected with I/IDO complexes using the snap-frozen 
method. From Figure 38a, strong IDO expression was observed in the epithelium and 
endothelium, but not the stroma. Magnified images of the positively stained areas 
further showed the characteristic features of the epithelium (multilayered cells with 
generally rounded nuclei) and endothelium (monolayer of cells with flat and elongated 
nuclei). Staining was also observed mainly in the outer layers of the epithelium, 
indicating that access by the peptide complexes and subsequent IDO expression were 
limited to the top few layers of epithelial cells. In contrast, little to no staining was 
observed in untransfected corneas, mock-transfected corneas or IDO-transfected 
corneas probed with an isotype IgG control antibody (Figure 38b-d). 
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Figure 38. Immunohistochemistry performed on corneas that were either a) transfected 
with plasmids encoding for IDO, b) untreated, c) mock transfected with GFP or d) IDO-
transfected but probed with an isotype antibody control. In a-c, IDO protein expression 
was probed using a HRP-based Dako EnVision anti-rabbit kit. Main picture and insets 
were taken at 10× and 40× magnification respectively. IDO expression was seen in the 
endothelial and epithelial layers but not in the stroma of the transfected cornea sample. 
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Figure 39. Overall scheme of the ex vivo treatment regime followed by MHC-
mismatched PK. a) Corneas were enucleated from C3H donors, b) transfected ex vivo 
using I/IDO complexes and c) sutured back onto BALB/c recipients. d) Sutures were 
then removed several days after surgery and the graft was scored daily based on clarity. 
e) Rejected corneas became opaque while f) non-rejected corneas stayed clear. 
 
 
 
3.28 Ex vivo manipulation failed to prolong graft survival after corneal transplantation 
     We next performed corneal transplantations. C3H mice were used as tissue donors 
and BALB/c mice the recipients in our PK model (Figure 39). Each animal received a 
corneal graft to the right eye and was monitored daily for the experimental end-point, 
which is corneal opacification (Figure 40a and b). The animals received corneas that 
had been either 1) transfected ex vivo for 24 hours with peptide I/IDO complexes, 2) 
transfected ex-vivo for 24 hours with peptide I/GFP complexes, 3) untransfected but 
maintained in culture for 24 hours or 4) freshly excised from donors just before surgery. 
It can be observed from Figure 40c that freshly obtained corneas survived the longest 
(median survival time, MST = 12 days), followed by untransfected corneas that had 
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been in overnight culture (MST = 10 days). Corneas transfected with I/IDO complexes 
(MST = 9 days) shortened (Logrank test, p<0.05) graft survival compared to the control 
groups but fared modestly better (Logrank test, p<0.05) than corneas transfected with 
I/GFP (MST = 8 days). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 40. Graft survival outcomes after PK with C3H as donors and BALB/c as 
recipients. Example of a) a successful graft whose cornea remained transparent and b) a 
rejected graft typified by corneal opacification. White arrows in both cases point to the 
donor/recipient boundary. c) Survival curves corresponding to different treatment 
methods prior to surgery. Corneas were transfected overnight with peptide I containing 
plasmids encoding for either GFP (green line, n=5) or IDO (red, n=5). Controls 
included untreated corneas either cultured in media overnight (blue, n=4) or freshly 
excised from a donor and immediately transplanted onto a recipient (black, n=6).   
 
 
 
3.29 Confocal observations revealed corneal toxicity following transfection                       
     Toxicity following transfection with a cationic vector is frequently observed 
(Almeida & Pokorny, 2009). We were therefore motivated to investigate if corneal 
toxicity can contribute to the shortening of graft survival following transfection and the 
overnight ex vivo incubation. To determine if there was cell detachment, we observed 
the endothelial layer en face under a confocal microscope after staining for their F-actin 
(which conveniently highlighted cell boundaries) and nuclei (Figure 41a). With these 
stainings, there was no obvious difference between the transfected and untransfected 
corneas as both endothelia appeared to be densely packed with a monolayer of cells.  
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Figure 41. Corneal endothelial cells observed en face before and after transfection with 
I/IDO complexes. a) The cornea endothelium was stained for its F-actin (phalloidin-
TRITC) and nuclei (DAPI) to reveal a monolayer of tightly packed endothelial cells 
characteristic of the layer. b) The cornea endothelium was first exposed to PI to stain for 
leaky cells and then fixed and mounted for confocal observations. Magnified images of 
the boxed regions-of-interest are shown to the right which reveal the densely-packed 
monolayer of cells characteristic of the endothelium and validate the identity of the 
layer under observation. 
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     We next exposed the corneas to propidium iodide (PI), a dye which penetrates leaky 
or compromised plasma membranes (Figure 41b). There was then a significant 
difference between transfected and untransfected corneas – the endothelial layer of the 
former was populated with a larger proportion of compromised, yet still adherent cells. 
Therefore, while differences in cell density were still not apparent, membrane toxicity 
was evident following transfection. A magnified view of the boxed area is provided to 
show the densely-packed monolayer of cells characteristic of the endothelium, 
validating the identity of the corneal layer under observation. 
 
3.30 Effects of chloroquine treatment on transfection and graft survival 
     We attempted to reduce the extent of toxicity induced in the endothelial cells by 
reducing the period of peptide exposure. A key consideration, however, was to maintain 
the level of IDO expression. Corneas were thus exposed to peptide I/DNA complexes 
for 1, 2, 4 or 24 hours in the presence of chloroquine before the medium was again 
changed to regular completed DMEM. All corneas were then assayed at the 48-hour 
time point for their IDO mRNA expression (Figure 42a). In general, chloroquine 
augmented the amount of IDO mRNA production. For instance, while IDO mRNA 
production was insignificant with less than four hours of transfection previously, 
significant amount of IDO mRNA was already detected after one hour of transfection in 
the presence of chloroquine. Encouragingly, the amount of IDO mRNA expression after 
four hours of transfection in the presence of chloroquine was less than 15% lower than 
that following 24 hours of transfection without. Longer periods of incubation with 
chloroquine, however, reduced the amount of IDO mRNA expression, most probably 
due to toxicity associated with the drug itself (Shewring et al., 1997).  
 
     Based on this, we performed another series of PK using corneas that were transfected 
for four hours in the presence of chloroquine. However, Figure 42b showed that the new 
regime failed to produce any benefits compared to the original overnight treatment 
(Logrank test, p>0.05) and did not prolong graft survival compared to untreated 
controls. 
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Figure 42. Effects of chloroquine on IDO mRNA expression and graft survival of ex 
vivo treated murine corneas. a) 100 μM of chloroquine was either absent (-) or present 
(+) when corneas were exposed to peptide I/DNA complexes (N/P 30) for the specified 
amount of time. Culture medium was then changed to regular completed DMEM and 
the corneas were further incubated up till the 48-hour time point. IDO mRNA 
expression was then assessed after DNase treatment and normalised to HPRT mRNA 
expression. b) Survival curves of grafted corneas following ex vivo manipulation. 
Corneas were transfected with peptide I/DNA complexes (N/P 30) for either 24 hours 
(no chloroquine, n=5) or 4 hours (with chloroquine, n=6).   
 
 
 
3.31 IDO was expressed only transiently following peptide-mediated transfection 
     The expression profile of IDO mRNA following peptide-mediated transfection was 
studied. Corneas were transfected for 24 hours and then homogenised on either day two 
or five for RT-PCR assessment. As can be seen from the dissociation curves generated 
at the end of RT-PCR amplification (Figure 43), IDO mRNA was not detected by day 
five. HPRT mRNA, on the other hand, was detected on both days. 
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Figure 43. Kinetics of gene expression by murine corneas following peptide-mediated 
transfection. Peptide/IDO complexes were introduced to the corneas on day 0 and media 
were changed on day 1. Corneas were then homogenised on either day 2 or 5 and the 
dissociation curves corresponding to a) IDO and b) HPRT mRNA targets were recorded 
after RT-PCR amplification.  
 
 
 
3.32 Addition of a KDEL motif had varying effects on transfection efficiency of peptides 
     The protein secretory pathway of a cell typically begins in a cytosolic ribosome 
where novel proteins are synthesised (Lord, 1996). The ribosome then attaches itself 
and releases the newly-synthesised protein into the endoplasmic reticulum (ER). At this 
stage, functional proteins are channelled via the Golgi apparatus to the trans Golgi 
network (TGN) where they will be packaged into plasma membrane-bound vesicles for 
export. Otherwise, incorrectly folded proteins are trafficked down the ER-associated 
degradation (ERAD) pathway, which will result in their expulsion from the ER. Such 
proteins will ultimately be degraded in cytosolic proteasomes after ubiquitinylation.  
 
     KDEL is a four amino acid sequence (lys-asp-glu-leu) that is well known as a 
retrieval signal. It can be found on ER-resident proteins and triggers the retrograde 
transport of such proteins from the Golgi apparatus or TGN back into the ER, should 
they accidentally leave the ER compartment (Lord & Roberts, 1998). It has been 
reported that following endocytosis, a small percentage of vesicles are trafficked to the 
TGN, where inbound and outbound vesicles interface (Hazes & Read, 1997; Sandvig & 
Deurs, 2002). We therefore hypothesise that adding a KDEL signal to the peptide can 
augment its transfection efficiency by exploiting retrograde transport back into the ER, 
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where it will presumably be recognised as a foreign, misfolded protein and be expelled 
into the cytosol. We then propose that the paucity of lysine residues on the peptide will 
result in the inefficient attachment of ubiquitin molecules (Hazes & Read, 1997), which 
in turn reduces the chance of proteasomal degradation. If so, this may be a novel 
pathway by which the complexes can gain cytosolic access.  
 
     We started with cell lines and as per earlier experiments with MCEC, we selected 
peptide F. We then synthesised two other peptides based on F, one with KDEL added 
onto its C-terminus (F-KDEL) and another with the scrambled KLED control (F-
KLED). We then used all three peptides to transfect CHO and MCF7 cells. From Figure 
44, varying effects were observed. With CHO cells, F-KDEL was not significantly 
different from F while F-KLED either transfected better or worse depending on the N/P 
ratio. With MCF7 cells, however, both F-KDEL and F-KLED performed better than F 
within the range of N/P ratios tested. It therefore appears that the addition of the 
retrieval signal either did not help or augmented transfection through a mechanism that 
was not specific to the KDEL sequence. 
 
 
 
 
 
 
 
 
 
 
 
Figure 44. Luciferase expression by CHO and MCF7 cells following transfection with 
peptide F or with either the KDEL retrieval signal or the scrambled KLED control 
sequence added onto its C-terminus. Error bars represent standard deviation of 
quadruplicates. 
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4. Discussion (peptide)  
     More than 10 million people worldwide are estimated to be blind in the cornea (Qian 
et al., 2004). For many of these patients, a successful corneal transplantation will be 
their last chance of sight restoration (George & Larkin, 2004). Unfortunately, 
immunological rejection is a major hurdle and frequently accounts for close to a third of 
all graft failures (Tan et al., 2008). The ex vivo delivery of immunomodulatory genes 
into the cornea has been actively researched as a strategy to prolong graft survival. 
While this approach offers clear advantages, it has not translated into clinical practice. 
Viruses are heavily explored for this form of experimental gene therapy due to their 
impressive transduction efficiency. However, safety is a key concern in viral gene 
delivery. We therefore wanted to develop safer non-viral vectors as an alternative. 
 
     Here, we have designed and synthesised novel vectors based purely on amino acids. 
The vectors featured an unique tri-block architecture where each block achieved 
specific functions – hydrophobic residues at the N-terminus to improve complex 
stability and uptake, a middle block of histidine residues to increase buffering capacity 
and octaarginine at the C-terminus for DNA binding and membrane penetration (Figure 
5). The C-terminus was aminated to eliminate any likelihood of the anionic carboxylic 
acid groups interfering with the DNA binding process. 
 
     We started with peptides F, I, W and H (Table 5 and Figure 6). These peptides 
differed only in their hydrophobic groups and could all bind DNA from N/P 2 onwards 
(Figure 7). Peptides F and I could further protect their DNA cargo from physical and 
enzymatic degradation, although only data for peptide I was presented (Figure 9). The 
ability to bind and protect a cargo are essential attributes that enable a vector to safely 
deliver DNA into cells. 
 
     Preliminary in vitro transfection experiments with three cell lines (HEK293, HepG2 
and 4T1) and two types of reporter plasmids (encoding for luciferase and GFP) 
demonstrated that peptides F and I were able to mediate gene expression with 
efficiencies that, at times, approached or even surpassed PEI (Figure 10). Data also 
showed the importance of the hydrophobic block in achieving high transfection 
efficiency as H and W (the latter being the least hydrophobic among W, F and I) 
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mediated significantly less protein expression than F and I. These trends were consistent 
with results obtained with MCEC and will be discussed again later. 
 
     Based on MTT assays and IC50 values, the peptide complexes were also less toxic 
than PEI complexes (Figure 11). Typically, cells became less viable with increasing 
vector concentration. However, complexes of F, I and W initially increased the viability 
of 4T1 cells with increasing peptide concentration, before becoming toxic again at the 
higher concentrations (Figure 11c). This effect was most pronounced for peptide F. The 
reason behind these repeated observations is unclear but we speculate that it may be due 
to the peptides serving as additional sources of essential amino acids (namely, 
isoleucine, phenylalanine and tryptophan) to the rapidly proliferating cancer cells. 
However, this does not explain why such effects are observed in 4T1 cells but not other 
cancer cell lines, e.g., HepG2 (Figure 11b).  
 
     The CD signals from peptides F and I revealed that they lacked distinct secondary 
structures in the pH range of 5.0 to 7.0 (Figure 12). Although studies have suggested 
that the secondary structure of a carrier can affect its membrane translocation, it remains 
debatable as to which structure, if any, is better. For instance, structures rich in α-helices 
were reported to be more efficient in inserting and crossing the lipid bilayers (Almeida 
& Pokorny, 2009; Lundberg et al., 2007). This is consistent with the view that α-helical 
structures are responsible for the membrane disrupting property of fusogenic peptides 
such as HA2 (Wagner et al., 1992a), melittin (Chen et al., 2006) and GALA (Subbarao 
et al., 1987) discussed earlier. However, formation of α-helices was also negatively 
correlated with uptake (Ye et al., 2010). Instead, an unordered structure was argued to 
be preferable as it afforded the flexibility needed to adopt the most energetically 
favourable conformation during membrane translocation (Caesar et al., 2006). While 
this prevents a simple interpretation of the results, we further note that the CD data 
presented here is for peptide alone. The secondary structure of the associated 
peptide/DNA complex is expected to be more relevant but cannot be elucidated due to 
technical complications arising from the size of the complexes. 
 
     We moved on to validate and optimise the tri-block design of the peptides using 
MCEC, a cell line highly relevant to our intended application. We started with the 
hydrophobic end of the peptides. Consistent with earlier results, H mediated the least 
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amount of luciferase expression (Figure 16a), once again demonstrating the importance 
of the hydrophobic block. W, being more hydrophobic than H, mediated significantly 
more gene expression than H but was still orders behind F and I in transfection 
efficiency. Promisingly, F and I were either comparable or superior to PEI within the 
range of N/P ratio tested. 
 
     The transfection efficiencies of peptides F and I were poor below N/P 15 and did not 
appear to vary to any large extent from N/P 15 to 30. While the logarithmic scale 
probably understated differences between the data bars, this nonetheless indicated that 
their efficiencies rapidly increased to near saturation once past N/P 15. Results obtained 
with peptide F next showed that a block of five hydrophobic amino acids was optimal 
for in vitro luciferase transfection experiments (Figure 16b). We also showed that the 
presence of the hydrophobic block resulted in complexes which were more stable 
(Figure 16c) and readily internalised (Figure 16d and e). These effects are presumably 
due to favourable interactions between the hydrophobic domains of the carrier and the 
plasmid (Jadhav et al., 2008) or plasma membrane (Duncan, 2006), respectively.  
 
     To have successful gene expression, the complex must escape intracellular 
degradation and release its DNA promptly for transcription. Having said that, an overly 
spontaneous or delayed DNA release are both undesirable as this means that the DNA 
either gets prematurely degraded or is inaccessible for transcription. The buffering 
histidine block can thus play an important role since, under the proton sponge 
hypothesis, a larger buffering capacity means that the vector would have a better chance 
of escaping into the cytosol and diffusing towards the nucleus. Titration experiments 
clearly showed that a greater buffering capacity can be achieved with a longer histidine 
block (Figure 17a). This validates the incorporation of histidine residues within the 
peptide design and can explain why I transfected better than G4 (Figure 17b). It was 
however surprising that I also performed better than H8, despite the latter having a 
greater buffering capacity. To answer this, we performed FRET experiments.                
 
     FRET is a powerful technique to study the process of vector unpackaging. In such 
experiments, the objects of interest are labelled with two fluorescent dyes functioning as 
a pair of donor and acceptor. During imaging, only the donor will be excited. However, 
if the acceptor is in close enough proximity – typically <10 nm (Wu & Brand, 1994) – 
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emissions from the donor will be able to excite the acceptor. For this study, plasmids 
were double-labelled with Cy3 (donor) and Cy5 (acceptor) and if the DNA remained 
condensed, FRET could be observed. Confocal observations with live cells then 
revealed that H8 suffered from a reduced propensity to release its DNA (Figure 18). 
Evidently, the larger number of positive charges from the protonated histidine residues 
resulted in both the increased buffering capacity of H8 and its reduced propensity to 
release DNA, which could have ultimately limited its overall transfection efficiency. 
 
     The proton sponge hypothesis is the most commonly cited explanation to account for 
the positive correlation between increased buffering capacity and transfection ability. It 
is hence easy to overlook the fact that so far, no study has provided any convincing 
evidence in direct support of its mechanism. In fact, discrediting observations exist. For 
instance, it was highlighted that ammonium sulphate, also a weak base that should 
theoretically provide buffering effects, did not improve transfection (Pouton & 
Seymour, 2001). Recent calculations have also revealed that the amount of strain that 
lipid vesicles can withstand before rupture is significantly larger than that which can be 
induced by endosomal buffering (Won et al., 2009). All these suggest that the proton 
sponge hypothesis can probably contribute, but should not be the only mechanism of 
endosomal escape. Moreover, increased buffering and endosomal escaping properties 
do not always produce an accompanying increase in transfection efficiency (Figure 17; 
Akita et al., 2010; Moore et al., 2009). This implies that, while important, cytosolic 
access is not the only bottleneck in the gene expression process. Another point that must 
be highlighted is that out of the multiple internalisation pathways (Figure 4), only the 
clathrin-mediated one is widely accepted to involve vesicle acidification (Lundin et al., 
2008; Rejman et al., 2004; Won et al., 2009). Vesicle acidification is, of course, an 
inherent requirement of the proton sponge hypothesis and whether vesicles from other 
pathways acidify is equivocal – some researchers suggest that macropinosomes (Akita 
et al., 2010; Pelkmans & Helenius, 2002) and caveosomes (Lundin et al., 2008; Sahay et 
al., 2010) do not undergo acidification, while others claim that macropinosomes do 
acidify (Räägel et al., 2009; Wadia et al., 2004). Furthermore, it is unclear if vesicles 
which do not acidify remain distinct from endo/lysosomes. For instance, it has been 
claimed that caveosomes (Pelkmans & Helenius, 2002; Sahay et al., 2010) and 
macropinosomes (Wadia et al., 2004) remain distinct from endo/lysosomes, while 
others argue that vesicles from different pathways can eventually interact (Mayor & 
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Pagano, 2007; Sahay et al., 2010). Thus, the proton sponge hypothesis, even if true, may 
not always be relevant to the internalisation pathway used by the cell. On top of that, 
definitive trafficking studies are still required to further our understanding on the nature 
of the various modes of uptake.  
 
     For cationic vectors, toxicity due in part to membrane disruption has been frequently 
observed to correlate with high transfection efficiency (Gabrielson & Pack, 2006; Rao 
et al., 2009). This may be because efficient membrane penetration can lead to a higher 
intracellular concentration of the complexes, but can also cause membrane leakage and 
necrosis. As observed, at a given N/P ratio, complexes of I generally transfected more 
efficiency than F (Figure 16a and Figure 19a) but were also more toxic (Figure 20). 
This was especially so at the higher N/P ratios. We therefore conducted a haemolysis 
experiment to investigate if there was a relationship between cytotoxicity and the extent 
of membrane disruption. In general, both F and I were only mildly haemolytic (Figure 
21). Haemolysis activity also increased with N/P ratio, consistent with trends in 
cytotoxicity assays. It was, however, surprising that complexes of F were more 
haemolytic than I, despite the latter being more toxic to MCEC. While results from 
cytotoxicity and haemolysis assays are not expected to agree quantitatively, a 
qualitative agreement is still anticipated. This disagreement in relative cytotoxic and 
haemolytic activity is not totally understood but may be due to the nature of the 
experimental models – one using eukaryotic cells and the other using erythrocytes 
which have no cellular repair mechanisms. Nonetheless, since F and I have identical 
histidine and arginine sequences, the difference in haemolytic activity should be due to 
the hydrophobic block which can, in turn, influence the way in which the positive 
charges are being presented. 
 
     We next showed that GFP expression can be observed in MCEC up till day 14 post 
transfection (Figure 19b) and moved on to study several transfection parameters. 
Conditions shown to improve transfection efficiency include the presence of serum 
during transfection (Figure 22a and b) and prolonged exposure to the complexes (Figure 
22c). Luciferase expression peaked two days following transfection (Figure 22e) and 
was relatively insensitive to the amount of DNA used within the range of 2.5-1.25 μg 
(Figure 22d). Additionally, the pH at which the complexes were formed also influenced 
DNA binding and transfection efficiency. Reducing the pH from 7.0 to 5.0 increased the 
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extent of protonation of the histidine block and resulted in tighter binding, as evidenced 
by the ethidium bromide exclusion experiment (Figure 23a). However, FRET 
experiments later revealed that DNA release in complexes formed at pH 5.0 was also 
hampered (Figure 24), which can account for why they were less efficient than 
complexes formed at pH 7.0 in transfecting MCEC (Figure 23b). Interestingly, the 
addition of complexes pre-formed at pH 5.0 to a large volume of media – whose pH is 
near neutral – did not seem to reverse the protonation state of histidine residues. This 
suggests that the interaction between DNA and protonated histidine residues may be 
tight enough to create a local microenvironment that is effectively shielded from the 
external milieu.  
 
     While it is clear that the hydrophobic group provided for greater complex stability, 
cellular penetration and transfection, the actual mechanism responsible for these effects 
remains to be explained. We note that the size of the large I/DNA complexes was 15-50 
µm (Figure 13), while H/DNA complexes were distributed within the range of 0.8-2.0 
µm. Peptides with other hydrophobic groups, e.g., F, W, G4 and H8 similarly formed 
aggregates (Figure 14). Further, the large and small populations of F/DNA complexes 
can be separated from the parent mixture by centrifugation and used to transfect MCEC 
individually. Doing so, we realised that the sediment containing the bigger particles was 
significantly more efficient than the supernatant in mediating luciferase expression in 
MCEC (Figure 25a). It is possible that the sediment may contain most of the DNA load. 
Considering earlier results which showed that transfection efficiency dropped 
precipitously between 1.25 and 0.625 μg of DNA, this can explain the inability of the 
supernatant to transfect MCEC. Another possible reason could be that the precipitation 
of complexes onto the cell layer may have augmented the internalisation and 
transfection efficiency of the sediments, or indeed, the F complexes compared to H 
complexes. Although the actual contribution of precipitation cannot presently be 
ascertained, we point out that large aggregated particles are not necessarily internalised 
with greater efficiency as they have also been observed to be poorly taken up by cells 
(Kwok et al., 2000). It is also noteworthy that the luciferase expression level mediated 
by F complexes was on average more than two orders higher than that achieved using 
calcium phosphate (Figure 25b), a system known to efficiently transfect cells by 
precipitation (Chen & Okayama, 1987). More importantly, the transfection mediated by 
F complexes was also orders higher than that achieved with W complexes (Figure 10a-c 
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and Figure 16a), despite both having comparable size. This argues that precipitation 
alone is not sufficient to ensure high transfection efficiency and that other aspects of the 
molecular design are important. The fact that G4, like I, also aggregated but released its 
DNA when challenged with 1 mg/mL of heparin (Figure 17c) also rules out the 
possibility that aggregation alone could have prevented access of the heparin to the 
complexes and caused them to appear more stable than they really were. Moreover, the 
experiment involving local injection into 4T1 tumors (Figure 15) demonstrated that the 
large peptide complexes can still be useful in biological systems or for applications 
where particle size is less of a consideration – e.g., the ex vivo manipulation of corneas. 
 
     Efforts were made to prevent the aggregation of peptide complexes. For instance, 
Kwok et al. (2000) reported that sucrose (5 wt%) prevented the aggregation of lys18-
based DNA complexes, which otherwise would form aggregates of up to 100 μm upon 
rehydration from its lyophilised state. We thus added sucrose during complex formation 
but still observed the precipitation of particles. Sonication was also used to physically 
break up the particles upon complex formation. We reasoned that the sonication process 
should not harm the DNA cargo as earlier experiments had shown that the peptide 
carriers were able to protect against shearing forces (Figure 9). However, this strategy 
too, did not help with the problem of aggregation. 
 
     We hypothesise that the hydrophobic residues are largely responsible for the 
formation of aggregates. This is consistent with the observation that removal of the 
hydrophobic block (i.e., peptide H) reduced the size of the complexes significantly. The 
presence of charged species (mainly arginine) within the peptides may also possibly 
explain why large aggregates were observed only upon complex formation – the 
addition of charge-neutralising DNA shielded the repulsive forces between adjacent 
cationic chains. A related example concerns the formation of amyloid fibrils where 
aromatic amino acids (in particular, phenylalanine) (Gazit, 2002, 2007) and 
hydrophobicity (Kim & Hecht, 2006) play critical roles in the well-ordered self-
assembly of β-sheet fibers. In this peptide system, however, a random aggregation 
process seems more likely as the peptides lacked distinct secondary structures.  
 
     Recently, it was demonstrated that particles up to 3 µm can still be internalised by 
non-phagocytic cells using endocytotic pathways (Gratton et al., 2008b), suggesting that 
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the actual size cut-off limit for internalisation may be larger than previously thought. In 
another study, dendrimers with sizes up to 900 nm were also observed to enter cells via 
caveolae-mediated endocytosis (Manunta et al., 2006). Although the peptide complexes 
here are still larger than 3 µm, it is possible that their internalisation involves 
fragmentation into smaller “bite-size” pieces. This fragmentation process has been 
observed during macropinocytosis and the pinching-off of membrane vesicles (Geng et 
al., 2007).  
 
     We were next interested in the mechanism responsible for the internalisation of the 
complexes. A series of co-localisation experiments with well-known endocytosis 
markers (Figure 26) was conducted and the effects of various inhibitors were quantified 
at both the uptake (Figure 28a and Figure 29) and gene expression (Figure 28b) level. It 
is important to study the effects at both the uptake and gene expression level because 
efficient internalisation may not lead to high gene expression if the DNA is ultimately 
not bioavailable.  
 
     Among the range of inhibitors surveyed, NaN3/DOG and heparin gave the most 
striking results, in both cases severely impeding uptake and gene expression. These 
show that the uptake of F/DNA complexes by MCEC was an energy-dependent process 
that was also critically dependent on interactions with HS. Apart from being rapidly 
internalised via endocytosis itself (Tyagi et al., 2001), HS is probably also involved in 
the initial binding step before internalisation (Ferrari et al., 2003). Furthermore, HS can 
also act as a co-receptor for endocytosis (Leonetti et al., 2010). Other inhibitors which 
disrupt the actin cytoskeleton and microtubules, inhibit the activity of dynamin or 
deplete cholesterol from the plasma membrane also reduced uptake and gene expression 
to varying extent, though none as significantly as NaN3/DOG or heparin. The 
involvement of multiple endocytosis pathways was then supported when the complexes 
were observed to co-localise with transferrin, cholera toxin B and dextran, which are 
thought to be internalised exclusively via clathrin-mediated endocytosis, caveolae-
mediated endocytosis and macropinocytosis, respectively. The involvement of a 
pathway which undergoes acidification (e.g., clathrin-mediated endocytosis) was 
implied when chloroquine increased transfection efficiency significantly (Figure 27). 
Drugs which inhibited macropinocytosis and caveolae-mediated endocytosis also 
reduced uptake and gene expression, further suggesting the involvement of multiple 
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pathways of internalisation. That said, neither of the pathways seemed to dominate as 
the respective inhibitors only reduced but did not abolish uptake when used alone. 
 
     As reviewed in Chapter one, the nature of the cell line and sequence of the peptide 
used for experiments can influence the pathways responsible for the uptake of tat and 
arginine-rich peptides. Another contributing factor mentioned was the detection method 
used in internalisation studies. The majority of experiments aimed at studying the 
endocytosis pathways of peptides (ours included) uses one or both of the following 
techniques: 1) assaying the effects of drugs that are known to inhibit specific 
endocytosis pathways at the uptake (by flow cytometry or confocal microscopy) and/or 
the gene expression level, or 2) using a confocal microscope to trace for any co-
localisation with known markers for endocytosis pathways. While both are sensible 
experiments, one must be aware of their limitations. Inhibitory drugs are usually 
pleiotropic and affect more than one pathway concurrently. For instance, dynasore has 
been used to shut down the clathrin-mediated pathway (Gratton et al., 2008a). However, 
dynasore is a drug that interferes with the activity of dynamin, an enzyme that is needed 
in both clathrin- and caveolae-mediated pathway to pinch off vesicles from the cell 
membrane (Macia et al., 2006). The same is true for methyl-β-cyclodextrin, which 
depletes cholesterol from the membrane (Richard et al., 2005) and cytochalasin, which 
disrupts actin formation (Belting et al., 2005). Both drugs can affect all three forms of 
endocytosis. We therefore paid close attention to the nature of the inhibitors and their 
mechanisms of action. Moreover, drugs that interfere with uptake are usually toxic and 
a safe effective dosage had to be established in preliminary experiments. Furthermore, 
we note that there is possible redundancy in uptake mechanisms where shutting off one 
pathway may activate another (Rodal et al., 1999), further complicating interpretation.    
 
     Both flow cytometry and confocal microscopy are fluorescent-based techniques and 
rely on either the carrier or/and its cargo to be labelled with a dye. However, the process 
of tagging the peptide with a dye can affect its property. For example, results from 
isothermal titration calorimetry showed that unlabelled tat 47-57 bound to HS more 
strongly that tat 47-57 labelled with fluorescein isothiocyanate (FITC), a florescent dye 
whose hydrophobicity was implicated in the weakening of binding affinity (Ziegler et 
al., 2005). In another study, FITC labelling was also observed to alter the trafficking 
properties of an octaarginine conjugate (Puckett & Barton, 2009). More significantly, 
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fixing of cells has been shown to be undesirable and even mild fixation can cause 
artifactual intracellular accumulation (Richard et al., 2003). As a result of this 
revelation, the validity of earlier publications has been challenged, especially in studies 
where cells were fixed and intracellular accumulation could still be observed despite 
low temperature incubation. We therefore only used live cells in all of our 
internalisation experiments. Surface-bound peptides are another source of confusion 
which must be separated from those which have been truly internalised. In our case, a 
brief trypsin wash is enough to digest and remove most of the surface-bound peptides. 
This was validated by the observation that treatment with NaN3/DOG, which blocked 
uptake but not surface binding, reduced signals to essentially background levels. 
 
     Above all, it is fair to say that our understanding of endocytosis is still not perfect. 
As mentioned earlier, it is not clear which other pathways, besides the clathrin-mediated 
one, can produce vesicles that undergo acidification. Whether vesicles from different 
origin eventually merge is another unresolved issue. Furthermore, both the size (Choi et 
al., 2006) and shape (Sharma et al., 2010) can affect the uptake of a particle and its in 
vivo distribution (Decuzzi et al., 2010). However, these physical parameters of peptide 
complexes are not frequently reported in the literature. With a plethora of factors that 
can affect outcome, it may be more realistic to accept that the uptake of arginine-rich 
peptides or their conjugate cannot be ascribed any universal route.   
 
    FRET experiments performed to trace the intracellular trafficking path of F/DNA 
complexes showed that DNA and peptide entered cells and stayed as a condensed 
complex for at least 4.5 hours after exposure (Figure 30). DNA uncondensation would 
have occurred to a significant extent by 8.5 hours and the accumulation of free DNA 
within nuclei can be clearly observed by 26 hours post-transfection.  
  
    We next showed that the peptides could be used to deliver plasmids encoding for a 
biologically relevant enzyme, IDO, whose overexpression in the cornea had previously 
been shown to prolong graft survival (Beutelspacher et al., 2006). IDO expression was 
detected at the mRNA (Figure 32a) and protein level (Figure 32b). The expressed IDO 
was also shown to be functionally active by detecting kynurenine in the culture 
supernatant (Figure 33) and capable of inhibiting CD4 T-cell proliferation (Figure 36). 
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In both cases, the addition of 1-MT reversed the effects of IDO, showing that the results 
were due to the action of the immunosuppressive enzyme. 
 
     We then moved on to tissue transfection. We first evaluated peptides F and I on their 
ability to deliver plasmids encoding for IDO into mouse corneas. Using RT-PCR, 
peptide I was determined to be better than F in mediating IDO mRNA expression and 
was selected for further studies (Figure 37a). The duration of transfection was explored 
and it was observed that four hours were insufficient to result in any significant IDO 
mRNA expression (Figure 37b). Increasing the transfection period to 24 or 48 hours 
increased the amount of IDO mRNA expression, but also complicated tissue handling 
due to stromal oedema and epithelium overgrowth into the endothelium (Comer et al., 
2002 and own observations). As a compromise between transfection efficiency and ease 
of tissue handling during surgery, we selected 24 hours as a suitable transfection period. 
Post PCR products also gave dominant bands at the expected positions in gel 
electrophoresis assays (Figure 37c). This indicates that genomic DNA was not detected 
since the primers spanned several introns and any contamination would result in the 
appearance of a separate heavier band. Contamination by plasmids was also eliminated 
by including a DNase digestion step during RNA extraction. However, an interesting 
observation is that a band corresponding to IDO amplification can still be detected with 
corneas mock-transfected with plasmids encoding for GFP. To account for this, we note 
that the electrophoresis experiments were conducted after 40 rounds of RT-PCR 
amplification where minute quantities of endogenous IDO mRNA present initially can 
be significantly multiplied. Moreover, conditions such a depleted dNTPs stock or an 
inactivated polymerase can potentially limit the later part of the amplification cycle for 
IDO-transfected corneas. Therefore, the bands in Figure 37c should be noted more for 
their positions (size in terms of base-pairs) rather than intensities (relative amount).       
  
    We determined the location of IDO expression within the cornea. Using an anti-IDO 
antibody and the snap-frozen IHC technique, strong positive staining was detected in 
the endothelial and the top few epithelial layers of IDO-transfected corneas (Figure 
38a). On the other hand, controls including untransfected corneas, GFP mock-
transfected corneas and samples probed using an isotype control (IgG) antibody gave 
only a weak background or no staining (Figure 38b-d). We were, however, surprised to 
detect IDO expression in the epithelium, especially after several groups have repeatedly 
Chapter four: Discussion (peptide) 
 
 138
reported that gene expression was restricted to the endothelia (Oral et al., 1997; Qian et 
al., 2004; Ritter et al., 1999). By far, studies reporting gene expression in the epithelium 
following ex vivo transfection are in the minority, although one such example was 
provided by Tsubota et al. (1998) who detected positive staining in the epithelium of 
human corneas following 48 hours of Ad5 adenovirus-mediated ex vivo transfection.  
 
     Although the true reason remains elusive, the tight cellular junctions of the 
epithelium may account for its barrier-like function, which makes the layer especially 
refractory to transfection (George et al., 2000; Tong et al., 2010; Tsubota et al., 1998). 
Traditionally, the corneal epithelium has been transfected using harsher means, for 
instance, the gene-gun method, which also caused significant collateral tissue damage 
(Merediz et al., 2000). Recently, however, there were several reports that demonstrated 
corneal epithelium transfection using non-viral vectors. For example, a lysine-rich 
peptide (Johnson et al., 2008) and hyaluronan-chitosan oligomer nanoparticles (Fuente 
et al., 2008) have both been used to mediate epithelial transfection. Another non-viral 
vector based on poly(propylene oxide)-poly(ethylene oxide) polymeric micelles was 
also shown to mediate epithelial gene expression, albeit only upon wounding the 
epithelium to compromise its integrity (Tong et al., 2010). This current peptide may add 
to the list of vectors capable of transfecting the corneal epithelium.     
  
    We then performed corneal transplantations using C3H mice as donors and BALB/c 
as recipients. This donor/recipient combination is mismatched at both their major and 
minor histocompatibility domains, thus providing a very robust model for the studying 
of immunological rejection. Corneas were transfected overnight before being sutured 
onto the recipients’ eye. It was observed that the overnight incubation alone was 
deleterious to allograft survival, as evidenced by the shortening of MST from 12 days 
(using fresh corneas) to 10 days (using untransfected corneas cultured overnight) 
(Figure 40). This observation was not surprising as an upregulation of chemokine 
expression was detected after corneas had been maintained in 37°C culture (Pillai et al., 
2008), indicative of trauma and the less-than-ideal culture conditions. Another study 
also showed that corneal allografts survived longer following transfection with Ad5 
adenovirus at 4°C, compared to 37°C (Qian et al., 2004). We nonetheless persisted with 
transfection at 37°C because we had previously shown that internalisation of the 
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peptide/DNA complexes was via an energy-dependent pathway. As a result, it was 
crucial to keep the cells metabolically active during transfection.   
 
     Using corneas that were transfected with the peptides further shortened the median 
survival time. Nonetheless, IDO-transfected corneas survived significantly longer 
(p<0.05), albeit only modestly so, compared to GFP-transfected corneas. The modest 
prolongation of survival with IDO-transfected corneas was presumably due to the 
expression of the immunosuppressive IDO enzyme. GFP expression, on the other hand, 
is toxic to cells. For instance, it was shown that corneas transfected with 
adenovirus/GFP survived shorter than corneas infected with empty adenovirus (Qian et 
al., 2004). In that study, both also survived shorter than untransfected corneas 
 
     To study if toxicity induced by the peptides can be responsible for the shortening of 
corneal allograft survival in spite of the overexpression of IDO, we examined the state 
of the endothelium with and without peptide-mediated transfection. We were interested 
mainly in the endothelium because this layer plays a pivotal role in maintaining corneal 
transparency and is also the dominant site of graft rejection. Staining for cellular F-actin 
allowed for the visualisation of cell-boundaries and revealed no obvious difference 
between corneas that had or had not been transfected (Figure 41a). In both cases, the 
density of the endothelial cells appeared comparable and were still adherent, as 
evidenced by the lack of gaping voids within the endothelial layer. However, staining 
with PI revealed that the membranes of the cells after transfection were compromised 
compared to untransfected ones (Figure 41b). Therefore, toxicity due to membrane 
disruption following peptide-mediated transfection may possibly have negated any 
beneficial effects due to IDO production. 
 
     To mitigate toxicity without sacrificing excessively on IDO expression, we 
attempted to reduce transfection – and hence, incubation – time while increasing 
transfection efficiency with the use of chloroquine. Doing so, transfection time could be 
shortened to four hours while the level of IDO mRNA expression was reduced by less 
than 15% (Figure 42a). A longer period of incubation with chloroquine is, however, 
undesirable as the drug is inherenetly toxic (Shewring et al., 1997). We thus performed 
another set of transplantation following four hours of chloroquine-augmented 
transfection. Unfortunately, this new regime also could not prolong the survival of the 
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graft compared to controls and is not significantly different (P>0.05) from the corneas 
transfected overnight with IDO (Figure 42b). It is possible that any benefits derived 
from the reduced transfection period are compensated for by the lower levels of gene 
expression and the toxic nature of chloroquine. 
 
     Another contributing factor for the failure of our treatment regime to prolong graft 
survival is the transient nature of gene expression mediated by non-viral vectors. 
Contrary to earlier data with MCEC where GFP expression, while transient, can still be 
observed at day 14 (Figure 19b), IDO mRNA could not be detected in transfected 
corneal tissues by day five, as evidenced by the lack of an IDO-specific dissociation 
peak following RT-PCR amplification (Figure 43). In contrast, a prominent IDO 
dissociation peak was detected on day two, while HPRT dissociation peaks were 
detected on both days. The transient gene expression may be due to a dilution effect as 
the endothelial cells on murine corneas, unlike human, are mitotic. Nonetheless, we 
note that transient gene expression or indeed, the lack of adequate IDO production alone 
should not cause a shortening of graft survival – it should, at most, fail to prolong. 
Hence, toxicity following peptide-mediated transfection remains the main culprit for the 
shortening of graft survival. However, it is possible that IDO-transfected corneas could 
have survived longer had they been able to benefit from the protective effects of a 
sustained IDO expression.  
 
     We attempted to increase the transfection efficiency of the peptides with the addition 
of a KDEL retrieval sequence. This then offers the possibility of shortening the corneal 
transfection period without chloroquine, which may potentially reduce toxicity. The 
KDEL sequence was chosen for its ability to trigger retrograde transport from the Golgi 
network to the ER where cytosolic access is then possible for misfolded proteins via the 
ERAD pathway (Lord & Roberts, 1998). Indeed, several toxins are known to exploit 
this pathway to gain entry into the cytosol. The bacterial cholera toxin, for instance, has 
a KDEL sequence and mutations to this signal can reduce its potency (Sandvig & 
Deurs, 2002). Conversely, ricin, a plant toxin that disables protein synthesis lacks the 
KDEL signal but nonetheless exploits retrograde transport to achieve its effects. This 
was shown when ricin, modified to have tyrosine sulfation and N-glycosylation sites, 
was detected in the cytosol to be sulfated and glycosylated, indicating that it had visited 
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the Golgi apparatus and ER respectively (Rapak et al., 1997). The additional of KDEL 
to ricin further augmented its toxicity (Wales et al., 1993).  
 
     Reports have suggested that a small percentage of endocytic vesicles do end up in 
the TGN (Hazes & Read, 1997; Sandvig & Deurs, 2002). Carrying a KDEL signal may 
thus be beneficial as retrograde transport can ideally lead to cytosolic access. The lack 
of lysine residues in the original peptide F sequence is also expected to reduce its 
chance of undergoing ubiquitinylation and subsequent proteasomal degradation. These 
inspired us to add the KDEL signal onto the hydrophilic C-terminus of peptide F where 
it has a better chance of being displayed for interaction. The KDEL sequence is 
expected to have a net negative charge – lysine (K) is positively charged but both 
aspartic acid (D) and glutamic acid (E) are negatively charged at pH 7 – and should not 
take part in DNA binding. Nonetheless, a concern was that DNA binding at the 
neighbouring octaarginine block may still sterically hinder access to the KDEL signal. 
F-KDEL performed as well as F with CHO cells; and although F-KDEL augmented 
transfection in MCF7 cells compared to F, so did the control peptide F-KLED (Figure 
44). This indicates that the addition of a retrieval signal either did not help or 
augmented transfection through a mechanism that was not specific to the KDEL 
sequence. The actual pathway is unclear but results did not warrant a further 
investigation with this group of peptides.  
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5. Introduction to polycarbonate vectors 
     Polycarbonates (PCs) are attractive biomaterials due to their biocompatibility, low 
inherent toxicity and adjustable mechanical properties. Importantly, the carbonate 
linkages are also susceptible to enzymatic biodegradation (Watanabe et al., 2007). PCs 
are, however, more recognised as an engineering material. Studies are therefore 
traditionally focused on synthesis and physical characterisation. Indeed, PCs were only 
recently explored for drug (Xie et al., 2008) and nucleic acids (He et al., 2010) delivery.  
 
     A popular way to prepare aliphatic PCs is via the ring opening polymerisation (ROP) 
of cyclic monomers. Such ROP reactions are enthalpically fuelled by the relief of 
monomer ring strain. Trimethylene carbonate (TMC) and its other 6-membered ring 
derivatives are the most prominent monomers from the carbonate family. 
 
     Carothers and Natta provided the first example of the ROP of TMC by adding a 
catalytic amount of K2CO3 to the bulk monomer while heating at 130°C (Carothers & 
Natta, 1930). A problem then was the lack of a suitable catalyst that afforded polymers 
with high molecular weight and narrow distribution. Today, many metallic catalysts can 
efficiently drive the ROP of cyclic carbonate monomers. Amongst them, those based on 
Sn (frequently as stannous octoate) (Watanabe et al., 2007), Zn (frequently as diethyl 
zinc) (Hellaye et al., 2008) and Al (Wang et al., 2002) are most popular. Other metallic 
catalysts surveyed for the ROP of carbonates, lactones or lactides include those based 
on: Li (Kuhling et al., 1991), Bi (Kricheldorf & Rost, 2005), Y (Urakami & Guan, 
2008), La (Schappacher et al., 2007), Sm (Schappacher et al., 2007), Sb (Gonzalez-
Vidal et al., 2008), Ti (Zhou & Ritter, 2008) and Sr (Guan et al., 2005). However, while 
high molecular weights are now achievable, it is commonly at the expense of 
polydispersity (Hori et al., 1996; Xie et al., 2008). Moreover, safety is a concern as 
traces of metal must be completely removed before bioapplication (Jiang et al., 2008). 
There is thus a demand for “greener” catalysts.  
 
     Lipase has been advocated as the more bio-friendly enzymatic catalyst. Among the 
species of lipase surveyed for ROP, those from Candida Antarctica (Dai & Li, 2008), 
Pseudomonas fluorescens (Svirkin et al., 1996), Pseudomonas sp. (Bisht et al., 1997a) 
and porcine pancreas (He et al., 2010) are most popular. Lipases immobilised on silica 
particles (e.g., Celite®) are also reported to be more active than free-floating ones (Feng 
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et al., 2002). Nonetheless, compared to their metallic counterparts, lipase is generally 
less efficient and affords poorer control over the polydispersity of the products 
(Henderson et al., 1996; Svirkin et al., 1996). Lipases may also be susceptible to heat 
denaturation (Bisht et al., 1997b) and solvent poisoning effects (Dai & Li, 2008). 
 
     To address the above limitations, Nederberg and colleagues reported a ROP route 
based on organocatalysis and synthesised a variety of functional PCs (Nederberg et al., 
2007). In that study, one of the anionic catalysts surveyed was the commercially 
available 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). DBU enabled high monomer 
conversion, while maintaining exquisite control over the molecular weight and 
polydispersity index (PDI = 1.1-1.2) of the products. Further, DBU is purely organic 
and does not contain any metallic component. We were therefore interested to use DBU 
in the synthesis of novel PC vectors.  
 
     In this study, we started with 2,2-bis(hydroxymethyl)propionic acid (bis-MPA). 
After sequential protection, ring closure, polymerisation and then deprotection, the 
carbonate backbone eventually exposed carboxylic groups onto which we conjugated 
various types of amine chains (Figure 45). The amine chains chosen contained a 
mixture of primary and secondary amines. The former would provide positive charges 
for DNA binding upon protonation in water while the latter would provide buffering 
capacity to aid the endosomal escape of the polymer/DNA complexes. The amine-
functionalised PCs were then self-assembled into micelles for gene delivery (Figure 46). 
The hydrophilic amine chains were expected to be exposed on the micellar surfaces. 
The effects of amine chain length on the biophysical properties of the micelles (i.e., 
buffering capacity, size and zeta potential) were studied. DNA binding ability of these 
micelles was evaluated using gel retardation assays and transfection efficiency was 
initially screened using three cell lines. Finally, the optimised lengths of carbonate 
backbone and amine chain were used to transfect MCEC to assess if these PC vectors 
could be useful in the immunomodulation of corneal transplantation. 
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Figure 45. Overall synthetic scheme and reaction conditions. Subscript n refers to the 
degree of polymerisation and m refers to the degree of amine conjugation achieved. 
Subscript o refers to the length of the amine chain used for conjugation (o = 2, 3 or 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Formation of cationic PC nanoparticles for gene delivery by self-assembly. 
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6. Experimental methods (polycarbonate) 
6.1 Materials 
     Bis-MPA, KOH, benzyl bromide, triphosgene, pyridine, palladium/carbon (Pd/C, 10 
wt%), N,N'-diisopropylcarbodiimide (DIC) and NHS were all purchased from Sigma 
(Singapore). Triethylenetetramine, tetraethylenepentamine, pentaethylenehexamine and 
celite 503 were purchased from Merck (Singapore). All the above reagents were used as 
received. Benzyl alcohol and DBU were purchased from Sigma, further dried with 
CaH2 overnight and distilled under reduced pressure for storage in a glove box. All 
other chemicals and solvents were at least of analytical grade and used as received. 
 
6.2 Polymer synthesis 
6.2.1 Benzyl-2,2-bis(methylol)propionate (1 in Figure 45) 
     Compound 1 was synthesised with a procedure reported previously (Ihre et al., 1996; 
Trollsas et al., 1997). Thin layer chromatography (TLC) with ethyl acetate:hexane (1:1 
v/v) as the mobile phase was used to confirm the purity of the white crystals. 1H NMR 
spectrum matched that reported in the literature (Ihre et al., 1996). 1H NMR (400 MHz, 
CDCl3, δ): 1.08 (s, 3H, -CH3), 2.85 (s, 1H, OH), 3.74 (d, 2H, -CH2OH), 3.95 (d, 2H, -
CH2OH), 5.22 (s, 2H, -CH2Ar), 7.36 (m, 5H, Ar). Yield: 61%. Atmospheric pressure 
chemical ionisation, APCI-MS: m/z calculated for 1, 224.3; found, 224.3. 
 
6.2.2 5-Methyl-5-benzyloxycarbonyl-1,3-dioxan-2-one (2) 
     23.0 g of 1 was dissolved in 250 mL of dichloromethane (DCM) containing 50 mL 
of pyridine. The solution was then chilled with a dry ice/acetone bath under an inert 
atmosphere. Meanwhile, 25 mL of DCM containing 15.0 g of triphosgene was dripped 
into the stirring solution over 1.5 hours under inert conditions. The reaction mixture was 
then stirred at room temperature for 2 additional hours before being quenched with 200 
mL of saturated NH4Cl solution. The organic layer was retained, washed 3 times with 
HCl solution (1 M, 200 mL), 2 times with saturated NaHCO3 solution (200 mL), dried 
with MgSO4 and evaporated to give 2 as a crude product. Recrystallisation from ethyl 
acetate finally afforded 2 as pure white crystals whose purity was confirmed with TLC 
(mobile phase: ethyl acetate:hexane, 1:1 v/v). 1H NMR data matched the literature 
where a different synthetic route was used (Al-Azemi & Bisht, 1999). 1H NMR 
(400 MHz, CDCl3, δ): 1.35 (s, 3H, -CH3), 4.21 (d, 2H, -CH2OH), 4.71 (d, 2H, -
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CH2OH), 5.23 (s, 2H, -CH2Ar) and 7.33 (m, 5H, Ar). Yield: 82%. APCI-MS: m/z 
calculated for 2, 250.3; found, 250.3. 
 
6.2.3 Polymerisation of 2 (Polymer B-Bn) 
     Monomer 2 was moved into a glove box (PL-2GB, Innovative Technology Inc., 
Newburyport, MA, USA) for polymerisation. 2.5 g of 2 was dissolved in 10 mL of 
DCM containing 30.4 mg of DBU. To achieve a targeted DP of 30, for example, 36.0 
mg of the benzyl alcohol initiator was added to the stirring solution to initiate 
polymerisation. The final product was isolated and purified by precipitation into cold 
methanol 3 hours later. Yield: 91%. 3 batches of polymers (A, B and C) were prepared 
with increasing molecular weight. 
 
6.2.4 Catalytic hydrogenation of Polymer B-Bn  
     2.2 g of polymer B-Bn was dissolved in 8 mL of ethyl acetate containing 250 mg of 
Pd/C. The reaction vessel was purged with N2 before being charged with H2 to 100 psi. 
The reaction was then left for 24 hours under continuous stirring. The catalyst was later 
removed by passing through a column packed with methanol-wetted celite. About 250 
mL of methanol was further used to completely flush out the product. The solvent was 
then evaporated to afford polymer B-COOH as white flakes. Yield: 95%.    
 
6.2.5 Amine conjugation onto polymer B-COOH  
     0.8 g of B-COOH was dissolved in 25 mL of anhydrous DMSO under an Ar 
environment. 756.4 mg of DIC and 689.9 mg of NHS were then separately dissolved in 
10 mL of DMSO. To activate the carboxylic groups, the DIC solution was first added 
dropwise, followed by NHS. The reaction was stirred for 3 hours at room temperature, 
after which the activated solution was added dropwise into a round bottom flask 
containing about 20 g of the selected amine [triethylenetetramine (4N), 
tetraethylenepentamine (5N), or pentaethylenehexamine (6N)] dissolved in 250 mL of 
DMSO. Conjugation took place for another 20 hours, after which the purified product 
was isolated by precipitating 4 times from ether.  
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6.3 Polymer characterisation 
6.3.1 Nuclear magnetic resonance (NMR)  
     Samples were prepared at 5 mg/mL in appropriate solvents and 1H or 13C signals 
were recorded with a Bruker 400 MHz Ultrashield Plus (Bruker BioSpin, USA). 
Chemical shifts were referenced to tetramethylsilane (TMS) and expressed as parts per 
million, ppm (δ). 
 
6.3.2 Gel permeation chromatography (GPC)  
     The weight (Mw) and number (Mn) average molecular weights of the polymers were 
determined using a 2695D separation module (Waters, Milford, MA, USA) fitted with a 
2414 refractive index detector. Either tetrahydrofuran (THF) or DMSO with 0.1% LiBr 
was used as the mobile phase. For THF GPC (Polymer A-Bn, B-Bn, C-Bn, A-COOH, 
B-COOH and C-COOH), the columns used were a Styragel® HR 5E followed by a 
Styragel® HR1 (Waters, Milford, MA, USA). The flow rate was 1.0 mL/min, the 
column temperature was 35ºC and results were calibrated against polystyrene standards. 
For DMSO GPC (amine-conjugated PCs), the columns used were two PL-gel MIXED-
E columns (7.8 x 300 mm) from Polymer Laboratories (Varian Inc., CA, USA). The 
elution rate was 1.0 mL/min, the column temperature was 60ºC and results were 
calibrated against PEG standards. 
 
6.3.3 MALDI-TOF  
     Samples were spotted onto a target plate, air dried and then analysed with an 
Autoflex II MALDI-TOF mass spectrometer (Bruker Daltonik GmbH, Bremen, 
Germany). The [M+H]+ spectrum was analysed with the Polytools 1.0 software 
provided to obtain Mw, Mn and DP. 
 
6.3.4 Differential scanning calorimetry (DSC)  
     The glass transition (Tg) and crystalline melting temperature (Tm) of polymers were 
determined with a DSC Q100 (TA Instruments, DE, USA). A heat/cool/heat cycle was 
employed at 10ºC/min under flowing N2 (50 mL/min). Tm was obtained from the first 
heating cycle while Tg was read off from the second heating cycle.  
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6.3.5 Thermogravimetric analysis (TGA)  
     The thermal profile of polymers was also recorded with a Pyris 1 thermogravimetric 
analyser (Perkin Elmer, MA, USA). The heating schedule was from 25ºC to 700ºC, at a 
rate of 5 ºC/min in flowing air (30 mL/min). 
 
6.3.6 Raman spectroscopy  
     Polymer samples were deposited on a clean glass slide and Raman signals were 
obtained with a Renishaw inVia Raman Microscope (Gloucestershire, UK) equipped 
with a 633 nm He-Ne laser and calibrated routinely at 520 cm-1 with a Raman 
calibration source mounted with a piece of silicon. Data processing was done with the 
WiRE2.0 software provided. 
 
6.3.7 Elemental CHN analysis  
     A Vario Micro Cube (Elementar Analysensysteme GmbH, Hanau, Germany) was 
used to process samples at 1150°C to obtain the relative weight percentages of C, H and 
N. The percentages of N of polymers B-4N, B-5N, B-6N, A-6N and C-6N were 19.5%, 
20.4%, 19.8%, 22.5% and 21.9%, respectively.   
 
6.4 Titration experiments 
     All methods were as reported in Chapter two, except that 0.01 M HCl was used as 
the titrant.  
 
6.5 Polymer/DNA complex formation, particle sizing and zeta potential 
     The protocol to form complexes was as described in Chapter two, except that the 
buffers used were either 20 mM acetate buffer (pH 5.0) or 10 mM phosphate buffer (pH 
6.0 or 7.0). N/P ratio is now defined as the molar ratio of polymer nitrogen to DNA 
phosphorus. 
 
     For particle size and zeta potential analysis, a Malvern Zetasizer Nano ZS 
(Worcestershire, UK) equipped with a 4 mW He-Ne (633 nm) laser was used. 
Measurements were carried out at 90° scattering, 25°C and in triplicate.  
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6.6 Morphology of the nanoparticles 
     A drop of the polymeric solution at 1 mg/mL was dripped onto the surface of a 
freshly prepared Si wafer and air-dried for 4 hours. The wafer was then sputter-coated 
with Pt and SEM observations were carried out at 6.0 kV with a JSM-7400F field 
emission scanning electron microscope (Jeol, Tokyo, Japan). 
 
6.7 Agarose gel retardation, in vitro gene expression and cytotoxicity assays 
     All methods were as described in Chapter two. 
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7. Results (polycarbonate) 
     Data in Chapter seven (results) and eight (discussion) have been published (Seow & 
Yang, 2009a). The overall synthetic scheme and reaction conditions are presented as 
Figure 45 while the physical properties of various polymers are summarised in Table 6. 
 
 
Polymer 
entry 
Mw 
(kDa) 
[a] 
Mn 
(kDa) 
[a] 
Mw/Mn 
(PDI) 
Mw 
(kDa) 
[b] 
Mn 
(kDa) 
[b] 
Mw/Mn 
(PDI) 
DP  
[c] 
Tg (°C) Tm 
(°C) 
A-Bn 5.3 4.5 1.18 - - - - 2.5 - 
B-Bn 9.2 7.7 1.19 - - - - 7.5 - 
C-Bn 13.7 11.4 1.19 - - - - 6.0 - 
A-COOH 3.1 2.9 1.07 2.5 2.2 1.12 15 47.0 167.0 
B-COOH 5.5 5.2 1.07 4.5 4.3 1.04 28 48.0 168.0 
C-COOH 9.7 8.4 1.15 7.5 6.8 1.09 44 59.9 171.5 
 
Table 6. Biophysical properties of various polymers before amine conjugation. [a] Mw 
and Mn estimated by THF GPC relative to polystyrene standards. [b] Mw and Mn by 
MALDI-TOF. [c] Degree of polymerisation by MALDI-TOF. Values from MALDI-
TOF were obtained by using the Polytools 1.0 software. 
 
 
 
7.1 Synthesis of benzyl-protected polymers 
     A series of benzyl-protected polymers with increasing molecular weight (A-Bn < B-
Bn < C-Bn) were first synthesised and their representative 1H and 13C NMR spectra are 
presented in Figure 47a and Figure 48a. All peaks were identified. The absence of ether 
signals at ~3.5 ppm (Gottlieb et al., 1997) in the 1H NMR indicated that side reactions 
leading to decarboxylation had not occurred. The GPC traces of the polymers (Figure 
49a) were smooth and sharp, indicating well-defined products with low PDI (PDI = 
Mw/Mn). As expected, the Tg values (Table 6) of A-Bn, B-Bn and C-Bn were higher 
than that reported for poly(TMC) (-18°C) (Wang et al., 2002) due to the presence of 
bulky benzyl groups.  
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Figure 47. 1H NMR spectra of a) polymer B-Bn in CDCl3, b) polymer B-COOH in 
DMSO-d6 and c) polymer B-6N in D2O. Peaks due to solvent used during synthesis or 
NMR have also been identified. 
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Figure 48. 13C NMR spectra of a) polymer B-Bn in CDCl3, b) polymer B-COOH in 
DMSO-d6 and c) polymer B-6N in D2O. Peaks due to solvent used during synthesis or 
NMR have also been identified. 
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Figure 49. Molecular weight distribution of various polymer preparations. a) GPC 
chromatograms of A-Bn and A-COOH. b) MALDI-TOF spectrum of A-COOH. 
Intensity of signals was provided in arbiturary units (a.u). Repeat unit m/z detected was 
160.0, in agreement with theoretical value. 
 
 
 
7.2 Synthesis of carboxylic-functionalised polymers  
     The benzyl groups were next removed via Pd/C catalysed hydrogenation to give 
polymers A-COOH, B-COOH and C-COOH. The success of this transformation was 
evidenced by the disappearance of the benzylic protons and carbons, and the 
concomitant appearance of a broad carboxylic proton peak in the respective NMR 
spectra (Figure 47b and Figure 48b). Their molecular weights by GPC relative to 
polystyrene standards were within expectation and agreed well with the values obtained 
using MALDI-TOF (Figure 49b and Table 6).  
 
     The physical properties of the polymers were altered significantly after 
hydrogenation. First, the -COOH polymer was a white semi-crystalline solid and 
exhibited an obvious crystal melting temperature, Tm, in the DSC profile (Figure 50a 
and Table 6). These were in contrast to the -Bn polymer, which existed as an amorphous 
sticky melt. This increase in crystallinity followed the removal of the bulky benzyl 
group which allowed for better stacking of the polymeric chains. Second, COOH-
functionalised PCs became soluble in polar solvents like methanol, DMSO and water 
(limited); whereas the benzyl-protected polymers were only soluble in chloroform and 
DCM. The thermal decomposition behaviour, however, did not change significantly. 
Both the benzyl-protected and deprotected polymers exhibited similar decomposition 
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profiles characterised by a sharp single-step degradation (over a span of 120°C) and an 
onset temperature of 210°C (Figure 50b). Poly(TMC) was reported to depolymerise at 
210°C under atmospheric pressure (Carothers & Natta, 1930). The similar 
decomposition temperature here may correlate to the thermal cleavage of the carbonate 
groups.    
 
 
 
 
 
 
 
 
 
 
 
Figure 50. Thermal profiles of various polymer preparations. a) DSC thermograms of 
various polymers in their first heating cycles where the crystal-melting temperature, Tm, 
if any, was obtained from the distinct endothermic peak. b) TGA of various polymers. 
Onset of decomposition was defined as the temperature at 90% weight. 
 
 
 
7.3 Synthesis of amine-functionalised PC gene carriers  
     Amines were successfully conjugated onto the polymeric backbone as evidenced by 
the appearance of amine protons in 1H NMR (Figure 47c) and the amide carbon in 13C 
NMR (Figure 48c). Using Raman spectroscopy, the characteristic amide I band (due to 
C=O bond stretching) was also observed at 1642 cm-1 (Figure 51), again confirming the 
chemical conjugation. Furthermore, signals due to the backbone protons (peak b in 
Figure 47a and b) disappeared in the 1H NMR spectrum of the amine-functionalised PC 
(Figure 47c) where D2O was the solvent. This suggests that the amine-functionalised 
polymers may have spontaneously assembled into nanoparticles in the aqueous medium 
such that the hydrophobic backbone became sequestered within the core and was no 
longer accessible for resonance.  
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Figure 51. Raman shifts of the polymer before (top) and after (bottom) amine 
conjugation. Intensity of signals was provided in arbitrary uits (a.u). The distinct amide 
I band at 1642 cm-1 indicates successful conjugation. 
 
 
 
     The degree of amine conjugation was estimated from the 1H NMR spectrum by 
taking the area ratio of methyl protons in segments with substitution (a′) to those 
without (a) (Figure 47c). These two peaks differentiate between carboxyl groups that 
had or had not been conjugated with amines. The degree of conjugation was estimated 
to be ~60% for B-4N, B-5N, B-6N, A-6N and C-6N. This was further corroborated by 
CHN elemental analysis (see methods). The thermal decomposition profile of the 
amine-conjugated polymers became more gradual (occurring over a span of 400°C) 
with an onset temperature of ~120°C (Figure 50b).      
 
7.4 Polymer B-6N has the strongest buffering capacity 
     To evaluate relative buffering capacity, polymers B-4N, B-5N and B-6N were all 
dissolved in water (0.5 mg/mL) and titrated against 0.01 M HCl. All titrations were 
carried out successively within the same day and with the same stock solution of HCl. 
The pH range examined was from 7.5 to 4.0 to mimic the endo/lysosomal transition 
during which early-stage endosomes mature and acidify into late-stage lysosomes. From 
Figure 52, it was observed that the volume of HCl required to acidify the polymeric 
solutions reduced from B-6N to B-5N to B-4N. This indicated that B-6N has the 
strongest buffering capacity per mg of polymer.                                      
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Figure 52. Buffering capacity of various polymer solutions when prepared at 0.5 mg/mL 
and titrated against 0.01 M HCl. The pH range examined spans the endo/lysosomal 
transition, during which early-stage endosomes acidify into late-stage lysosomes. 
 
 
 
7.5 Particle size, shape and surface charge of the PC nanoparticles  
     Nanoparticles were formed by dissolving the amine-functionalised PCs in water 
buffered at pH 5.0 or 7.0. Their hydrodynamic diameter and surface zeta potential were 
then measured. From Figure 53, it can be observed that a lower pH resulted in smaller 
particles. For instance, the size of pure B-6N particles was reduced from ~400 nm at pH 
7.0 to ~240 nm at pH 5.0. This may be due to the higher degree of protonation of the 
amines at a lower pH, consistent with the more positive zeta potential measured for B-
6N particles at pH 5.0 (+45 mV) compared to pH 7.0 (+20 mV). The increase in 
hydrophilicity may have led to a smaller size. At a fixed pH of 5.0, however, 
conjugation with a longer amine chain resulted in smaller particles – nanoparticles of B-
4N and B-5N were both larger than B-6N. This again may be due to a hydrophilicity 
effect and a longer amine chain seemed to impart a better hydrophilic/hydrophobic 
balance. As expected, the zeta potential of particles made from B-4N and B-5N were 
less positive than B-6N. SEM then showed that particles of B-6N were generally well 
dispersed and spherical in shape (Figure 54).  
 
     Polymer/DNA complexes were then prepared at different N/P ratios and subjected to 
size and zeta potential analysis. Compared to the pure polymer, size generally increased 
after DNA incorporation (Figure 53a). Due to charge neutralisation, the surface 
potentials of the complexes were also less positive (Figure 53b). 
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Figure 53. Particle size and surface charge of the polymeric particles measured by 
dynamic light scattering. a) Hydrodynamic diameters and b) surface zeta potentials of 
pure PC nanoparticles (Poly) and PC/DNA complexes fabricated at various pH and N/P 
ratios. Error bars represent standard deviation of triplicates. 
 
 
 
 
 
 
 
 
 
 
 
Figure 54. Morphology and size of the polymeric particles. Polymer B-6N nanoparticles 
were first deposited onto a Si wafer, air dried and then imaged using SEM. 
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7.6 Polymer B-6N can bind DNA most efficiently 
     The DNA binding ability of polymers B-4N, B-5N and B-6N was next evaluated. 
Polymer/DNA complexes were first formed at various N/P ratios and then subjected to 
agarose gel electrophoresis. As seen in Figure 55, a N/P of 100 was needed before B-4N 
could fully retard DNA migration. In contrast, B-5N could do so at N/P 50 while B-6N 
needed only a N/P of 25. Polymer B-6N therefore bound DNA most efficiently.  
 
 
 
 
 
 
 
Figure 55. DNA binding assay. Polymers B-4N, B-5N and B-6N were used to form 
complexes with DNA at the various N/P ratios indicated and then subjected to gel 
electrophoresis migration. DNA which was stably bound to the polymers gave no bands 
upon imaging.  
 
 
 
7.7 In vitro transfection efficiency of the PC vectors 
     Having shown that the polymers can stably bind DNA, we moved on to in vitro 
transfection experiments. Polymer/DNA complexes were formed and three cell lines – 
HEK293, HepG2 and 4T1 – were used for the initial screening of transfection efficiency 
and also to determine the range of effective N/P ratios (Figure 56). Polymers B-4N, B-
5N and B-6N were first compared. As observed from Figure 56a, luciferase expression 
became more significant at higher N/P ratios. Further experiments were therefore 
performed with a N/P of at least 100. With HEK293 and HepG2 cells, B-6N performed 
the best and could mediate a peak luciferase expression that was about 0.2 and 4 times 
that of PEI, respectively. In 4T1 cells, however, B-5N mediated the highest expression 
level which was about 7 times that of PEI. These observations may be explained by the 
superior buffering capacity and DNA binding ability of B-6N and B-5N compared to B-
4N, which itself can only mediate luciferase expression levels comparable to that of the 
naked DNA control.  
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     Based on these results, pentaethylenehexamine was chosen for further study and was 
conjugated onto polymer backbones with different molecular weights to afford two 
additional polymers: A-6N and C-6N. Compared to B-6N, both A-6N and C-6N 
consistently performed less efficiently in all cell lines tested. This suggests that within 
the molecular weight range studied, the properties of B-6N (Mw=12.8 kDa and Mn=12.0 
kDa by DMSO GPC) are optimal for the in vitro transfection of cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56. In vitro luciferase expression in a) HEK293 at low N/P ratio, b) HEK293 at 
high N/P ratio, c) HepG2 and d) 4T1 cells when transfected with various polymer/DNA 
formulations. Error bar represents standard deviation of quadruplicates. PEI was used at 
its optimal N/P ratios: N/P 10 for both 4T1 and HEK293, and N/P 20 for HepG2. 
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7.8 PC vectors are virtually non-toxic to cells 
     The amount of toxicity induced by the best polymer for each cell line (in terms of 
luciferase expression) was quantified using the MTT assay. As revealed by Figure 57, 
cell viability was in excess of 94% (for HEK and 4T1) and 88% (for HepG2) upon 
exposure to the polymer/DNA complexes under the same transfection conditions. This 
was in sharp contrast to PEI, which induced significant cytotoxicity (Figure 11).  
 
 
 
 
 
 
 
 
 
 
 
Figure 57. MTT viability assay. Viability of HEK293, 4T1 and HepG2 cells after 
exposure to polymer/DNA complexes (B-6N for HEK293 and HepG2; B-5N for 4T1). 
Error bar represents standard deviation of octuplicates. For both B-5N and B-6N, a final 
polymer concentration of 0.12 and 0.25 mg/mL will approximately correspond to N/P 
100 and 200 respectively. 
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7.9 PC vectors are still less efficient than peptide-derived vectors in transfecting MCEC 
     Finally, we compared the relative transfection ability of the PCs and peptide-derived 
vectors. Two of the best constructs from each class of vector (peptide F and I versus PC 
B-6N and C-6N) were selected to transfect the relevant MCEC line. As seen in Figure 
58, although the PC vectors are non-toxic to MCEC, they remain orders behind the 
peptides in luciferase expression efficiency. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 58. A comparison of the in vitro transfection ability of various novel 
formulations. Selected peptides (F and I), PC (B-6N and C-6N) and novel polymer 
P(MDS-co-CES) were directly compared in their ability to transfect MCEC. The a) in 
vitro luciferase expression efficiency and b) toxicity mediated by the various vectors are 
as shown. Error bar represents standard deviation of quadruplicates in a) and 
octuplicates in b). 
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8. Discussion (polycarbonate) 
     The peptides are efficient vectors. However, due to their large particle sizes, their 
systemic application appears unfeasible as they will most likely suffer from poor 
biodistribution. Further, they may cause blockade in small capillaries and are 
susceptible to rapid clearance from the body. The peptides may thus be limited to ex 
vivo applications. We were therefore motivated to develop an alternative vector whose 
particle size is smaller, well-defined and more suitable for in vivo applications. We 
became interested in polymeric systems because they offer great versatility in design 
and synthesis. We chose PCs because of its suitability as a biomaterial whose synthesis 
was facilitated by the identification of DBU as an efficient metal-free catalyst for the 
ROP of carbonate monomers. Moreover, PC vectors are relatively unexplored. 
Interestingly, a recent publication even reported that the backbone modification of PC 
with cationic chains for gene delivery was achieved for the first time (He et al., 2010), 
despite postdating our contribution (Seow & Yang, 2009a). 
 
     In this study, we chose the post polymerisation modification route, i.e., functional 
groups are added after polymerisation, as opposed to starting with pre-functionalised 
monomers. Therefore, a series of benzyl-protected PCs with increasing molecular 
weight (A-Bn, B-Bn, C-Bn) was first synthesised. The benzyl protection was then 
removed by catalytic hydrogenation to expose dangling carboxyl groups (A-COOH, B-
COOH, C-COOH) onto which a variety of aliphatic amines (triethylenetetramine to 
give B-4N, tetraethylenepentamine to give B-5N and pentaethylenehexamine to give B-
6N) was conjugated via DIC/NHS chemistry. The overall synthetic route is presented as 
Figure 45 and the physical properties of various polymers are summarised in Table 6.    
 
     Benzyl alcohol was the initiator and DBU was the anionic catalyst in the 
polymerisation reaction. Mechanistically, it was proposed that DBU donates its lone 
pair and hydrogen bonds with benzyl alcohol to activate it for the nucleophilic attack of 
cyclic monomers (Nederberg et al., 2007). Ideally, the desired molecular weight of the 
product can be achieved by controlling the initiator to monomer feed ratio. However, 
water molecules acting as competitive initiators can lead to unwanted chain initiation, in 
turn resulting in lower-than-desired molecular weight and higher PDI. Consequently, 
the ROP reaction was carried out under strict anhydrous conditions. For safety and 
convenience, this reaction was also carried out in solution at room temperature, rather 
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than in bulk where a high temperature is needed to melt all the reactants into their liquid 
phases for reaction. The broadening of polydispersity is also a risk of bulk 
polymerisation due to the relatively inefficient mixing of viscous reactants.  
 
     During optimisation of polymerisation conditions, samples were extracted after 
stipulated reaction time and analysed by GPC. It was observed that the molecular 
weight failed to increase significantly after 6 hours while PDI continued to broaden 
(data not shown). This can be explained by the occurrence of back-biting reactions, as 
also reported by researchers working with other carbonate monomers (Gonzalez-Vidal 
et al., 2008; Shen et al., 1999). A reaction time of 3 hours was finally chosen to achieve 
the desired molecular weight and polydispersity (PDI < 1.20). 
 
     The next step was to remove the benzyl protecting groups by hydrogenation. A 
reported concern of this reaction was intra-chain cleavage (Xie et al., 2008), which was 
not observed here as supported by the unimodal peak detected by GPC (Figure 49a). 
After hydrogenation, the polymer became a flaky semi-crystalline solid that was soluble 
only in polar solvents. It also had a prominent Tm endotherm (Figure 50a) that 
disappeared during the second DSC cycle. This indicates that the kinetics of crystal 
reformation was on a time scale longer than that of a typical DSC cycle.  
 
     A series of aliphatic amines were then successfully conjugated onto the carbonate 
backbone using DIC/NHS chemistry, as shown using NMR (Figure 47c and Figure 48c) 
and Raman spectroscopy (Figure 51). The amines contained a mixture of primary and 
secondary amino groups. It was intended that the latter would provide buffering 
capacity to facilitate endosomal escape, while the former would protonate in water for 
DNA binding (Wood et al., 2005). The amide bond is expected to be formed mainly at 
sites containing a primary amine (i.e., chain-end) as it is less sterically hindered and 
more reactive than the intra-chain secondary amines. Crosslinking was, however, a 
concern since there were two chain-ends per amine chain. Crosslinking is undesirable as 
it consumes the primary amines meant for DNA binding and also broadens the 
molecular weight distribution of the products. To minimise the occurrence of 
crosslinking, the following reaction conditions were used: 1) the amines were in 20× 
excess and 2) diluted in a large volume of solvent. 3) The order of addition was such 
that the activated-COOH polymers were dripped dropwise into the amine solution under 
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vigorous stirring. These measures increased the chance of PC chains reacting with free, 
instead of conjugated amine chains.    
 
     According to the NMR spectra, B-4N, B-5N and B-6N had similar degrees (~60%) 
of amine conjugation. Therefore, among the three polymers, B-6N should have the 
highest number of nitrogen atoms per backbone chain and, upon calculation, also the 
highest nitrogen weight percentage. The sensitivity needed to detect the differences in 
nitrogen weight percentages was, however, beyond the technique of elemental analysis.   
 
     The small differences in nitrogen content were nonetheless detected in the titration 
experiment. In this experiment, all polymers were dissolved to 0.5 mg/mL and the 
amount of HCl needed to bring the pH from 7.5 to 4.0 – mimicking the endo/lysosomal 
transition – was measured. At a given concentration, the number of available nitrogen 
atoms increased from B-4N to B-5N to B-6N. As expected, the amount of acid needed 
also increased, albeit modestly, in the same order (Figure 52). Evidently, B-6N has the 
largest buffering capacity per mg of polymer.  
 
     Particles were next formed using the various polymers and their sizes and surface 
potentials were measured (Figure 53). In general, a longer amine chain conjugated and a 
lower pH led to the formation of smaller particles with more positive surface potentials. 
Upon DNA binding, however, particle size increased and surface potential reduced.  
 
     Data suggests that nitrogen atoms are needed in large excess (at least N/P 100, 50 
and 25 for B-4N, B-5N and B-6N respectively) for the complete binding of DNA 
(Figure 55). We note that the N/P calculation includes all available nitrogen atoms, 
although only a proportion will be protonated at a given pH. Additionally, the amine 
chains may not be perfectly exposed on the particle surfaces for binding. These factors 
account for the apparent excess of nitrogen atoms required for complete DNA binding. 
 
     Three cell lines were then used to screen B-4N, B-5N and B-6N for transfection 
efficiency and also to determine the range of effective N/P ratios (Figure 56). It was 
observed that the minimum N/P ratio needed for complete DNA retardation was lower 
than that required for significant gene expression. For instance, B-6N could already 
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bind DNA at N/P 25 but gene expression peaked only beyond N/P 80. This suggests 
that complete DNA condensation alone is insufficient for significant protein expression.  
 
     Taken together, results demonstrate that selected PCs (B-6N and B-5N) mediated 
high levels of luciferase expression in the cell lines tested. Importantly, these results 
were obtained in the presence of serum, a condition typically associated with reduced 
transfection efficiency. While the high N/P ratio needed for transfection is probably a 
consequence of the imperfect contribution from all the nitrogen atoms, the polymers 
ultimately cause minimal cytotoxicity (Figure 57). Furthermore, being biodegradable, 
the accumulation of these polymers is not expected to be a major concern. 
 
     The molecular weight of the carrier was next optimised. Polymers A-6N, B-6N and 
C-6N were produced with similar degrees of amine conjugation but different backbone 
length. In Chapter one, it was mentioned that molecular weight can influence the 
strength of DNA binding and that a carrier which binds with moderate strength is ideal. 
While we do not have direct evidence that points to the modulation of DNA binding 
strength as a contributing factor, results nevertheless revealed that B-6N consistently 
mediated more gene expression than both A-6N and C-6N (Figure 56). This suggests 
that the molecular weight of B-6N presumably offers the best balance between DNA 
binding and release.     
 
     Using the relevant MCEC line, we compared two of the most promising PC vectors 
(B-6N and C-6N) against peptides F and I (Figure 58). As expected, the PCs caused 
virtually no toxicity but their transfection efficiencies were also orders lower than the 
peptides. The reason for the inability of the PCs to transfect MCEC is unclear. 
 
     We further surveyed another polymer – P(MDS-co-CES) – for the transfection of 
MCEC (Figure 58). P(MDS-co-CES) is a novel polymeric vector that was shown to be 
highly efficient in drug and DNA co-delivery in vitro and in vivo (Wang et al., 2006), 
and siRNA delivery in vitro (Beh et al., 2009). Indeed, the transfection efficiency of 
P(MDS-co-CES) micelles is significantly higher than the PCs. However, they cause 
substantial toxicity and are also not suitable for our application. 
 
 
Chapter nine: Conclusions 
 
 170
 
 
 
 
 
Chapter nine 
 
Conclusions 
 
Chapter nine: Conclusions 
 
 171
9. Conclusions 
     We have designed novel tri-block arginine-rich oligopeptides and demonstrated that 
they could efficiently mediate the expression of reporter genes (luciferase and GFP) in a 
variety of cell lines including MCEC. The presence of a hydrophobic block and a 
buffering component within the tri-block design were systematically shown to be 
important in influencing the transfection performance of the peptide. Importantly, we 
showed that the peptides could deliver plasmids encoding for IDO, a biologically 
relevant protein. IDO expression was detected in the MCEC cell line and actual corneal 
tissue samples at both the mRNA and protein level. The IDO expressed was also shown 
to be functionally active and capable of inhibiting CD4 T-cell proliferation. However, 
corneas which were transfected with peptides overnight or for four hours in the presence 
of chloroquine failed to prolong graft survival in our murine transplantation model 
relative to untreated controls. Toxicity following peptide-mediated transfection most 
probably abolished any beneficial effects due to the local overexpression of IDO. Future 
work should therefore focus on further reducing toxicity while boosting the transfection 
efficiency of this peptide carrier. 
 
     A potential limitation of the peptide carriers is their large particle size, which 
becomes problematic during in vivo applications. We therefore developed an alternative 
vector based on PC. Indeed, DNA complexes fabricated from PC were smaller (in the 
nm range) and more homogeneously distributed. Unfortunately, the PC vectors suffered 
from poor efficiency in transfecting MCEC and were not developed further.  
 
     An area that deserves more attention is the development of vectors that can bind 
nucleic acids using non-electrostatic forces, e.g., by hydrophobic forces or physical 
entanglement with flexible PEG chains. The stability and in vivo behaviour of such 
vectors then need to be thoroughly evaluated. Another challenge is to further improve 
strategies that are already in place to shield the cationic charges, e.g., by attaching PEG 
chains that are intracellularly cleavable so as to increase the circulation time of the 
complexes without compromising excessively on transfection efficiency. Advances in 
either will enable peptides or indeed, other classes of material to further realise their 
potential as non-viral vectors. 
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